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2 Abstract 
Depleted of dopamine, the dynamics of the Parkinsonian brain impact on both “action” 
and “resting” motor behaviour. Subthalamic nucleus deep brain stimulation (STN DBS) 
has become an established means of managing these symptoms, although its mechanisms of 
action remain unclear. Functional magnetic resonance imaging (fMRI) using the blood 
oxygen level dependent (BOLD) contrast provides the opportunity to study the human 
brain in vivo, collecting indirect measures of neural activity across the whole brain. To date, 
technical difficulties and safety concerns have precluded the use of fMRI in DBS patients. 
Previous work from this department has demonstrated that scanning patients with certain 
DBS systems and MRI equipment is both safe and feasible.  
This thesis explores the neuromodulatory actions of STN DBS on both action and resting 
motor behaviours in patients with Parkinson’s disease (PD) using fMRI. In brief, I present 
two fMRI studies conducted on STN DBS patients, one task-based, and one resting, 
collected under a previously approved protocol. I then present experiments exploring the 
safety of scanning DBS patients using an improved protocol, and then detail two further 
experiments collected under this new protocol, again one task-based, and one resting. 
Specifically, I employ statistical parametric mapping to determine DBS-induced changes in 
motor evoked responses. Using dynamic causal modelling (DCM) and Bayesian model 
selection, I compare generative models of cortico-subcortical interactions to explain the 
observed data, inferring which connections DBS may be affecting, and which modulations 
predict efficacy. I proceed to use stochastic DCM to model the modulatory effects of DBS 
on endogenous (resting-state) dynamics. 
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This work casts DBS in terms of modulating effective connectivity within the cortico-basal 
ganglia motor loops. I discuss how this may explain its current usage in PD, as well as 
exploratory uses to treat other pathological brain states. 
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If you're dumb, surround yourself with smart people. If you're smart, surround 
yourself with smart people who disagree with you. 
Isaac Jaffe in Sports Night, written by Aaron Sorkin, 1998. 
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5 Introduction 
Before concluding these pages, it may be proper to observe once more, that an 
important object proposed to be obtained by them is, the leading of the attention 
of those who humanely employ anatomical examination in detecting the causes 
and nature of diseases, particularly to this malady. By their benevolent labours 
its real nature may be ascertained, and appropriate modes of relief, or even of 
cure, pointed out. 
James Parkinson, An essay on the Shaking Palsy, 1817. 
Almost two centuries on from Parkinson’s first description of the “shaking palsy”, the 
causes and progression of Parkinson’s disease (PD), as well as its treatments, are still being 
investigated. Deep brain stimulation (DBS) has become an established treatment for 
advanced PD, and may prove an efficacious therapy for a variety of other neurological and 
psychiatric diseases. This thesis explores the mechanism underlying the therapeutic effect of 
DBS, with the ultimate goal of improving the clinical efficacy, and reducing side effects of 
DBS therapies. Given the extensive evidence for the beneficial effects of subthalamic 
nucleus (STN) DBS in the treatment of advanced PD, this work specifically addresses STN 
DBS, which typically improves motor impairment and quality of life substantially.  
This thesis details five experiments that were carried out over the past three years; two 
fMRI studies using a previously safety-tested scanning procedure, one set of experiments 
confirming the safety of an improved scanning procedure, and two further fMRI studies 
collected under the new procedure. The fMRI studies explore the physiological 
repercussions of therapeutic STN DBS in patients with advanced PD, either whilst 
performing voluntary movements, or whilst lying in the scanner with eyes closed (“at rest”). 
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The findings are duly discussed, and conclusions drawn about the neuromodulatory effect 
of DBS. 
This introduction is in five parts; Section 5.1 rehearses the fundamental principles of brain 
functional organisation and defines key concepts in neural architecture at the systems level. 
Section 5.2 discusses Parkinson’s disease, the functional anatomy of the basal ganglia and 
the repercussions of dopamine depletion. Section 5.3 explores the local neuroanatomy and 
histology of the STN, the surgical procedure and the clinical evidence for STN DBS. 
Section 5.4 reviews the neural response to DBS, including an in depth review of the 
neuroimaging literature investigating STN DBS (5.4.2), providing a context for my 
experiments. Section 5.5 introduces the safety of MRI in patients with implanted DBS 
devices. I conclude outlining the aims of this body of work (5.6). Introductions to the 
methods used throughout this thesis are outlined in Chapter 6. 
5.1 The functional architecture of the human brain 
DBS is an invasive procedure involving the stereotactic placement of an electrode targeting 
a deep brain structure. Before elaborating on how DBS may be achieving its therapeutic 
effect, it is important to introduce the fundamental principles of the functional architecture 
supporting behaviour, which will ultimately frame subsequent questions and experiments.  
Since the invention of phrenology by Franz Joseph Gall in the late 18th century, identifying 
brain regions with specific functions has become a central theme in neuroscience, and has 
arguably guided neuroimaging and ‘brain mapping’ over the past few decades. Centuries of 
scientific exploration have concluded that the functions cannot simply be localised to parts 
of the brain. Rather, the brain adheres to two fundamental and mutually dependable 
properties of functional organisation: (1) functional segregation, which states that the 
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cortical infrastructure supporting a behaviour or function involves multiple components 
that are specialised in processing task-relevant information, and are often spatially 
distributed; and (2) functional integration, which states that proper function is dependent 
upon optimal integration, or communication, of specialised components (Friston, 2011, 
1994). The specialisation of a given cortical region is dictated by its functional connections, 
and vice versa, thus any disturbance in either the viability of a specialised brain region, or 
the brain’s ability to integrate information, will lead to a disturbance of proper function. 
From a clinical perspective, this could produce signs, symptoms or a clinical phenotype. 
Early lesion studies and invasive electrical stimulation observations, as well as the more 
contemporary cartographic neuroimaging literature, has firmly established functional 
segregation as a principle of brain organisation. However, characterising functional 
integration, or connectivity, has proved more difficult to establish and assess.  
5.1.1 Brain connectivity: Concepts and nomenclature 
The 100 billion neurons that comprise the human brain do not work in isolation. 
Anatomically, these neurons form a relatively invariant structural architecture, upon which 
rests a dynamic, modular and hierarchical functional network, capable of the rich 
computations that underpin cognition.  
The cerebral cortex is organized horizontally into six laminae, each containing characteristic 
cell types with typical projection patterns. The smallest proposed vertically organised unit, 
the minicolumn (or microcolumn), typically contains 80-100 neurons (more in the striate 
cortex). Macrocolumns (or modules) comprise 60-80 minicolumns bound by short-
distance (intrinsic) horizontal connections, measuring 300-600 µm in diameter (i.e. 5-10 
macrocolumns would be expected in a typical 3mm isotropic voxel). Additionally, intrinsic 
connections project vertically between laminae within a given macrocolumn. In contrast, 
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extrinsic connections project to distant macrocolumns either in other cortical areas from 
layers II/III, or subcortical structures from layers V/VI (Buxhoeveden and Casanova, 2002; 
Mountcastle, 1997). 
The brain can be considered a large and densely connected network, composed of sub-
networks, which are themselves comprised of many sub-modules that compute lower-level 
operations (Buckholtz and Meyer-Lindenberg, 2012; Park and Friston, 2013). This 
conceptual hierarchy can be extended down to the neural level. The function of a module 
to is to integrate the computations of its sub-modules. For example, the primary motor 
cortex (M1) can be considered a sub-module of the motor network, but is comprised of a 
multitude of cortical columns encoding both low- and high-level kinematic features 
(Georgopoulos et al., 1986; Sergio et al., 2005). Defining a connection (or edge) in vivo has 
traditionally been more complicated than defining a component (or node) of a network; 
nodes are generally simply defined by functional specialisation, i.e. if they show significant 
changes in activity with the onset of a task/stimulus. 
It is thus important to establish a consistent nomenclature when referring to either different 
types of connections, or different methods of characterising connectivity. In this thesis, fMRI is 
the primary mode of data collection and the terms “extrinsic” and “intrinsic” connections 
are used in an anatomical sense; extrinsic connections are long range connections that 
connect two distant functional regions (e.g. neurons projecting from M1 to the putamen), 
usually mediated via white matter projections. In reality of course, each functional region is 
composed of a number of interconnected macrocolumns, which similarly project (to a 
greater or lesser extent) to a spatially segregated second functional region.  Connections 
within a given functional region are referred to as intrinsic connections and are recurrent, 
and mediated by GABAergic neural populations conferring a self-inhibition, in line with 
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the known functional anatomy of the neocortex (Bastos et al., 2012; Douglas and Martin, 
1991).  
I will refer to three characterisations of connectivity that are commonly discussed in the 
neuroimaging literature: 
1. Structural connectivity refers to the presence/abundance of physical extrinsic 
connections via white matter projections, usually inferred noninvasively using 
diffusion tensor imaging (DTI), which is unable to determine direction or 
differentiate excitatory or inhibitory connections. For this, some tracing techniques 
can be employed, but obviously are limited to post-mortem examination. 
2. Functional connectivity refers broadly to any statistical dependency between the 
functional time series of distant nodes. This is most commonly, and most simply a 
correlation between the BOLD signal of two regions (Biswal et al., 1995) or the 
coherence within a specific frequency band at distant electroencephalography 
(EEG) sensors. As before, this form of connectivity is symmetrical, and is unable to 
identify excitatory or inhibitory connections; simply that the functional signature of 
two regions is correlated. With regard fMRI data, analyses of functional 
connectivity include seed-voxel correlations, independent component analyses 
(ICA) & principle component analyses (PCA). This is discussed further in 6.6. 
Psychophysiological interaction (PPI) analyses (Friston et al., 1997) are examples of 
context-dependent connectivity, which some regard as effective connectivity given 
they are regression-based. Others believe they fall somewhere in between functional 
and effective connectivity given PPIs can be conceptualised as context-dependent 
correlations between BOLD data at distant nodes. 
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3. Effective connectivity is defined as the influence one neural population exerts on 
another under a particular network model of causal dynamics that is parameterised 
in some way. In this work, the parameters representing connection strengths are 
referred to as coupling parameters. In contrast to functional connectivity, effective 
connectivity describes directed connections, which may be context-sensitive, and 
can be either excitatory or inhibitory. For our purposes, coupling can either be (1) 
“driving”, in other words, the input defines the receptive field of the node, or (2) 
“modulatory”, where the input alters the effectiveness of the drive, without 
influencing the receptive field (Crick and Koch, 1998; Sherman and Guillery, 
1998). This can be conceptualised as a gain modulation of the target. Analyses of 
effective connectivity include Granger causality modelling (Granger, 1969), 
structural equation modelling (McLntosh and Gonzalez-Lima, 1994), and dynamic 
causal modelling – DCM (Friston et al., 2003). The work presented herein employs 
DCM and PPI, both of which are discussed in detail in 6.5 & 6.6. 
Equipped with these definitions and conceptual perspective of brain function, we turn our 
attention to PD and the repercussions on the motor system and basal ganglia. 
5.2 Parkinson’s disease, basal ganglia physiology and 
pathophysiology 
The first symptoms perceived are, a slight sense of weakness, with a proneness to 
trembling in some particular part; sometimes in the head, but most commonly 
in one of the hands and arms. 
James Parkinson, An essay on the Shaking Palsy, 1817. 
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5.2.1 Overview and clinical presentation 
Idiopathic PD is a progressive neurodegenerative disorder primarily affecting motor 
control. As the disease advances, non-motor symptoms commonly manifest, impacting on 
domains such as cognition, sleep, and autonomic control. Patients characteristically present 
with asymmetric motor symptoms, affecting both motor behaviours at rest, as well as motor 
behaviours on action. The cardinal clinical signs include; (1) “pill rolling” resting tremor of 
frequency approximately 4-6Hz, (2) akinesia, (3) “lead-pipe” rigidity, i.e. velocity 
independent increases in muscle tone, and (4) impairment of posture and balance. Akinesia 
describes many clinical features that can be roughly divided into hypokinesia, and 
bradykinesia. Hypokinesia describes the reduction in frequency and amplitudes of everyday 
movements. Examples include reductions in arm swing, stride length, and blinking rate, as 
well as micrographia and hypomemia. Bradykinesia describes slowness of movements, and 
fatigability of repetitive movements. In addition, patients commonly display gait and 
balance impairment, stooped posturing, and hypophonia (Rodriguez-Oroz et al., 2009).  
PD is caused by the degeneration of dopaminergic (DA) neurons in the pigmented 
brainstem nuclei, particularly the substantia nigra pars compacta (SNc). The remaining 
SNc neurons display distinctive intraneuronal inclusion bodies, known as Lewy bodies, 
formed of misfolded proteins; specifically, the pre-synaptic protein alpha-synuclein (Braak 
et al., 2003). Post-mortem examinations reveal that 76% of patients with parkinsonism 
display this pathology, the remainder showing SN loss without Lewy body deposition 
(Hughes et al., 1992; Rajput et al., 1991). 
Diagnosis is clinical, based largely on a consistent patient history and clinical signs. 
Dopamine transporter (DAT) scans using the radiopharmaceutical Ioflupane ([123I]FP-
CIT) can aid diagnosis. Ioflupane has a strong affinity for pre-synaptic dopamine 
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transporters and decays to emit gamma radiation, which can be detected using single 
photon emission tomography (SPECT) imaging. PD patients show characteristic 
reductions in DAT binding in the striatum, particularly in the putamen secondary to 
dopaminergic denervation (Scherfler et al., 2013; Tatsch and Poepperl, 2013).  
Management of PD patients involves a multidisciplinary team consisting of neurologists, 
physiotherapists, speech and occupational therapists, and at later stages, urologists, 
neuropsychologists and neurosurgeons. Initial management is usually some form of 
pharmacological replacement of DA, either using the DA precursor drug L-dopa, or using 
agonists of the DA receptors (e.g. ropinirole, pramipexole). A host of other agents are often 
co-prescribed, either with the intention of reducing the peripheral side effects of, and 
boosting central DA uptake (e.g. Dopa decarboxylase inhibition using carbidopa; COMT 
inhibition using entacapone), or reducing DA breakdown (e.g. monoamine oxidase-B 
inhibition using rasagiline). Other agents such as anti-cholinergics, beta-blockade and 
amantadine are also often utilised. 
Most patients display significant initial improvements with medical therapy, particularly L-
dopa; failure to respond should prompt reconsideration of the diagnosis (Cotzias et al., 
1967; Hughes et al., 1992; Rascol et al., 2000). However, a large proportion of patients 
develop long-term motor complications following chronic medical therapy (Ahlskog and 
Muenter, 2001; Rascol et al., 2000). Specifically, the response to L-dopa becomes 
progressively more erratic and unpredictable, making it impossible for patients to go about 
their daily lives, and significantly impairs their quality of life.  
Patients with such fluctuations are considered to have advanced disease, and may benefit 
from neurosurgical intervention, specifically DBS. Before considering the details of DBS, it 
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is valuable to familiarise oneself with the relevant neuroanatomy, and functional circuits 
that are routinely targeted. 
5.2.2 Functional anatomy of the basal ganglia 
The basal ganglia (BG) are a group of subcortical nuclei deep in the cerebrum with no 
direct sensory inputs, and no direct motor output to the spinal cord (Rothwell, 1994). The 
major components of the BG include the (1) striatum, which is divided by the internal 
capsule into the caudate nucleus and putamen, (2) the globus pallidus (GP), which is 
divided by the medial medullary lamina into internal (GPi) and external (GPe) segments, 
(3) the STN, and (5) the substantia nigra (SN), which can be roughly divided into a pars 
reticulata (SNr), and the SNc. In reality, there is dense and reciprocal structural 
connectivity linking almost all of these nuclei. The following description concentrates on 
the key pathways discussed in the literature. In humans, the GPi and SNr are considered 
functionally analogous, both acting as the major outputs of BG circuits.  
The striatum acts as the input nucleus of the BG, whose GABAergic medium spiny 
neurons (MSNs; also known as spiny projection neurons, SPNs) receive divergent and 
convergent glutamatergic inputs from almost all of the cortical mantle (Kress et al., 2013; 
Shepherd, 2013). MSNs possess extensive dendritic trees; cortical afferents synapse distally 
on the dendritic tree, on the tips of dendritic spines. However, MSNs have their excitability 
regulated by fast-spiking inhibitory interneurons, whose synapses land perisomatically, 
resulting in very little baseline activity despite the dense glutamatergic drive from the 
cortex. There are two types of MSNs, differing in electrophysiological properties, 
projection target and expression of neuropeptides and DA receptors. Five G-protein 
coupled receptors mediate DA signalling, all of which are expressed in the striatum, but 
subtypes 1 and 2 are most abundant. MSNs expressing DA receptor subtype 2 (D2R), 
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which inhibits intracellular adenyl-cyclase through G-protein signalling, project to the GPe 
and form the proximal limb of the indirect pathway. Those expressing the D1R, which 
activates adenyl-cyclase signalling, project to the output nuclei forming the direct pathway 
(Lanciego et al., 2012). 
SNc DA neurons project to the striatum and synapse with MSNs at the dendritic spine 
base, and are thus, morphologically, in a position to modulate the gain of incoming cortical 
transmission. Nigrostriatal axons innervate both subpopulations of MSNs, producing 
opposing effects on their activity, as a result of their heterogeneous receptor expression 
(Surmeier et al., 2007); DA typically reduces the excitability of D2R MSNs, and increases 
the excitability of D1R MSNs (Albin et al., 1989).  
MSNs projecting to the GPe synapse on a pool of fast-firing GABAergic neurons, which in 
turn project to the STN. The GPe is also in receipt of reciprocal connections from both the 
STN and GPi (Nambu et al., 2000). The anatomy of the STN (and its surroundings) is 
discussed later. In brief, the STN is the only glutamatergic BG nucleus, and also receives its 
own cortical afferents via the hyperdirect pathway, its name reflecting the relatively faster 
conduction time to reach the output nuclei compared to the direct or indirect pathways 
(Nambu, 2005; Nambu et al., 2002). Neurons of the STN project back to the GPe, as well 
as to the output nuclei - forming the final limb of the indirect pathway.  
Like the neurons of the GPe, GPi/SNr neurons are GABAergic. Their major efferent 
projection is to the VA and VL thalamic nuclei, terminating mainly on thalamo-cortical 
projection neurons such that electrical stimulation of the output nuclei produces a 
monosynaptic inhibition of the thalamo-cortical projection neurons. In addition, GPi/SNr 
neurons project to the centromedian thalamic nucleus, habenula, pedunculopontine 
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tegmental nucleus, and superior colliculus, as well as contralateral VA/VL thalamic nuclei 
(Parent and Hazrati, 1995a). The neurons of the VL thalamus in turn project back to the 
cortex, closing the cortico-striato-thalamo-cortical loop. 
It was first proposed that this loop served to integrate diverse cortical inputs, “funnelling” 
information, via the VL thalamus, specifically to M1 (Kemp and Powell, 1971). However, 
contemporary understanding is that at least five parallel loops pass through the BG, each 
with distinct (but overlapping) cortical sources and targets. Each circuit typically has 
multiple cortical inputs of similar functional specialisation, projecting to the striatum, but 
only one of them receives the majority of the output from the VL thalamus (Alexander et 
al., 1986). Functionally, two are thought to involve skeletomotor (M1) and oculomotor 
areas (FEF) of cortex, and three target non-motor frontal cortex (dorsolateral prefrontal 
cortex - DLPFC, orbitofrontal cortex - OFC and anterior cingulate cortex - ACC). At each 
structure in the loop, these circuits are thought to be partially3 anatomically segregated, and 
somatotopically organised. Regarding the motor circuit, cortical sources include M1, S1, 
PM and SMA, primarily projecting to the putamen as opposed to the caudate nucleus 
(Künzle, 1978, 1975) – these initial observations have recently been replicated using DTI 
(Tziortzi et al., 2014). The cortical target however is primarily thought to be the SMA, 
which in turn projects to other cortical motor regions, as well as down the pyramidal tract 
(Alexander et al., 1986). See Figure 5.1 (over-leaf). 
                                                   
3 While the circuits are largely segregated, at each point in the circuit activity within the loop can 
be modulated by the activity of “neighbouring” loops (Redgrave et al., 2010). 
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Figure 5.1 The basal ganglia parallel loops & direct and indirect pathways. (A) The five loops of 
the BG outlined by Alexander et al., 1986; motor, oculomotor, DLPFC, OFC, ACC circuits, 
including the anatomical portion of the respective striatal, pallidal and thalamic nodes they pass 
through. Red arrow = glutamatergic projections, Blue arrow = GABAergic projections, Green 
dotted arrow = DAergic projections. (B) Summary of the three classic pathways from cortex to 
thalamus. The two pools of MSNs labelled (1) project directly to the GPi, and (2) project 
polysynaptic to the GPi via the GPe and STN. Purple arrows show the direction of ‘activity’ in 
the thalamus following cortical stimulation flowing through the three pathways (according to 
classic rate based BG models). Abbreviations not used in text body: b = body, h = head, FEF = 
frontal eye fields, MDpl = medialis dorsalis pars paralamellaris, MDmc = medialis dorsalis pars 
magnocell ularis, MDpc = medialis dorsalis pars parvocellularis, VAmc: ventralis anterior pars 
magnocellularis; Vapc: ventralis anterior pars parvocellularis; VLm: ventralis lateralis pars 
medialis; VLo: ventralis lateralis pars oralis; VP: ventral pallidum; VS = ventral striatum, c1- = 
caudolateral; cdm- = caudal dorsomedial, dl- = dorsolateral, 1- = lateral, Idm- = lateral 
dorsomedial, m- = medial, mdm- = medial dorsomedial, pm- = posteromedial, rd- = 
rostrodorsal, r1- = rostrolateral, rm- = rostromedial, vm- = ventromedial, vl- = ventrolateral. 
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From a functional perspective, a large and growing literature has mapped aspects of 
associative learning, goal-directed and habit behaviour control to the cortico-BG system. 
To summarise, lesion and electrophysiological data from rodents (Yin and Knowlton, 
2006) and non-human primates (Miyachi et al., 1997), as well as functional imaging in 
humans (Lehéricy et al., 2005), have demonstrated that the parts of the striatum in receipt 
of associative projections are necessary for (or show increased activity during) goal-directed 
control, whereas the motor striatum mediates stimulus-response habitual control. The 
elaborate intrinsic architecture of the circuits, and the qualitative similarity between loops, 
have led many to suggest the BG serve a generic selection function, with associative circuits 
acting to select the most appropriate from a number of mutually exclusive behaviours 
(possibly by comparing the utility of predicted outcomes) to yield a goal-directed action, 
whereas motor loops may select from a host of possible stimulus-response options 
(Redgrave et al., 2010). 
5.2.3 The impact of dopamine depletion 
Patients presenting with clinical signs of PD are thought to have already lost ~50% of their 
SNc neurons, and 80% of their striatal DA (Fearnley and Lees, 1991). PD signs fit well 
with the early anatomical models of the BG (Albin et al., 1989; DeLong, 1990). Put 
simply, DA depletion results in under-stimulation of the direct pathway, and over-activity 
in the STN and GPi, suppressing output to the cortex, producing a lack of movement. 
However, a number of inconsistencies in the model have since been pointed out, including 
reports that increased firing in the STN & GP are associated with PD improvements in 
primate models (Hashimoto et al., 2003), as well as findings that pallidotomies improve 
dyskinesia (despite theoretically reducing disinhibition of the thalamus), and 
thalamotomies do not worsen PD (Quiroga-Varela et al., 2013). 
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Most of our knowledge regarding the neural response to DA depletion either comes either 
from animal models of PD (primarily the OHDA rat, and MPTP primate4), or from 
recordings either during DBS surgery or from the electrodes themselves before patients 
receive their implantable pulse generators (IPG). It is important to remember that patients 
undergoing DBS are those with advanced PD (on average, 14 years post-diagnosis), and 
thus have extensive DA degeneration. On the other hand, these patients are typically DA-
responsive, enabling characterisation of DA-dependent physiology. 
Spectral analysis of local field potential (LFP) recordings from the STN of DBS patients 
reveal highly consistent peaks in beta (13-35Hz) band activity (Little and Brown, 2012), 
that is most prominent in motor STN territories (Stein and Bar-Gad, 2013), that 
desynchronises upon administration of DA (Hammond et al., 2007), and is replaced by 
increased power in the theta (4-7Hz) and gamma (30-70Hz) bands (Brown et al., 2001). 
These changes have also been recorded in STN single units (Levy et al., 2002), MUA 
(Weinberger et al., 2006), BUA5 (Moran et al., 2008), as well as in M1 using EEG 
(Silberstein et al., 2005) and electrocorticography (ECoG) (N. Mallet et al., 2008). Beta in 
the STN and cortex desynchronises in preparation of, and during movements, leading 
some to suggest beta to be a functional signature of promoting “the status quo” at the 
expense of voluntary movements, potentially due to a loss of computational capacity, or 
information coding space associated with oscillatory activity (Brittain and Brown, 2014; 
Brittain et al., 2014).  
Human functional imaging using pharmacological manipulations in PD patients, or 
comparing them to control populations, has provided further insights particularly into the 
                                                   
4 See List of Abbreviations for full chemical names of OHDA and MPTP neurotoxins. 
5 See section 6.2.2 for description of multiple and background unit activity (MUA and BUA). 
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cortical sequelae of DA depletion. A series of papers by David Eidelberg’s group have 
demonstrated a reproducible metabolic profile associated with PD, characterised by 
increased metabolic activity in the BG, thalamus and cerebellum, and relatively decreased 
activity in the premotor (SMA/PM) and parietal cortices, correlating with clinical measures 
of akinesia and rigidity (Spetsieris and Eidelberg, 2011). Furthermore, PD patients show an 
increased expression of a normal movement related metabolic pattern (i.e. increases in M1, 
premotor cortices and cerebellum) whilst at rest, but not during movement (Ko et al., 
2013). 
5.3 STN DBS 
Electrical stimulation has long been used as a means of exploring brain function. While 
reports of the therapeutic effects of stimulation date back as far as the 1960s, it was not 
until relatively recently that the true value of DBS was realised (Hariz et al., 2010). In 
1987, Benabid et al. implanted a series of tremor-dominant PD patients with electrodes 
targeting the ventralis intermedius nucleus of the thalamus (Vim). They found that chronic 
130Hz stimulation reduced tremor in a similar manner to therapeutic thalamotomy 
(Benabid et al., 1987). Following the discovery of the primate MPTP model of PD (Burns 
et al., 1983), neurophysiologists began characterising neural firing rates throughout the BG 
network. This led to the discovery that STN neurons displayed increased firing rates in the 
Parkinsonian state, and subthalamotomy in these primates produced improvements in all 
major contralateral motor disturbances (Bergman et al., 1990). It was later shown that 
similar improvements could be achieved using chronic stimulation, once again 
demonstrating the similarities between stimulation and ablative procedures (Benazzouz et 
al., 1993).  
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Within a few years, these findings began to have implications on clinical practice. In 1995, 
The Lancet published a seminal case series of akinetic-rigid PD patients receiving bilateral 
STN DBS. Stimulation produced marked improvements in tremor, bradykinesia, and 
rigidity (Limousin et al., 1995). Since then, STN DBS has been increasingly adopted, and 
has become an accepted treatment for advanced PD. This section briefly reviews the 
anatomy, histology, physiology and pharmacology of the STN, and the clinical efficacy of 
STN DBS.  
5.3.1 Neuroanatomy and electrical fields: What are we “stimulating”? 
The STN is a biconvex (almond-shaped) grey matter nucleus lying in a double-oblique plane 
in the midbrain; its superior pole is both lateral and posterior to its inferior one. From 
superior to inferior pole, the STN is approximately 10mm. Estimates of volume vary 
slightly in the literature; limited post-mortem data suggest ≈ 120mm3 (Hardman et al., 
2002), while most others agree a volume of 175 ±20.3 mm3 (Lambert et al., 2012; 
Lévesque and Parent, 2005). 
One convex surface faces anterior, lateral and inferior (STNali), whereas the other surface 
faces posterior, medial, and superior (STNpms). Laterally, the STNali abuts the crus cerebri 
superiorly (separating it from the GPi), ansa lenticularis (white matter bundle running from 
the GPi to the VA/VL thalamus), and SN inferiorly. The STNpms borders the lenticular 
fasciculus medially, zona incerta (ZI) superiorly (separating it from the thalamic fasciculus 
and thalamus), and the hypothalamic area inferiorly. The ansa lenticularis and lenticular 
fasciculus project independently from the GPi before merging into the thalamic fasciculus, 
terminating in primarily the VLa, VApc, and VM nuclei of the thalamus. The 
cerebellothalamic fasciculus, which sits inferior to the thalamic fasciculus however, projects 
from the cerebellar nuclei and targets primarily the VLp nucleus of the thalamus 
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(equivalent to Vim thalamus in Hassler’s nomenclature) (Gallay et al., 2008). If one were 
to consider brain regions that are either directly within millimetres of the electrode itself, or 
are in direct receipt of projections carried in white matter bundles passing around the 
electrode, it is easy to imagine that multiple subcortical nuclei are likely to be directly 
manipulated, with unknown effects on how those regions process their afferents from 
distant regions (e.g. the cortex), or whether these effects are reflected in their efferent 
projection.  
Computational models of the electric field generated by therapeutic DBS parameters 
suggest that current is not purely limited to the body of the STN. Field patterns are 
dependent on the anisotropy of conductivity tensors of the surrounding anatomy. Using 
tensors derived from DTI (Tuch et al., 2001), fields were found to extend into the ZI, 
fields of Forel and internal capsule (McIntyre et al., 2004a). While spreading to the internal 
capsule can evoke clinically recognisable effects (tonic muscle contractions – usually of the 
face), it remains unknown what results from stimulating the smaller tracts. One recent 
study proposes spread to the cerebellothalamic fasciculus may underlie stimulation-induced 
dysarthria (Aström et al., 2010). Such studies highlight the possibility that some of the 
adverse effects of DBS may result from collateral damage; i.e. modulation of structures 
neighbouring the target. 
The neurons of the STN itself are primarily glutamatergic, with a small GABAergic 
population accounting for ~7.5% of total neurons (Hamani et al., 2004; Lévesque and 
Parent, 2005). Primate tracing studies (Carpenter and Strominger, 1967; Haynes and 
Haber, 2013; Parent and Hazrati, 1995b; Whittier and Mettler, 1949), and recently, high 
resolution DTI in human subjects (Brunenberg et al., 2012; Forstmann et al., 2012; 
Keuken et al., 2013; Lambert et al., 2012) have revealed the structural connectivity profile 
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of the STN. The STN mostly receives projections from the cerebral cortex and GPe. 
Additionally, the STN receives axons from the centromedial, parafascicular and 
venteroanterior thalamic nuclei, the substantia nigra, and the pedunculopontine tegmental 
nucleus, although the functional relevance of these sparser connections remains unknown. 
Cortical afferents form the hyperdirect pathway (see section 5.2.2), originating from mostly 
frontal regions including M1, SMA, pre-SMA, FEF, DLPFC, and ACC. Additionally, the 
STN receives afferents from S1 and the insula cortex. Lambert et al. recently reviewed 130 
STN tracing articles published between 1947 and 2011; their results are summarised in the 
ideogram below (Lambert et al., 2012). 
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Figure 5.2 Taken from (Lambert et al., 2011). Ideogram of afferent and efferent anatomical 
connections of the STN reported in the literature between 1947 and 2011. Red represents 
afferent, blue efferent. Several papers report on a structure called the parasubthalamic nucleus at 
the STN’s medial border; these connections are included separately. The width of the lines 
represents the normalised proportion (as a percentage) of the respective connections; see (Lambert 
et al., 2011) for more information. 
The structural connectivity signature has led some to suggest that the STN can be 
parcellated into motor, limbic and associative subdivisions, with greatest clinical efficacy, 
and minimal side effect risk presumed to be associated with targeting the motor-STN 
(Haynes and Haber, 2013; Lambert et al., 2012; Parent and Hazrati, 1995b; Welter et al., 
2014). As discussed though, the stimulation field is likely to extend beyond the borders of 
the STN itself, let alone its putative subdivisions. As a result, efforts have been made to 
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shape the field to avoid limbic and associative domains. Subtle improvements in cognitive-
motor dual task performance have been reported using field shaping (Butson et al., 2007; 
Frankemolle et al., 2010; Mikos et al., 2011).  
5.3.2 Surgical procedure and between-centre variability 
Surgical procedure varies between centres, and is likely responsible for some between-centre 
variability in targeting accuracy, risks of haemorrhage and infection, and 
electrophysiological findings. Typical electrode implantations at the National Hospital for 
Neurology and Neurosurgery proceed as follows:  
1. Pre-operative stereotactic MRI under general anaesthesia to localise the target 
nuclei.  
2. Trajectory planning using commercially available software (FramelinkTM, 
Medtronic, Minneapolis, Minnesota). 
3. Validation of trajectory using manual calculation from frame fiducials. 
4. Trajectory correction based on audited accuracy data. 
5. Exposure of the cranium, drilling the burr hole, and coagulation the dural and pial 
membranes at the calculated stereotactic entry point on one side,  
6. Dynamic impedance monitoring using a blunt-tip radiofrequency (RF) electrode 
along the trajectory to the target, confirming the path does not enter the ventricle, 
and reaches grey matter. 
7. Removal of the RF electrode and ‘soft’-passing of a quadripolar DBS electrode 
along the track created by the RF electrode. Anchoring of electrode to burr hole 
cover.  
8. Steps 5-8 are repeated if electrodes are implanted bilaterally. 
9. Post-operative stereotactic MRI to verify electrode location within the target.  
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The procedure has been highly finessed and employs a number of measures to maximise 
target accuracy (e.g. trajectory validation and correction, minimising pneumocephalus and 
CSF leak to reduce brain-shift). Perhaps more importantly, this procedure enables most 
bilateral implantations to only require two deep brain ‘passes’ (one for each hemisphere), 
reducing the risk of haemorrhage. This is in contrast to many centres utilising intra-
operative electrophysiology, requiring multiple brain passes to select an appropriate 
electrode target.  
5.3.3 DBS hardware & stimulation parameters 
In this centre, patients are typically implanted with Medtronic DBS systems. Each DBS 
system comprises at least three implanted components; (1) the electrodes (‘leads’), (2) an 
IPG or ‘pacemaker’, and (3) extension cables connecting the IPG to the electrodes. All 
components contain some metallic materials including platinum-iridium, stainless steel, 
titanium and silver as part of the conducting circuit or casing. Four metal contacts lie at the 
end of each electrode (thus ‘quadripolar’), in contact with the target neural tissue. 
Successful surgery typically results in at least one contact lying within the body of the target 
nucleus, in the case of the STN, typically two. Following recovery, a voltage is induced 
either between a contact and the IPG case (monopolar stimulation) or between two 
adjacent contacts (bipolar stimulation), causing current to flow through the target tissue.  
The type of stimulation employed, and the parameters of stimulation determine the 
properties of the current field produced. Stimulation parameters that are commonly 
optimised include the amplitude (i.e. the magnitude of the induced voltage, typically 2-3V 
in STN DBS for PD), frequency (i.e. the rate of pulse delivery, typically 130Hz), and the 
pulse width (i.e. the length of each stimulation pulse, typically 60µsec). 
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Figure 5.3 The Medtronic 3389 electrode used in DBS patients studied in this thesis. The 
deepest most distal contacts are 0 and 8.  
5.3.4 Clinical efficacy in Parkinson’s disease 
STN DBS has become an established treatment for patients with advanced PD. Following 
two case series documenting off-medication improvements (1) in clinical rating scales 
(Unified Parkinson’s Disease Rating Scale; UPDRS), (2) activities of daily living, and (3) 
reductions in medications at 1 year follow up (Limousin et al., 1998, 1995), continuing to 
five years (Krack et al., 2003), randomised control trials have demonstrated STN DBS to 
be superior to medical therapy alone in patients with advanced disease (disease duration 
~13 years) and severe motor symptoms (Deuschl et al., 2006). STN DBS is most effective 
at improving off-medication motor impairment, reducing UPDRS-III (indexing motor 
impairment) by 54% at five years (Krack et al., 2003). Given its invasive nature, serious 
adverse effects are more common with STN DBS than medical therapy alone; the key risks 
of surgery are intracerebral haemorrhage, infection and peri-operative neuropsychiatric 
disturbances. Stimulation-related side effects can include speech disturbance (many report 
STN DBS worsens verbal fluency scores (Merola et al., 2013)) dyskinesia, eyelid apraxia, 
and freezing of gait. Targeting the STN as opposed to GPi produces similar (Follett et al., 
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2010), if not superior motor effects (Odekerken et al., 2013). The matter of side effects 
profile has long been debated, the latest trials suggesting any differences are not statistically 
significant (Odekerken et al., 2013). STN DBS has recently been shown to be superior to 
medical therapy alone in PD with early motor complications (i.e. disease durations ~7.5 
years), producing similar improvements to those seen in patients with advanced disease 
(Schuepbach et al., 2013). 
 
Figure 5.4 Clinical efficacy of STN DBS. Plot and caption taken from Krack et al., 2003. 
5.4 The neural response to STN DBS  
5.4.1 Neuroimaging & DBS: PET, SPECT and fMRI 
Neuroimaging offers whole-brain in vivo assays of brain function. While these studies 
sacrifice the rich temporal resolution afforded by electrophysiological techniques and rely 
on inferences made on indirect measures of neural activity (e.g. regional cerebral blood flow 
– rCBF; blood oxygen level dependent signal - BOLD), neuroimaging provides a non-
invasive measure of global activity. This is an important strength given the likely diffuse 
effects of electrical stimulation. While it is common practice to use functional magnetic 
resonance imaging (fMRI) in cognitive neuroscience, most neuroimaging exploring DBS 
employ either positron emission tomography (PET) or single photon emission tomography 
(SPECT); both are nuclear medicine techniques requiring intravenous 
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radiopharmaceuticals. The physiological basis of neuroimaging signals is an expansive topic, 
and has been discussed at length (Attwell and Iadecola, 2002; Logothetis and Wandell, 
2004). For completeness, I provide a brief overview of the techniques relevant to the DBS 
literature. As the predominant form of data collection in this thesis, fMRI is also discussed 
in detail in section 6.2. 
Both PET and SPECT require injection of a radiopharmaceutical, a waiting period for the 
pharmaceutical to accumulate in the tissue of interest, and then collection of a signal that is 
in some way caused by the decay process of the radioactive label. PET detects pairs of 
gamma rays travelling in opposite directions emitted from the annihilation of an electron 
and a positron, which is emitted from the radiopharmaceutical as it undergoes beta decay. 
In contrast, SPECT uses a gamma camera to detect gamma rays directly emitted from the 
radiopharmaceutical as it undergoes gamma decay. The type of data acquired from these 
scans thus depends entirely on the radio-labelled ligand used. Typically, the DBS literature 
employs radioligands that either quantify rCBF, rCGM, dopamine receptor binding 
potential, or dopamine transporter (DAT) concentration. Table 5.1 summarises the key 
radiopharmaceuticals used to study the effects of DBS. 
Functional MRI differs from the aforementioned methods in a number of important ways. 
Firstly, fMRI typically does not require the injection of a contrast material, and does not 
rely on radiation exposure, minimizing any radiation exposure. Secondly, fMRI has 
significantly improved spatial and temporal resolutions; this is particularly useful when 
scanning small structures such as the BG, or measuring the response to individual events, as 
opposed to blocks of events. Thirdly, fMRI is (relatively) widely available, requiring (only) 
a MRI scanner, and is significantly less expensive, given it does not require the preparation 
of radiopharmaceuticals.  
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Name Quantifies Description 
H2[15O] PET rCBF Radio-labelled water molecule used as a proxy for 
regional cerebral blood flow. Highly transient signal. 
[99mTc]-ECD SPECT rCBF Small lipophilic molecule that crosses the blood brain 
barrier. Used for as a proxy for regional cerebral blood 
flow. Highly transient signal. 
[18F]DG PET rCGM Radiolabelled glucose molecule. Glucose is key for 
neural metabolism, and is thus used as a proxy for 
metabolism. 
[11C]-Raclopride PET D2R binding Radiolabelled D2R antagonist with lower affinity to 
receptor than DA. When DA is released from 
presynaptic terminals, Raclopride is displaced from D2R. 
Therefore, low binding means high DA binding. 
[123I]FP-CIT SPECT DAT 
concentration 
Known commercially as DaTSCAN. Has a high binding 
affinity for presynaptic DA transporters on nigostriatal 
DA neurons. 
Table 5.1: Commonly used nuclear medicine techniques in the DBS literature. rCBF = regional 
cerebral blood flow; rCGM = regional cerebral glucose metabolism; DAT = dopamine 
transporter. 
5.4.2 Review of the neuroimaging literature 
A MEDLINE search was used to identify all neuroimaging studies exploring the effect of 
specifically STN DBS on neural activity published in peer-reviewed journals between 1987 
and 1st January 2014 using the following search terms: ("DBS" OR "stimulation" OR "deep 
brain stimulation") AND ("STN" OR "subthalamic") AND ("fMRI" OR "functional 
magnetic" OR "PET" OR "positron emission" OR "SPECT" OR "single photon" OR "ASL" OR 
"arterial spin label*" OR "cerebral activity" OR "blood flow") AND ("1987/01/01"[Date - 
Publication] : "2014/01/01"[Date - Publication]). Article abstracts were examined to exclude 
any non-relevant papers. Reference lists of the remaining articles were searched for any 
additional relevant papers not found in the initial search. Single case reports were not 
included unless they concerned STN DBS fMRI.  
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In summary, 7 studies concerned potential confounds of DBS neuroimaging (peri-
operative period, haemodynamic coupling), 8 studies examined the effect of STN DBS on 
striatal DA, 3 reported results in animal models of STN DBS, and the remainder explored 
the effect of STN DBS on regional activity. Only 6 human studies used fMRI, the others 
either PET or SPECT; 37 of which were task-based, and 21 explored endogenous activity. 
Of the task-based studies, 15 concerned the motor system, the rest studied the effects of 
STN DBS on cognitive function, which are not reviewed here. 
5.4.2.1 Potential confounds: The peri-operative period & microlesion effect of 
electrode implantation 
Following implantation of the electrode, without current passing through the target, 
patients typically show some peri-operative clinical improvement thought to be related to 
oedema of the target nucleus (Jech et al., 2012). While inherently confounded by scan 
order, four studies have explored the so-called “microlesion effect”. Comparing 
preoperative and postoperative ‘OFF’ FDG uptake at rest in restricted volumes 
encompassing the STN and GP respectively, one study has reported reductions in rCGM 
in both regions at six months post-surgery, suggesting implantation has a long-term lesion-
like effect. However, these reductions were noted in absence of statistically significant 
clinical improvement, and analysis was restricted to these regions alone (Hilker et al., 
2008). An earlier study conducting a whole brain search did not find any significant 
differences (Hilker et al., 2004). However, a similar smaller study (n=6) with <3 months 
follow-up time reported reductions in additional regions including the putamen and VL 
thalamus, and concomitant increased resting rCGM in sensorimotor and cerebellar cortex. 
Again though, these findings were in absence of clinical effect of implantation alone 
(Pourfar et al., 2009). A recent study comparing pre-op fMRI with the first or third 
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postoperative day both quantified the degree of inflammation, changes in UPDRS-III, and 
changes in regional BOLD responses in response to visually guided tapping. Patients 
showed significant increases in both cortical and subcortical oedema and clinical 
improvement following implantation (postoperative day 3 > postoperative day 1), 
associated with reductions in BOLD responses in the thalamus, putamen, GP, M1, SMA, 
cingulate and insula cortex during voluntary movements (Jech et al., 2012). 
These findings illustrate (1) the long-term lesion-like effect following implantation – 
although this does not seem to be clinically manifest, and (2) the potential confound of 
scanning patients within days of electrode implantation. 
5.4.2.2 Potential confounds: The effect of STN DBS on haemodynamic coupling 
An important consideration when using neuroimaging methods to explore functional 
changes associated with an intervention is to confirm that the intervention (usually drug) 
does not alter the assumed constant haemodynamic coupling between neural activity and 
blood flow (Iannetti and Wise, 2007). This is particularly relevant to DBS of the STN 
given reports in rats that microstimulation of neurons in a functionally restricted region of 
the subthalamus/ZI/Forel's field/prerubral zone elevates rCBF (Glickstein et al., 2001; 
Golanov et al., 2001), potentially confounding rCBF PET/SPECT and BOLD fMRI. To 
address this question, Hirano et al., collected rCBF and rCGM at rest in the same patients 
receiving either a levodopa infusion or active STN DBS, revealing that while levodopa 
produces flow-metabolism dissociation in BG nuclei (including the putamen, GP, thalamus 
and brainstem), flow and metabolism remain correlated during STN DBS (Hirano et al., 
2008). Another study using functional transcranial Doppler to compare flow velocity in the 
posterior cerebral artery during visual stimulation (specifically chosen because visual 
perception is not thought alter under STN DBS) similarly did not find a significant 
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difference associated with DBS (Azevedo et al., 2010). Thus, at present there is little 
evidence to suggest DBS alters haemodynamic coupling.  
5.4.2.3 The effect of STN DBS on striatal dopamine 
Following observations of increased striatal DA release (Benazzouz et al., 2000a), 
metabolism (Paul et al., 2000), and potential neuroprotective effects of STN DBS in 
animal models, a number of studies have explored the effect of DBS on striatal dopamine 
concentrations using either [11C]-Raclopride or [18F]DOPA PET, or DaTSCAN SPECT. 
Five studies (total n=34) have reported no detectable effect of STN DBS on Raclopride 
displacement, regardless of whether DBS was unilateral (Abosch et al., 2003; Arai et al., 
2008), or bilateral (Hilker et al., 2003; Strafella et al., 2003b; Thobois et al., 2003). 
Similarly, two larger studies (total n=65) exploring the neuroprotective effect of 12 months 
of STN DBS on DA innervation have reported similar rates of decline to that found in 
patients treated medically (Hilker et al., 2005; Lokkegaard et al., 2007). One study 
involving patients with severe wearing off phenomena have reported a stabilisation of 
raclopride binding associated with therapeutic DBS (i.e. less fluctuation between on and 
off-drug binding), although only three subjects were studied (Nimura et al., 2005). At 
present therefore, there is little in vivo evidence to support the hypothesis that STN DBS 
exerts its mechanism of action by DA modulation in the striatum, and might explain why 
Hirano et al., did not detect any flow-metabolism uncoupling discussed above (Hirano et 
al., 2008). 
5.4.2.4 The effect of STN DBS on endogenous activity 
There have been 22 studies exploring changes in rCBF/rCGM induced by STN DBS 
whilst patients lay at rest, usually with eyes closed. Additionally, a number of other studies 
have reported contrast results detailing the main effect of DBS, averaging across task and 
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resting sessions. The average (range) cohort age at scanning is 60 (53-65), with disease 
duration of 13 (7-16) years. The average reported cohort stimulation parameters are a 
frequency of 159Hz (130-186Hz), amplitude of 3V (1.9-3.65V), and pulse width of 71µs 
(60-93µs). 
Studies either compare, (1) before vs. after - a pre-operative resting session to one collected 
usually after at least 3 months of fully implanted therapeutic DBS, or (2) ON vs. OFF - 
after at least 3 months of fully implanted therapeutic DBS. Before vs. after studies usually do 
not involve having the DBS switched off after it is first initiated, thus truly explore the 
chronic effect of therapeutic stimulation, and any plastic changes that may entail. In 
contrast, ON vs. OFF studies explore acute changes in manipulating STN DBS, almost 
always from a state of chronic therapeutic stimulation, to a temporary inactivated state, 
followed by reactivation; studies vary in how long they wait in each window before 
scanning (usually switched to the scanning condition about 10-30 minutes before the scan, 
although some report doing this the day before scanning (Hilker et al., 2004)). Given 
discontinuation of STN DBS removes >70% of its therapeutic effect within the first 15 
minutes, such ON vs. OFF manipulations usually capture most of the therapeutic effect6. 
A summary of the findings of each study is presented in Table 5.2; studies are divided into 
before vs. after, ON vs. OFF, and task studies reporting main effects of DBS. Regarding 
regions of the BG, most studies report increased activity in the thalamus and STN (Arai et 
al., 2008; Asanuma et al., 2006; Bradberry et al., 2012; Ceballos-Baumann et al., 1999; 
Garraux et al., 2011; Geday et al., 2009; Hershey et al., 2003; Herzog et al., 2006; Hilker 
et al., 2008, 2004; Hill et al., 2013; Karimi et al., 2008; Sestini et al., 2005; Volonté et al., 
2012). Before vs. after studies also report GP activity increases (Hilker et al., 2008, 2004; 
                                                   
6  Indexed using UPDRS-III. Calculated from data presented in Temperli et al., 2003. 
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Sestini et al., 2005; Zhao et al., 2004), although the study with the largest cohort (Cilia et 
al., 2009), and the ON vs. OFF studies report metabolic decreases (Arai et al., 2008; 
Asanuma et al., 2006; Wang et al., 2010). The putamen has similar contradictory results 
(Asanuma et al., 2006; Bradberry et al., 2012; Hilker et al., 2004; Wang et al., 2010; Zhao 
et al., 2004), with few (and opposing) reports of caudate nucleus activity changes (Garraux 
et al., 2011; Le Jeune et al., 2010). The mixed results of the putamen and GP (which are in 
close proximity, both comprising the lentiform nucleus) are possibly due to the low spatial 
resolutions achievable with PET/SPECT. Similarly, changes in the cerebellum are mixed 
and often poorly reported, or not included in the scanning volume. 
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Table 5.2 Literature review: The effect of STN DBS on resting rCBF/rCGM. WB = whole 
brain corrected statistics, SVC = small volume corrected statistics. Light blue = Before vs. after 
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studies. Blue = ON vs. OFF studies. Green = Main effects results averaged over task and rest 
sessions.  
$ Hill et al., 2013 compare rCBF in ROIs under two different STN stimulation settings (dorsal 
vs. ventral); only significant results in both settings included.  
£ Bradberry et al., 2012 compared DA to DBS therapy; results of common regions and DBS 
alone regions included.  
@ Garraux et al., 2011 normalised their data according to the standardised uptake value 
(SUV) after noting a significant difference between SUV during ON and OFF conditions. This 
normalisation is not used in other studies and may explain why they only report increases in 
metabolism. Additionally found increases in V2.  
°Scanned on medication.  
*Sestini et al., 2005 collected data at both 4 months and 42 months post-op; * includes outcome 
at 4 months, ** includes changes from 4-42 months Additionally found increase in SN.  
^Scanned during unilateral STN DBS. 
ǂ Cilia 2009 additionally found increases in the hippocampus. 
|| Hershey 2003 addtionally found increases in the red nucleus and decreases in the claustrum 
Abbreviations not in text body: BA = Brodmann area, MFG = middle frontal gyrus, APFC = 
anterer prefrontal cortex, IFG = inferior frontal gyrus, IPFC inferior prefrontal cortex, Prec = 
precuneus, Ang G = angular gyrus, Spm G = Supramarginal gyrus, ITG = inferior temporal 
gyrus, MTG = middle temporal gyrus, STG = superior temporal gyrus, PHG = 
parahippocampal gyrus, OccT = Occipitotemporal junction, Tpol = temporal pole, V. Ass = 
visual association area.  
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Regarding cortical modulation, most changes are noted in the frontal lobe, especially the 
motoric cortices. Ten studies report reductions in activity in M1 (Asanuma et al., 2006; 
Bradberry et al., 2012; Ceballos-Baumann et al., 1999; Cilia et al., 2009; Geday et al., 
2009; Hershey et al., 2003; Herzog et al., 2006; Le Jeune et al., 2010; Limousin et al., 
1997; Payoux et al., 2004); only Sestini et al., report any whole-brain corrected increases in 
M1, and that was only when comparing ON stimulation scans at 4 months to 42 months, 
potentially showing the DBS effect wearing off (Sestini et al., 2005). Results from the SMA 
show similar reductions (Bradberry et al., 2012; Ceballos-Baumann et al., 1999; Cilia et al., 
2009; Geday et al., 2009; Hershey et al., 2003; Herzog et al., 2006; Le Jeune et al., 2010; 
Limousin et al., 1997; Payoux et al., 2004; Tanei et al., 2009), however three studies report 
increased activity in its rostral portion, the pre-SMA (Garraux et al., 2011; Sestini et al., 
2005, 2002). The PM shows mixed responses; five studies report reduced flow during DBS 
(Cilia et al., 2009; Hershey et al., 2003; Karimi et al., 2008; Le Jeune et al., 2010; Payoux 
et al., 2004), whereas three studies report increased metabolism (Garraux et al., 2011; 
Nagaoka et al., 2007; Zhao et al., 2004). Prefrontal regions, especially the DLPFC, 
typically show increases in activity under DBS, although these have been mostly detected in 
before vs. after studies (Garraux et al., 2011; Haegelen et al., 2005; Hilker et al., 2004; Li et 
al., 2006; Sestini et al., 2005, 2002). There are mixed results regarding the ACC; before vs. 
after studies report increased activity with DBS, although larger studies (Cilia et al., 2009), 
and task studies reporting main effects (Ceballos-Baumann et al., 1999; Limousin et al., 
1997), note decreased activity with DBS. 
Changes reported in the parietal, temporal and occipital lobes are more sparse; however, 
elevated activity in the precuneus/posterior cingulate cortex and middle temporal gyrus 
activity have been reported under STN DBS at rest (Asanuma et al., 2006; Cilia et al., 
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2009; Garraux et al., 2011; Geday et al., 2009; Hilker et al., 2004; Le Jeune et al., 2010; Li 
et al., 2006). 
5.4.2.5 Endogenous activity correlates 
Many authors additionally explore correlations between endogenous activity and clinical 
phenotype. Perhaps unsurprisingly given the changes discussed above, clinical impairment 
measured with the UPDRS-III has been found to correlate with activity in various parts of 
motoric cortex. Payoux et al., report correlations in akinesia subscores with endogenous 
activity in both M1 and the a medial portion of the cerebellum (Payoux et al., 2004), while 
a longitudinal imaging study scanning at both 5 months and 4 years post-DBS report 
strong negative correlations between total UPDRS-III and activity in the pre-SMA and PM 
(Sestini et al., 2005). Similarly, percentage improvements have been found to correlate in 
both the SMA and ACC (Karimi et al., 2008; Lyoo et al., 2007; Paschali et al., 2013; 
Volonté et al., 2012), and combined subscores of rigidity and tremor of one hemibody have 
been found to be positively correlated with activity in the precentral gyrus (Nagaoka et al., 
2007; Volonté et al., 2012). One study has additionally found activity within the PPN 
correlates with improvements in postural stability, although made use of rather liberal 
statistical practice (Karimi et al., 2008).  
Additionally, others have attempted to identify regions correlated with stimulation 
parameters. One small study conducted on medicated patients found activity in the STN 
was positively correlated with DBS frequency, whereas M1 and SMA exhibited significant 
negative correlations (Haslinger et al., 2005). 
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5.4.2.6 The effect of STN DBS on motor-evoked activity 
Only studies examining voluntary limb movements are considered here; a number of other 
studies employing designs involving other types of movements, e.g. speech (Pinto et al., 
2004) are not discussed. The results are summarised in Table 5.3; only movement x DBS 
interaction results are detailed.  
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Table 5.3 Literature review: The effect of STN DBS on motor-evoked activity. *Thobois et al., 
2002 used a learned sequential joystick movement task. Only the movementxDBS interaction 
results are included. ~Strafella et al., 2003 only report the comparison of unilateral vs. bilateral 
DBS during movement. ~~ Grafton et al., 2006 used a visuo-motor feedback task where the 
subjects had to adjust their movement speeds according to the visual feedback. Responses were 
increased by DBS in the posterior cerebellum, but decreased in the anterior cerebellum. 
Similarly, responses were increased in a lateral portion of PM, but decreased in a medial region. 
**Hesselamnn et al., 2004 present a case study of intraoperative fMRI whilst a patient 
performed finger opposition under different STN DBS conditions. ^Scanned during unilateral 
STN DBS.  
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In contrast to the “resting state” studies, those examining the interaction between STN 
DBS and movement-evoked activity all employ an ON vs. OFF design. Six PET/SPECT 
studies have addressed this question, as well as one intraoperative fMRI case study 
(discussed in 5.4.2.8). Limousin et al., used an upper limb movement task using a joystick, 
asking six patients to move in one of four directions when they heard an auditory cue, 
using their more affected hand. Unilateral STN DBS contralateral to hand movements 
increased motor-evoked activity in the DLPFC, ACC and SMA. However, the main effect 
of STN DBS was to reduce activity in M1 and PM (Limousin et al., 1997). An almost 
identical study in a larger PD cohort reported consistent main effects, additionally 
reporting activity in the PM, and rostral (or pre-) SMA to increase during movements, and 
reductions were found in the caudal SMA and M1 (Ceballos-Baumann et al., 1999). 
During a learned motor sequence task, Thobois et al., detected increases in motor-evoked 
responses in the thalamus and putamen, as well as in the DLPFC, in response to unilateral 
STN DBS, and reductions in M1, parietal cortex and the SMA (Thobois et al., 2003). 
Talairach coordinates reported in this study suggest the reductions occurred in the pre-
SMA, contradicting (Ceballos-Baumann et al., 1999); the different tasks may underlie this 
apparent discrepancy. Another unilateral DBS study simply requiring subjects to perform 
paced fist clenches, report increases M1, the ACC and cerebellum under DBS, however 
subsequent analysis revealed these apparent increases were due to reductions in the baseline 
(i.e. resting) condition in these three regions (Payoux et al., 2004). During a visually guided 
tracking task, which arguably engages more cerebellar processing than joystick movements, 
unilateral stimulation increased motor-evoked responses in the SMA (reported coordinates 
equivalent to the pre-SMA), posterior cerebellum and prefrontal cortex. Reductions were 
also noted in the anterior cerebellar cortex and parts of the PM (Grafton et al., 2006). The 
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only study to consider bilateral STN DBS (only reporting results comparing unilateral vs. 
bilateral) found increased motor-evoked responses in the ACC and SMA (particularly pre-
SMA) using the same joystick task discussed previously (Strafella et al., 2003a). 
In summary therefore, movement-evoked responses appear to be increased by STN DBS in 
the prefrontal (DLPFC), cingulate (ACC) and pre-SMA. Only one study has found 
subcortical changes, and responses in the cerebellum, PM and M1 appear mixed, probably 
dependent on the motor task employed.  
5.4.2.7 Parkinson’s disease “covariance patterns” & STN DBS 
The PD related pattern (PDRP), first proposed by David Eidelberg (Eidelberg et al., 1994; 
Spetsieris and Eidelberg, 2011), employs a network approach to the analysis of PET time 
series, and its expression has been found to correlate with PD severity and striatal DA 
(Asanuma et al., 2006; Eidelberg et al., 1994). Authors use a PCA-based approach to 
identify a number of orthogonal principal components amongst an entire cohort, and then 
define a pattern as PD-related if the amount of variance it explains in PD patient data is 
significantly different to that of control data. The classic PDRP, as referenced earlier 
(section 0), shows increased metabolic activity in the BG, thalamus and cerebellum, and 
relatively decreased activity in the premotor (SMA/PM) and parietal cortices. In addition, a 
number of other symptom related patterns have since been described including a tremor-
related network (PDTP) with co-varying increased activity in the cerebellum, dentate 
nucleus, putamen and M1 (Mure et al., 2011). Both PDRP and PDTP expression has been 
shown to reduce during active STN DBS (Asanuma et al., 2006; Wang et al., 2010). 
Additionally, abnormal expression of normal motor related metabolic patterns that occur at 
rest in PD, is reduced by DBS (Ko et al., 2013). These analyses are essentially quantifying 
the expression of modes of functional connectivity, i.e. patterns of functionally connected 
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brain regions, which are specifically related to disease states. To summarise, this literature 
suggests STN DBS reduces the expression of pathological modes of functional connectivity.   
5.4.2.8 Functional MRI during active DBS in human patients 
As discussed above, fMRI has a number of advantages over nuclear neuroimaging 
techniques. However, the use of fMRI to address DBS questions has been severely limited 
by concerns regarding the safety of scanning patients with implanted electrodes in contact 
with neural tissue. Two notable and unfortunate case studies have highlighted the potential 
dangers of DBS interacting with MRI scanning when safe operating conditions are not 
observed (Henderson et al., 2005; Spiegel et al., 2003). The specific safety concerns 
regarding MRI-DBS interactions are discussed in detail later (section 5.5.1).  
Excluding experiments detailed in this thesis, there have been a handful of reports of the 
use of fMRI in DBS patients, in addition to a number of studies conducted on sedated 
animal models of DBS (see 5.4.2.9). Six studies have described fMRI in STN DBS 
patients, five of which used 1.5T scanners. One study examined the micro-lesion effect and 
has been discussed above (Jech et al., 2012), the remainder studied effects of DBS on the 
BOLD signal.  
Jech et al., were first to report a series of three patients with unilateral electrodes who had 
fMRI following electrode implantation, before the electrodes were attached to the IPG. 
The electrodes were attached to an external pacemaker that was turned on and off every 30 
seconds during the fMRI session. Such a design enabled the authors to identify which areas 
showed changes in response to acute STN DBS. No formal group analysis was performed, 
but subcortical increases were reported in the GP, thalamus, SN, superior colliculus, as well 
as cortical increases in one patient in the PM and DLPFC, all ipsilateral to the stimulating 
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electrode (Jech et al., 2001). Another study reports a patient who showed a good motor 
response in one hemibody, and emotional disturbances when the contralateral electrode 
contact was employed. Using the same block design as before in the peri-operative period, 
the authors describe different patterns of BOLD changes when each electrode was 
activated, with motor improvements associated with subcortical increases in the thalamus, 
putamen, and cerebellum, cortical increases in PM, and decreased BOLD response in the 
SMA. Increases in the insula and temporal cortex, as well as decreases in patietal areas are 
also reported (Stefurak et al., 2003). Hesselmann et al., performed intra-operative fMRI in 
a patient performing blocks of self-paced finger opposition, once without stimulation, and 
then with unilateral STN DBS at three different bipolar configurations. DBS was 
associated with decreases in contralateral (to hand movements) M1, and ipsilateral 
cerebellum, regardless of which contacts were stimulated.  DBS at different contacts (thus 
theoretically moving the field of stimulation, changing the structures exposed to DBS) 
produced different magnitudes of reductions, although these differences are not formally 
statistically analysed. With one electrode combination, which also produced the greatest 
magnitude of reductions in the above, contralateral increases were detected in the caudate, 
putamen and insula cortex (Hesselmann et al., 2004). Another series of five patients were 
scanned using 3T fMRI using a similar alternating ON-OFF unilateral stimulation block 
design. Again, while no group analysis was performed, most stimulated hemispheres 
showed ipsilateral increases in the GP, putamen, thalamus and contra-lateral cerebellum, 
and some showed ipsilateral increases in DLPFC and insula cortex (Phillips et al., 2006). 
One final published report examined changes in functional connectivity within motor 
cortical regions following STN DBS in 13 patients, finding increases in eigenvector 
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centrality7 in the left PM, that correlated with contralateral clinical disability (Mueller et al., 
2013). While these results are interesting and employ a relatively novel approach that 
speaks to similar hypotheses of connectivity that are tested in this thesis, they are difficult to 
discuss in full, as the report is only a brief letter, and provides little detail regarding data 
collection and analysis8. 
While these studies have successfully overcome the technical challenges of scanning DBS 
patients, a number of comments about study design should be noted: 
1. MRI safety – As discussed later, most in vivo studies make reference to on-site 
thermometry to confirm that MR-induced heating at the electrode tips does not 
exceed international and local guidelines (see 5.5.1).  
2. Peri-operative scanning – All the published fMRI studies have occurred during the 
peri-operative period. As discussed above, following implantation of the electrodes, 
oedema itself can have therapeutic effects (Jech et al., 2012), and can alter the 
neural response to DBS. For example, the patient with emotional responses to peri-
opertaive stimulation reported in (Stefurak et al., 2003), did not have the same 
response 4 weeks post-op to identical stimulation (although it still only produced 
‘mild’ improvements in contralateral symptoms). Furthermore, the patients (who 
are usually older people) have only recently undergone a general anaesthesia, which 
may similarly alter responses. 
                                                   
7 Eigenvector centrality is a graph theoretical description of the functional connectivity of each 
voxel in a search volume of interest (ideally the whole brain). Voxels with many, strong 
correlations with other voxels receive a high eigenvector centrality score (Lohmann et al., 2010; 
Mueller et al., 2013). 
8 The authors are currently preparing a manuscript detailing their findings (personal 
communication). 
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3. Statistics – Given the technical challenges involved in scanning patients either 
during or just after surgery, one can understand why only a handful of patients have 
been studied, and thus why statistical thresholding in these reports have been fairly 
liberal (most do not correct for multiple comparisons, or present any formal 
second-level statistics). 
4. Artefact – Of the six reports (and others detailing similar case studies in Vim DBS 
patients), all observe a susceptibility dropout artefact surrounding the tips of the 
electrodes. The use of unilateral stimulation in patients with bilateral electrodes 
have confirmed that the BOLD signal changes are due to the stimulation, and not 
simply an artefact produced by the electrodes (Phillips et al., 2006). 
5. Therapeutic stimulation – Few studies have reported whether the stimulation 
parameters they employed during fMRI were actually therapeutic. For example, 
Hesselmann et al., report certain stimulation parameters produced the greatest 
BOLD changes, but does not specify if these parameters were eventually chosen for 
chronic therapy (Hesselmann et al., 2004).  
6. Bipolar stimulation – All studies conducted before IPG implantation have 
employed bipolar stimulation, creating current fields that are more focal to the 
target structure than monopolar fields, that are commonly used therapeutically.  
To summarise, only a handful of patients have been studied with fMRI, all of which within 
days of electrode implantation, before having had their IPG implanted. The designs have 
been mostly alternating blocks of ON and OFF stimulation in an attempt to determine the 
regions displaying acute changes in activity, with only a single study exploring effects of 
STN DBS on movements. In contrast to the PET/SPECT literature, the fMRI studies have 
 Introduction  |  63 
63 
not investigated the effect of therapeutic stimulation as much as they have mapped the key 
afferent and/or efferents of the STN.  
5.4.2.9 Functional MRI in animal models of STN DBS 
Two relatively recent studies have been published using fMRI in animal models of STN 
DBS. Using 6 second trains of 130Hz, 1V or 2V pulses (pulse widths = 500µs) in 
anaesthetised pigs, Min et al., report voltage dependent event-related responses in both PM 
and M1, as well as responses in prefrontal, insula and cingulate cortices, and the striatum 
(Min et al., 2012). Similarly, a study in healthy rats where the frequency of STN DBS was 
manipulated in a block design report frequency dependent activity increases in M1, S1 and 
cingulate cortices, peaking at therapeutic frequencies (100-130Hz) (Lai et al., 2014). Both 
these studies were conducted on healthy anaesthetised animals, with very different local 
anatomy, particularly the size of the STN: the authors report that the rat STN is roughly 
0.8mm3, 50mm3 in the pig, and 240mm3 in the human9 (Min et al., 2012), requiring 
augmented stimulation parameters to avoid an excessively large current field (e.g. both 
studies used long pulse widths that are not typically used in therapeutic stimulation). 
5.4.3 Electrophysiology & STN DBS 
A lot of work characterising the changes in firing rates in BG nuclei following STN DBS 
has been undertaken. Studies from the animal literature have demonstrated frequency 
dependent reductions in STN firing rates following DBS (Beurrier et al., 2001; Meissner et 
al., 2005), and similar observations were noted in human single unit recordings (Welter et 
al., 2004). However, both GABA-mediated inhibition, and excitatory responses have been 
                                                   
9 Although this figure for human STN volume is markedly larger than most reports in the 
literature. 
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observed down-stream in the rat SNr during STN DBS, suggesting DBS activates the 
efferent pathways of the target (Maurice et al., 2003). 
As attention has shifted to the spectral changes associated with PD (see 0), many have 
attempted to map oscillatory activity under DBS. However, capturing electrophysiological 
data during active DBS has been limited due to the artefacts associated with high frequency 
stimulation. In an attempt to minimise stimulation artefact, most studies either (1) record 
at distant downstream sites, e.g. STN DBS reduces GPi beta power (Brown et al., 2004), or 
(2) record immediately after a period of therapeutic stimulation in patients who show 
slightly longer responses to stimulation finishing, e.g. DBS reduces local beta power in 
these patients, correlating with clinical effect (Kühn et al., 2008). Eusebio et al., are the 
only authors so far to document the effects of DBS on the STN LFP in vivo, demonstrating 
time-locked reductions in beta power – see Figure 5.5, taken from (Eusebio et al., 2011a). 
Similarly, closed-loop DBS using beta power as a biomarker of pathology has been shown 
to be superior to standard DBS (Little et al., 2013). Thus, there is growing evidence that 
DBS suppresses expression of local beta oscillatory activity, that is known to be elevated in 
the off-drug state (Brown et al., 2001; Eusebio et al., 2012). STN DBS has also been 
shown to reduce STN beta phase coupling with gamma amplitude in M1, although the 
precise role of phase amplitude coupling is as yet unknown (de Hemptinne et al., 2013).  
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Figure 5.5 Example of beta power suppression during active STN DBS above ~1.5V. (A) power 
spectrum of the STN LFP recorded off-medication with DBS OFF showing a large peak at 
13.6Hz. (B) Time-frequency spectrogram showing the timings of DBS being scaled up over time, 
turned OFF, and turned back ON again (C). Taken from (Eusebio et al., 2011a). 
5.4.4 Conclusions 
While much work has been done to characterise the neural response to STN DBS, the 
neuroimaging literature is plagued with inconsistency. Looking across studies, the direction 
of modulation in certain regions appears ambiguous. The reason for this can only be 
speculated. One contributing factor is likely the variability in targeting accuracy and 
stimulation parameters used, essentially meaning that different centres may be stimulating 
slightly different parts of the STN and surrounding anatomy. Given the regional anatomy 
of the target (see section 5.3.1), it is likely that this is an important determinant. Frequency 
of stimulation is of particular interest given that (1) frequency is an important determinant 
of clinical efficacy, and (2) this is reflected in neuroimaging signals (Haslinger et al., 2005; 
Lai et al., 2014). Other factors that could be relevant include patient heterogeneity 
(including presence of genetic mutations, disease duration, time between implantation and 
scanning), medication state and whether patients had unilateral or bilateral stimulation. 
Studies exploring the effect of STN DBS on nigrostriatal DA in humans appear more 
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consistent. Despite claims from the animal literature, results of the human functional 
imaging studies fail to evidence any marked changes in DA innervation. 
With particular relevance to this thesis, one key conclusion of the literature to date is the 
paucity of fMRI studies in these patients. This is largely due to the safety concerns of 
scanning patients with implanted devices. That being said, there have been a handful of 
studies in DBS patients, using both 1.5T and 3T scanners, with no reported adverse effects 
of scanning, suggesting that under a safe protocol, fMRI is feasible in these patients. This is 
discussed further in section 5.5.1.  
The literature to date has dealt almost exclusively with questions of functional segregation; 
in other words, which regions display altered activity under stimulation. However, few have 
considered the effects of DBS on functional integration, particularly whether and how STN 
DBS may alter effective connectivity the between regions of the BG and the motor system. 
It may thus be unsurprising that there remains little mechanistic understanding of what 
DBS is doing the BG, and how altered brain responses result from stimulation.  
5.5 Functional MRI in patients with implanted DBS 
5.5.1 Safety 
The major, well documented MRI safety concern is rapid temperature increases at the tips 
of the electrode contacts, due to coupling of the electrical component of radiofrequency 
(RF) oscillating electromagnetic field excitation pulses applied during MRI to the DBS 
circuit (known as ‘resonant coupling’ or ‘the antenna effect’) (Carmichael et al., 2007; 
Georgi et al., 2004). The resulting induced currents produce thermal energy elevating tissue 
temperature to potentially dangerous levels. Furthermore, there is an additional risk that 
voltages induced in the DBS circuit during MRI could lead to potentially harmful 
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uncontrolled neural stimulation independent of IPG function. The current UK and 
international guidelines propose that MRI-induced heating should not cause the 
temperature within the brain to exceed 38°C, requiring any intra-cerebral heating at the 
electrodes to be <1°C (HPA, 2008). 
Previous in vitro studies using various media modelling the thermal and electrical 
characteristics of neural tissue suggest that electrode heating during MRI is dependent on a 
number of factors including coiling of the DBS leads (Baker et al., 2005), hardware type 
and brand (Gleason et al., 1992), scan specific absorption ratio (SAR) (Finelli et al., 2002), 
field strength (Kainz et al., 2002), as well as the geometry of the RF transmit coil relative to 
the leads (Rezai et al., 2005). On site thermometry at this centre has previously shown that 
heating in a Medtronic Kinetra DBS system remains <1°C if scanning is restricted to 1.5T, 
using a head-transmit/receive coil, and limiting scanner-reported sequence head SAR to less 
than 0.4W/Kg (Carmichael et al., 2007). Under these restrictions, this centre routinely 
perform post-implantation electrode placement verification MRI as part of clinical practice 
(Zrinzo et al., 2011).  
As discussed, previous in vivo fMRI studies have mostly been done at 1.5T, using a head-
transmit/receive coil and low head SAR sequences. However, centres vary regarding how 
much heating is unacceptable. For example, a 1.5T fMRI DBS study reports to have used a 
turbo spin echo sequence with head SAR 0.98 W/Kg resulting in 1.1°C of heating (Jech et 
al., 2012). Another study conducted at 3T reports using a GE-EPI sequence that produced 
a maximal heating of 1.36°C, quoting guidance from the European Committee for 
Standardization (EN-45502-1:1997) advising that heating should be kept <2°C (Phillips et 
al., 2006). 
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5.5.2 Experimental feasibility 
Assuming safe operation can be established, GE-EPI fMRI comparing the BOLD signal 
‘ON’ and ‘OFF’ DBS stimulation presents an interesting avenue of research. 
However, there are a number of potential experimental confounds; the simplest study 
design would assume that the IPG output is not disrupted by the MR environment. In 
other words, it is essential that the IPG delivers the intended stimulation during MRI, 
otherwise the states compared would not relate to the true DBS ON and OFF conditions. 
In addition, MRI-induced temperature changes could theoretically also confound 
experimental data physiologically (Boulant, 1998; Guatteo et al., 2005; Kiyatkin, 2007; 
Travis et al., 1995; Tryba and Ramirez, 2004) potentially altering the assumed constant 
haemodynamic coupling between blood flow and neural activity. Thirdly, the MRI proton 
resonant frequency is sensitive to tissue temperature thus local RF-induced temperature 
increases could cause confounding signal changes during the fMRI experiment independent 
of activation.  
5.5.3 Conclusions 
There are a number of variables that affect the safety of scanning patients with implanted 
DBS systems, and work at this centre has established a protocol that maximises the safety 
for operated patients (Carmichael et al., 2007). However, this protocol has a number of 
limiting factors that could be improved if found to be sufficiently safe.  
Firstly, from a pragmatic perspective, the current safety studies have only formally tested 
the Medtronic Kinetra system, a relatively older device that has been all but replaced in the 
vast majority of patients by the Medtronic ActivaPCTM. Thus, it is important to ensure that 
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scanning patients with newer devices is similarly safe and feasible, so as to maximise the 
number of patients that could be recruited to have an fMRI. 
Secondly, the quality of the data is partly determined by the coils used to collect the data. 
The rationale for using the head-transmit/receive coil is to restrict RF transmission to the 
head, in turn theoretically minimising the heating effect at the electrode tips. While this is 
obviously advantageous, the receive mode of this coil furnishes a lower SNR than that of 
multi-array head receive coils. It is therefore important to establish whether or not scanning 
under this optimised arrangement is safe and feasible.  
5.6 Aims of this thesis 
The overarching aim of this thesis, its raison d'être, is to enhance our understanding of the 
therapeutic mechanisms of STN DBS in patients with advanced PD using fMRI. 
Specifically, the aims of this thesis are fourfold: 
1. Confirm the experimental feasibility of fMRI in patients with advanced disease 
with implanted STN DBS systems. 
2. Identify regions of the brain that are involved in motor control and are modulated 
by STN DBS in patients with PD, and characterise this modulation. 
3. Characterise the neuromodulatory effect on functional integration between cortex 
and subcortical structures, both during movement, and during rest. 
4. Enhance the quality of data acquisition in these patients by using MRI equipment 
that deliver an improved signal to noise ratio, and confirm the safety of scanning 
patients under this protocol. This is specifically dealt with in my third experiment. 
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6 Materials and methods 
Parts of the following chapter have been published in Kahan & Foltynie (2013), Neuroimage. 
6.1 Summary 
In this chapter, I outline the foundations of the key methods employed that are common to 
most of my experiments. Specifically, I discuss (1) BOLD fMRI, (2) analysis of task-evoked 
activity using SPM (Friston et al., 1995, 1994a, 1990), and finally (3) dynamic causal 
modelling of fMRI data (Friston et al., 2003). 
The precise methods used in each experiment are outlined in detail in their respective 
chapters. 
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6.2 Functional MRI 
Magnetic resonance imaging (MRI) is a means of non-invasively imaging three-
dimensional volumes, most commonly, various parts of the body. In contrast10, fMRI is 
specifically used to detect the magnetic repercussions of changes in blood oxygenation that 
result from changes of neural activity. The fundamental principles of how this is achieved 
are discussed below.  
6.2.1 The BOLD contrast mechanism 
The brain is full of hydrogen atoms, which are essentially single protons with an inherent 
property (similar to mass or charge) called spin. Protons possess a net spin of 1/2. In the 
semi-classical vector model, the spins behave like spinning tops and they can be represented 
by vectors, while in the quantistic representation their behaviour can be described in terms 
of energy states. The two descriptions are complementary, and help describe different 
characteristics of the spins. When placed in a strong (static) magnetic field (B0), particles 
with net spin align themselves in parallel or anti-parallel with B0, in a similar way to how a 
bar magnet might align itself, with a larger number of spins parallel than anti-parallel to B0. 
The resulting net alignment is parallel to B0 and of a relatively low energy state. Aligned 
with B0, a particle with net spin can absorb a photon and change to a higher energy state 
anti-parallel to B0. The frequency of photon absorbed is dependent on B0, and the 
gyromagnetic ratio of the particle (for hydrogen 1H = 42.58 MHz / T). This frequency is 
known as the Larmor frequency. MRI uses static magnetic fields (typically 1.5T or 3T) and 
electromagnetic waves of radiofrequency (i.e. RF pulses) to manipulate the energy states of 
hydrogen nuclei within a given volume. Once ‘excited’ to a higher energy orientation, 
protons slowly ‘relax’, i.e. return to the low energy alignment with B0. The relaxation time 
                                                   
10 Pun intended 
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depends on the tissue types (i.e. it is different in white matter, grey matter, and 
cerebrospinal fluid). The process of relaxation to the low-energy alignment in physiological 
tissue can be characterised by changes in two dimensions; (1) longitudinal regrowth - 
measured by the T1 decay constant, and (2) transverse relaxation - measured by the T2 
decay constant (or T2* if local field homogeneities are considered). T2* images are the type 
of images acquired in fMRI. T2* in a given region is highly dependent on the local 
homogeneity of the magnetic field (increased inhomogeneity decreases the T2* signal), 
which in turn is dependent on the composition of the blood in the immediate vicinity, 
which in turn is dependent on the physiological state of neural tissue. Thus, T2* is an 
indirect measurement of neural activity, and is herein referred to as the BOLD contrast 
mechanism (Logothetis and Wandell, 2004).  
The BOLD contrast is sensitive to the oxygenation of haemoglobin. The magnetic 
properties of the ferrous ion buried within the haem group of haemoglobin are dependent 
on whether it is bound to oxygen or not; deoxyhaemoglobin (dHb) is paramagnetic and 
disrupts the homogeneity of the field, whereas oxyhaemoglobin (oHb) has a magnetic 
moment of zero (Pauling and Coryell, 1936). Thus, higher levels of dHb reduce the T2* 
signal (Ogawa et al., 1990a, 1990b). 
Neurons are dependent on a rich oxygen supply to maintain their energetically expensive 
lifestyles; the brain is responsible for approximately 20% of the body’s resting metabolism. 
The “energy budget” is spent mainly on restoring ion movements generated by postsynaptic 
currents, uptake of neurotransmitters, and action potentials (Attwell and Laughlin, 2001). 
These demands scale with the electrical activity of the neural tissue, and thus more oxygen 
is required in order for neurons to respire aerobically. While there exists heterogeneity 
across the cortex and between subjects, following a discrete physiological stimulus (e.g. 2 
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seconds of visual stimulation), the BOLD signal shows a typical response known as the 
haemodynamic response function (HRF). While neurophysiological responses to such 
stimuli occur within milliseconds, the HRF is delayed; occurring 1-2 seconds after stimulus 
onset, rises to a peak within 6-9 seconds, and then returns to baseline; the total time course 
is typically 10-15 seconds (Kwong et al., 1992). This increase is due to an increase in CBF 
that (for reasons unknown) over-compensates for any initial oxygen consumption, resulting 
in a net influx of oHb, known as “functional hyperaemia” (Fox and Raichle, 1986; Fox et 
al., 1988). This effect is thought to be driven by glutamate released from pre-synaptic 
terminals, as opposed to a feedback hyperaemia from increased [CO2] or decreased [O2] 
(Attwell et al., 2010a). 
Importantly, the BOLD signal is a relative measure. In other words, a control condition is 
always needed to identify parts of the brain associated with the task condition. For example, 
if one wants to identify the neural correlates of finger movements, during the length of the 
scan, the subject must perform finger movements as well as periods of rest. 
6.2.2 Electrophysiological correlates of BOLD 
Given its latency to stimulus onset, and haemodynamic origins, it is worth briefly 
considering how the BOLD signal relates to commonly employed electrophysiological 
characterisations of neural activity. Placing an electrode in the extracellular space permits 
measurement of the mean extracellular field potential (mEFP); depending on the size (thus 
impedance) and placement of the electrode tip, the mEFP can detect action potentials of 
nearby large neurons (Henze et al., 2000), or a combination of dendritic synaptic events 
and summed action potentials from hundreds of local neurons. The latter can be separated 
using signal filtering into local synaptic voltages (LFPs, by applying a low pass filter 
<200Hz), and multiple-unit spiking activity (MUA, by applying high-pass filter >300Hz) 
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(Logothetis, 2003). In other words, the LFPs measure slower waveforms, thought to reflect 
synaptic inputs and local intra-cortical processing, whereas MUA measures the output 
action potentials of the principal neurons (Einevoll et al., 2013). Simultaneous acquisition 
of mEFP and BOLD data in the primate visual cortex reveal that signal changes following a 
visual stimulus are best predicted by the marked magnitude changes observed in the LFP 
signal, suggesting the BOLD signal represents afferents and intra-cortical processing as 
opposed to spiking output (Friston, 2008; Goense and Logothetis, 2008; Logothetis, 2008; 
Logothetis et al., 2001). That being said, a number of studies demonstrate a linear 
relationship between BOLD and spiking rate (Rees et al., 2000), which may not be 
surprising given spiking is often correlated with responses in the LFP frequencies 
(Logothetis, 2003). 
6.3 Experimental design 
6.3.1 Within-subject designs 
The four fMRI experiments reported in this thesis employ within-subject designs. In other 
words, data is collected from same group of subjects both with and without therapeutic 
DBS. This conforms with the majority of previous studies on DBS. The gold standard for 
this type of study would be a so-called double-blind design, whereby neither the patient nor 
the experimenter knows whether the DBS is active or not. The striking efficacy of STN 
DBS in advanced PD (particularly whilst off medication) does complicate this process; 
especially if the patient is accustomed to what ON and OFF feel like. This is similarly true 
for the experimenter, most obviously in assessing clinical or behavioural responses to DBS. 
The method of behavioural task assessment differed between experiments and is discussed 
in the relevant chapters. 
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Using a within-subject design does however predispose to carry-over effects such as fatigue 
or practice effects. To nullify these effects, the order of data collection was randomised 
across the group; i.e. half of the group were scanned ON DBS and then OFF DBS, and 
half the group in the reverse order.  
6.4 Statistical Parametric Mapping 
Throughout this work, analyses of fMRI data were done using the latest version of 
SPM12b (http://www.fil.ion.ucl.ac.uk/spm/), implemented in MATLAB (The MathWorks, 
Inc., Natick, MA, USA). Processing and analyses were largely executed in the command 
line using bespoke looping scripts in an effort to minimise human error. Some of my 
generic scripts (that call SPM functions) have been made available online for sharing and 
development. In what follows, I briefly describe the spatial processing that is a pre-requisite 
to all fMRI data analysis, as well as statistical foundations of the analysis of task-evoked 
sessions using the general linear modelling (GLM) approach. Throughout this thesis, the 
term session refers to a series of whole-brain images (or scans) collected sequentially at a 
defined inter-scan time interval (also known as repetition time - TR). Scans refer to 
individual images within a session; a typical fMRI experiment will run over multiple 
sessions, each comprised of >5 minutes worth of scans. 
6.4.1 Pre-processing 
All functional imaging data, regardless of which software suite employed, undergo a series 
of within-subject spatial pre-processing steps before statistical analysis. All of the imaging 
data in this thesis underwent the following pre-processing: 
1. Field Map Correction: EPI datasets are especially vulnerable to geometric distortions 
caused predominantly by inhomogeneity in the static magnetic field (Jezzard and 
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Balaban, 1995). These are often most prominent surrounding the petrous portions 
of the temporal bones, and the frontal sinuses, producing characteristic 
deformations of the medial temporal lobes and orbitofrontal regions. Following 
each session, we collected data mapping the magnetic field. Specifically, we 
measured the change in phase of the MR signal for two images with different echo 
times. This routine creates a voxel displacement map (VDM) from the field map 
data, which is used to correct such distortions. 
2. Realignment & Unwarping: It is almost impossible to keep entirely still throughout 
the duration of a scanning session. This routine realigns a session of scans from the 
same subject using the first image as a reference by estimating a 6 parameter spatial 
transformation, under rigid-body assumptions, i.e. three translations, and three 
rotations about different axes. The unwarping procedure aims to remove any 
susceptibility-by-movement interaction that may underlie residual movement-
related variance (Andersson et al., 2001). The realignment parameters are then 
saved and can be subsequently included as covariates in the first-level GLM analysis 
to further discount any effects of movement during statistical analysis. 
3. Coregistration: This routine performs within-subject coregistration of functional 
sessions and anatomical data by maximising mutual information using a rigid-body 
model. Following this procedure, the registration of functional and structural data 
was visually inspected using the CHECK REG facility. 
4. Segmentation & Normalisation: The purpose of this procedure is to warp individual 
subject data to a standard anatomical space, permitting between-subject comparison 
using a standardised coordinate system for reporting results. Study specific 
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templates were not used in the warping procedure, and loss of signal regions were 
not masked away using lesion masks. 
5. Spatial smoothing: This step convolves image volumes with a Gaussian full-width 
half maximum (FWHM) smoothing kernel. Spatial smoothing both reduces any 
remaining inter-subject difference in gyral anatomy, and boosts the signal-to-noise 
ratio. 
6.4.2 First-level analysis (within-subject) 
Questions appealing to functional segregation are best addressed by using a mass-univariate 
GLM approach (Friston et al., 1995, 1994a). Once the scans and sessions have been 
aligned (see above), the data from each voxel is treated as individual functional time series 
of certain anatomical locations. First-level (i.e. within-subject) analyses comprise a model or 
design matrix that defines the experimental setup and the scientific questions to be explored. 
Each row represents a scan (or time point in the time series), and each column an 
explanatory variable, of which there are two types; (1) stimulus functions, which are simply 
the timing onsets of either individual events or the blocks of experimental manipulation of 
interest, (2) regressors (or covariates), which are known sources of variance orthogonal to 
the stimulus functions, usually reserved to account for known sources of noise, e.g. head 
realignment parameters taken from the realignment procedure (see 6.4.1). Prior to 
modelling, the BOLD signal is high-pass filtered removing any ultra-slow frequency drifts 
(<0.0078Hz) typically resulting from changes in the ambient temperature in the scanner 
(known as scanner drift). 
Under the assumption that the BOLD signal is the output of a linear time-invariant 
system, (in other words, the response is independent of time, scales linearly with the neural 
response, and successive responses superpose in a linear fashion,) stimulus functions are 
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convolved with a canonical HRF, which accounts for the delayed and dispersed nature of 
the BOLD signal (Henson, 2004).  
The GLM approach attempts to model the observed data as a linear combination of 
explanatory variables. For example, a GLM with two explanatory variables (𝑥!, 𝑥!) can be 
expressed as a function of time: 
𝑦 𝑡 = 𝑥! 𝑡 𝛽! + 𝑥! 𝑡 𝛽! + 𝜀 𝑡  
𝜀 𝑡 ~𝑁 0,𝜎!𝜉  
In other words, the observed data at a particular time point, 𝑦 𝑡 , is equal to the linear 
combination of the explanatory variables, plus an error (or residual) term, which conforms 
to a zero mean normal distribution with a variance 𝜎!, multiplied by the noise 
autocorrelation, 𝜉. The linear mixture is determined by the regression coefficients (𝛽!,𝛽!), 
which are estimated using an ordinary least squares approach (Friston et al., 1995, 1994a; 
Kiebel and Holmes, 2004); in other words, in our example, 𝛽 is optimised based on 
minimising the discrepancy between 𝑦 and 𝑥!𝛽! + 𝑥!𝛽!. If the explanatory variables have 
no predictive capacity of the data, 𝛽 = 0. An example design matrix is illustrated in Figure 
6.1. 
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Figure 6.1 Example design matrix for SPM first level analysis. y, the observed BOLD signal 
recorded from a single voxel over time is equal to the sum of two stimulus functions (convolved 
with the HRF), multiplied by their beta coefficients, plus a constant (explanatory variable of 
ones), multiplied by its beta. The design matrix is a scans x explanatory variables matrix. White 
= high, grey = low. 
Statistical inference is conducted through specifying contrasts (simply weighted sums) of 𝛽. 
Returning to our example, the null hypothesis that we may want to disprove is that 𝑥! has 
no effect on 𝑦, i.e. we wish to test the hypothesis that 𝛽! > 0. A contrast weight vector [1 
0] is specified and multiplied by our estimate 𝛽!, or 𝑐′𝛽 in vector notation. A T-statistic is 
calculated according to the formula: 
𝑇 = 𝑐′𝛽𝑣𝑎𝑟 𝑐′𝛽  
In other words, the test statistic T is equal to the contrast of 𝛽, divided by its variance, 
which is dependent on both the variance of error term 𝜀, as well as the nature of the 
contrast and design matrix (e.g. collinearities of explanatory variables). The contrast 
provides a T statistic for every voxel in the brain, from which P values can be inferred, 
reflecting the probability that 𝛽! > 0 at that voxel is due to chance alone.  
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Similarly, one may wish to test multiple linear hypotheses at once (e.g. whether 𝑥! or 𝑥! 
significantly explained the observed data). Such inferences appeal to F contrasts, where an F 
statistic is calculated according to following formula: 
𝐹 ∝ 𝑅𝑆𝑆! − 𝑅𝑆𝑆𝑅𝑆𝑆  
Put simply, the F statistic is proportional to the normalised difference in the residual sum 
of squares of the reduced model (RSS0; i.e. a model that does not include either 𝑥! or 𝑥!) 
and the informed model (RSS; i.e. a model including 𝑥! or 𝑥!).  
The result of either contrast analysis is a contrast image containing a test statistic for each 
voxel. The image is then thresholded to a pre-determined level of significnace creating a 
SPM. The statistical foundations and derivations of both the T and F tests are discussed at 
length elsewhere (Friston et al., 1994a; Poline et al., 2004). 
6.4.3 Second-level analysis (between-subjects) 
First-level inferences from multiple subjects can then be taken to the second level to make 
between-subject inferences, or put simply, what responses are common/different amongst 
the cohort. Studies reported in this thesis explore common changes in regional responses 
upon activating therapeutic DBS. This is pursued using a within-subject design. In other 
words, each subject is scanned whilst performing a task, with and without therapeutic DBS. 
Typically, the first level analysis results in a contrast image identifying voxels significantly 
demonstrating a task x condition interaction. Using a summary statistic approach, these 
contrast images become the data for a second-level analysis, where we test the hypothesis at 
the group level, taking into account the between subject variability (i.e. a random effects 
analysis), creating a new group-level SPM. 
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6.5 Psychophysiological interactions 
PPI analyses appeal to questions of functional integration. Specifically, PPIs are an efficient 
way of searching the brain for voxels exhibiting context-dependent coupling with a source 
region. Original descriptions of PPIs suggest they are a very simple measure of effective 
connectivity as they are based on linear regression analyses, which are, by their very nature, 
directed (Friston et al., 1997), however, some consider them to describe functional 
connectivity. 
The purpose of the PPI is to identify voxels in the brain that demonstrate a context-
dependent change in coupling with a source region. In a standard 2 x 2 experimental design 
(i.e. two experimental effects, each with two conditions; e.g. attention – high vs. low, and 
visual stimulus – static vs. motion), the observed data can be summarised by the following 
linear model: 
𝑦 = 𝐴𝑡𝑡!!"! − 𝐴𝑡𝑡!"# 𝛽! +    𝑉𝑖𝑠!"#$"% − 𝑉𝑖𝑠!"#"$% 𝛽!+ 𝐴𝑡𝑡!!"! − 𝐴𝑡𝑡!"# 𝑉𝑖𝑠!"#$"% − 𝑉𝑖𝑠!"#"$% 𝛽! + 𝐺𝛽! + 𝜀 
Where 𝛽 are regression coefficients for the following; 𝛽! = main effect of attention, 𝛽! = 
main effect of visual stimulus, 𝛽! = attention x motion interaction, 𝛽! = covariates, and 𝜀 = 
error. Replacing one of the experimental effects with a region of the brain (V1) would 
produce the following: 
𝑦 = 𝐴𝑡𝑡!!"! − 𝐴𝑡𝑡!"# 𝛽! +   𝑉1𝛽! + 𝐴𝑡𝑡!!"! − 𝐴𝑡𝑡!"# 𝑉1𝛽! + 𝐺𝛽! + 𝜀 
Using this formulation, 𝛽! = main effect of V1, and 𝛽! represents the PPI between activity 
in V1 and attention. Placing a simple T contrast [0 0 1 0] would thus identify voxels that 
show an attention dependent coupling with V1. In other words, the regression slope 
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between the source activity and the target will be significantly different under a high 
attention setting. 
Unfortunately, interpretation of PPIs can be somewhat confusing, due to two potential 
explanations of the observed interaction. Specifically, a significant PPI between region A, 
condition U, and region B, could either mean that (1) condition U modulates the effective 
connectivity from A to B, or (2) activity in region A modulates the sensitivity of region B to 
input U. This is represented in graphical form in Figure 6.2. 
 
Figure 6.2 Two possible interpretations of a PPI. A PPI created using BOLD signal from region 
A, and the psychological condition U, finds region B to be significantly modulated. This could 
mean that either (A) input U modulates the effective connection from A to B, or (B) region A 
modulates the sensitivity of B to inputs from U. Modulatory effects always in green with solid 
circle arrow. 
6.6 Dynamic Causal Modelling 
“A Bayesian is one who, vaguely expecting a horse and catching a glimpse of a 
donkey, strongly concludes he has seen a mule” 
Stephen Senn, 1997 
Dynamic causal modelling is a method used to fit differential equation models of a group 
of interacting regions (or nodes) to neuroimaging data using Bayesian inference, yielding 
estimates of the (context dependent) coupling (or effective connectivity) within and 
between nodes (Friston et al., 2003). Using a fictitious example, I will briefly outline the 
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method, as well as extensions that are employed in this thesis. I will conclude with a brief 
discussion of why I chose DCM and not other methods. 
In the case of fMRI, one could consider the BOLD signal a dependent, measurable (or 
observed) variable (y) of the underlying neural activity (z) that cannot be measured with 
fMRI (thus, the neural activity is an example of a “hidden state variable”). This concept has 
been used in all GLM-based analysis of fMRI data, and is identical in DCM with one key 
difference (see footnote11).  
In a fictitious visual perception experiment, imagine a subject is placed in an MRI scanner 
and presented with a visual stimulus periodically (Figure 6.3). The timings of stimulus-
presentations are used to create an explanatory variable of the whole-brain BOLD data, and 
we find three clusters (that is, groups of voxels) are significantly explained by this 
explanatory variable (i.e. regions that show an altered response). Now imagine one knew 
the functional architecture of the highlighted brain regions; that is, how information 
propagates through these connected and functionally specialised regions to produce the 
observed results. 
One such architecture could be as depicted in Figure 6.3b. In this example, presentation of 
the visual stimulus u1 may cause a change in the neural activity (z) of region 1 (z1), which in 
                                                   
11Standard GLM analyses rely on convolving a stimulus function (representing onsets and 
durations of stimuli – an assumed neural model) with a HRF to produce an explanatory 
variable (an exogenous input) that is used to identify brain regions related to the stimuli. This 
essentially treats voxels as isolated regions, testing to see which voxels are sensitive to the input. 
DCM also uses convolution models, with two key differences: Firstly, neural states (z) causing 
BOLD data (y) in DCM are sensitive to both exogenous inputs (as in GLM analyses) and 
afferents from other regions. Secondly, the convolution model implicit in DCM is nonlinear due 
to some mild nonlinearities in the haemodynamic response, dealt with in GLM analyses by 
including basis functions of the HRF (Friston, 2002; Friston et al., 2003). In short, DCM is 
simply a generalisation of the convolution models used in all GLM analyses, the only important 
difference is that DCM allows the experimenter to additionally consider the effects of other 
regions on a their neural model. 
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turn causes a change in the measurable BOLD signal (y) of region 1 (y1). Z1 then causes an 
effect on z2, mediated by the extrinsic connection from 1 to 2 (a2,1). Likewise, z2 in turn 
causes an effect on z3. In addition, these regions contain some self-inhibitory properties, 
mediated by intrinsic connections, e.g. a1,1, preventing runaway outbursts of neural activity. 
Note that this chain of events only occurs with presentation of our visual stimulus, thus the 
model only explains the network dynamics in that instance. It does not tell us the dynamics 
when the stimulus is not present (e.g. at rest) or when the visual stimulus changes (to say, 
an emotional face). Obviously, this functional architecture is only one possible model of 
how our visual perception data are generated; there are a number of other equally plausible 
models that could underlie this network. 
Measures of effective connectivity in DCM consider the rate of change of neural activity 
with respect to time (ż) in response to some incoming signal (be it from another brain 
region or an exogenous environmental stimulus). Most (possibly all) connections that exist 
in the brain are reciprocal, thus in order to mathematically dissect the effect of one region 
on another, we must consider that the impact of one region onto another is delayed in time 
(utilising the principles of dynamical systems theory) (Daunizeau et al. 2011).  
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Figure 6.3 Our fictitious visual perception fMRI experiment. This experiment consists of two 
experimental manipulations or ‘inputs’ (u); u(1) = visual stimulus input, u(2) = drug input. 
Coupling parameters denoted by a(k,j) represents the effective connectivity from node j to k, in the 
context of stimulus u(1). Parameters labelled c(k,u) denote the effect of the input on target node k. 
Parameters labelled b(k,u) denote the modulatory effect of the input on target connection. When 
the subject views the stimuli in the control state (A), three brain regions are shown to be related 
to the onset of the stimuli. The BOLD signal from each of these regions is represented by y(1), y(2) 
and y(3). (B) The BOLD signal from a single region is produced by a change in its underlying 
neural activity z, which has not been measured during the experiment. The underlying neural 
activity of region 1 has an effect on the underlying neural activity of region 2 (an extrinsic 
connection); the strength of this effect is determined by the value a(2,1). The underlying activity of 
region 1 also has some self-inhibitory dynamics (intrinsic connection), determined by the value 
a(1,1). The equations of motion (C) show the rate of change of each of the regions’ underlying 
neural activity, ż. During the drug condition, an interaction is found in region 2 (D). This is 
modelled as a modulatory drug input having an effect on the strength of the extrinsic connection 
a(2,3) (E). The strength of this effect is determined by the value b(2,u2). (F) The equations of 
motion have thus changed to accommodate this additional modulatory input.  
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In order to quantify effective connectivity, one must create a plausible model of how the 
observed BOLD signal y may be generated by these influences (this is known as a 
“generative model”), just as was done in Figure 6.3b. This departure from analysing y, to 
considering how y is generated is an important distinction to understand. When we model 
data it is important to consider we are rarely able to fully explain how observed data are 
generated by complex systems – the aim of modelling is really to provide a parsimonious 
and plausible mechanism with which to better understand such systems.  
DCM has become the method of choice for modelling causal interactions in neuroimaging 
data. The most common implementation of DCM (standard/deterministic DCM) assumes 
that the system modelled is fully deterministic, meaning that the evolution of hidden neural 
activity over time in a given region (ż) is purely due to its afferent (incoming) connections 
and experimental inputs (as described in Figure 6.3c). Note the distinction between an 
afferent and an input. An afferent arrives from a node (distant or self), whereas an input is 
introduced by the experimenter (for example visual input from the retina, via the lateral 
geniculate nuclei – neither of these neural populations are themselves included in the 
model, rather it is assumed that they convey the convolved stimulus function coding visual 
input to a region). Theoretically therefore, if all the afferents and inputs to a region 
(including intrinsic connections) were removed, the rate of change of neural activity z (ż), 
would be zero, thus activity would remain constant. Such assumptions may not always be 
ideal as they forgo autonomous dynamics that may characterise certain brain regions (e.g. 
SN neurons), or periods where there are no experimental inputs (such as resting state 
fMRI), or regions not showing experimentally evoked effects.  
The effect an afferent has on the dynamics of the node depends on the connection strength 
(or “coupling parameter” – e.g. the size of value a2,1) and the activity at the source of the 
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afferent. This is similarly true of inputs; the influence of an experimental input is 
determined by the value of c1,u1. 
6.6.1 Bilinear effects 
Now imagine the visual experiment is repeated in the same subject, this time after they 
have received a drug infusion (for pure theoretical perfection, imagine that this drug had no 
effect on neurovascular coupling, and had very slow pharmacokinetics) Figure 6.3. New 
fictitious findings now show the same regions to be active again, and the BOLD signal y1 
and y3 remains unchanged. However, an interaction between visual stimulation and drug 
was noted in the observed responses of region 2; under drug, y2 consistently increases.  
Now, returning to our generative model, we can say that because the observed y1 and y3 are 
unaffected by the drug, it is likely that z1 and z3 have also remained largely unaffected. The 
changes noted in y2 can only be explained by changes in z2, and – under deterministic 
assumptions – this must be explained by a change in one (or more) of the coupling 
parameters of its afferents. In order to explain interactions, separate experimental inputs can 
enter the model as modulatory effects on a connection, as shown in Figure 6.3e. In our 
example, the effect of drug (u2) is modulating the connection a2,3, according to the strength 
of the modulatory effect, b2,u2, culminating in changes in ż2. Notice that these are changes 
to a rate of change (ż2), thus are called “second order” or “bilinear effects”. This is because 
the modulatory input and the afferent input interact to affect the rate of change of neuronal 
activity. The astute reader will notice that changes in ż2 could have been caused by 
modulatory effects on any of the other afferents into node 2 (a2,1 or a2,2 or both). This 
highlights the problem of competing hypotheses (explanations) in data modelling and will 
be discussed later.  
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6.6.2 DCMs estimate the coupling parameters given the structure of the 
model, the experimental inputs, and the observed data 
The purpose of a DCM analysis is to estimate the coupling parameters of a model (the a, b 
and c values), and evaluate how well a particular model explains the observed data. This 
allows the experimenter to make inferences about the structure of the network, as well as/or 
quantify the coupling strength and direction of coupling between regions. Importantly, 
neither of these questions can be answered by looking at correlation strengths as in 
functional connectivity. 
6.6.3 The evolution equations 
In our example, we have three equations that define ż for each of our nodes (under 
deterministic assumptions); these are known as the equations of motion (or evolution 
equation) because they described the motion or rate of change of the hidden neuronal states 
(displayed in Figure 6.3C & F). Equations of motion in DCM generally take the form: 
𝑑𝑧𝑑𝑡 = 𝑧 = 𝐹 𝑧,𝑢,𝜃  
In bilinear DCM, F, in a DCM with m inputs, is specifically: 
𝑧 = 𝐴𝑧 + 𝑢!𝐵!𝑧!!!! + 𝐶𝑢 
In other words, the rate of change of the hidden neural activity in a given region is a 
nonlinear function of the current hidden state at a distant region times the strength of the 
endogenous coupling between the two nodes (A), plus any bilinear effects of the inputs on 
any afferent coupling (B), plus any driving inputs arriving at the node multiplied by the 
coupling of the exogenous input (C).  
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6.6.4 Model estimation 
DCM uses an expectation maximisation (EM) algorithm to produce probabilistic estimates 
of the expected value of each parameter, in addition to its variance (under the assumption 
that the parameter values conform to Gaussian assumptions, i.e. the parameter values are 
normally distributed). These values (or posterior estimates) are conditional on the model 
structure, thus models with a different architecture, will have different posterior estimates. 
In other words, posterior estimates are the most likely parameters, given a particular model 
and data. The aim of the estimation process is to refine the model parameters, so that the 
model produces a predicted signal that is as close as possible to the observed BOLD data.  
In order to do this, one would need to understand the relationship between the z values for 
each node and the observed BOLD signal y. The relationship between neuronal state and 
observed signal can be modelled as a series of nonlinear biological processes depending on 
the neuroimaging modality utilised. For fMRI data, this originates with neuronal activity, 
causing an increase in the vasodilatory signal. This results in a proportional increase in flow 
into the region with concomitant changes in blood volume and deoxyhaemoglobin content, 
causing the observed change in BOLD response (Friston et al. 2000; Buxton et al. 1998). 
This is called the haemodynamic forward model or the observation model, mapping the 
hidden state to the observed data. This mapping is dependent on a number of 
haemodynamic parameters that, like the coupling parameters, require estimation. 
EM tunes the coupling and haemodynamic parameters so as to maximise the concordance 
between predicted and observed BOLD signal in a way that avoids using unlikely 
parameters (large parameters that render the model unstable or those that deviate 
substantially from prior assumptions on both coupling and haemodynamic parameters – 
the latter based on those obtained in (Friston 2002)). 
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6.6.5 Model evidence 
The estimation procedure additionally scores the model in terms of how well it explains the 
data. It is important to note that this scoring is corrected for how many free parameters 
were estimated; mathematically, a model that has modulatory effects at two connections has 
the potential to explain the data better (i.e. it could be more accurate) than a model with 
modulatory effects on one connection. This would introduce a bias towards complex, 
“over–parameterised” models guilty of “over-fitting”; models that capture noise and over-fit 
data are less generalizable, thus have limited mechanistic value. This scoring is in terms of 
model evidence (or more accurately, the Free energy, which is an approximation of the model 
evidence), and is a compromise between model accuracy and model complexity, avoiding 
bias towards over-parameterised models.  
6.6.6 Bayesian model selection 
The model evidence can subsequently be used to compare a series of models to assess which 
of a number of plausible models is the most likely to have generated the observed data. This 
necessitates the investigator to have a series of equally likely competing hypotheses of the 
underlying functional architecture (or model space) to test a priori.  
Differences in relative log-evidences (the logarithm of model evidence) can then be 
summarised as a conditional probability for each competing model, representing the 
probability of that model, given the observed data. This process of comparing the evidence 
for different models is known as Bayesian model selection (BMS) and has been extended to 
compare models in group studies, and compare different families of similar models (Penny 
et al. 2004; Stephan, Penny, et al. 2009; Penny et al. 2010).  
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6.6.7 Extensions: Two-state DCM for fMRI 
Two-state DCM for fMRI incorporate an excitatory and inhibitory state per region 
(Marreiros et al., 2008). Under default settings, all extrinsic projections are between 
excitatory states, meaning extrinsic connections are always excitatory, which may be more 
biologically plausible when dealing with long-range cortico-cortical projections. In contrast 
to standard DCMs where the intrinsic dynamics are simply represented by the intrinsic 
coupling parameter, in two-state DCM intrinsic dynamics are mediated via four intrinsic 
coupling parameters, of which only one is free to vary during model estimation. This 
extension is useful for a number of reasons. I have chosen to make use of this extension in 
my later chapters because of its ability to incorporate prior beliefs regarding the nature of 
extrinsic coupling. By default, an extrinsic connection projects from the excitatory 
subpopulation of one node to the same subpopulation in another, rendering the coupling 
excitatory. By the same logic, inhibitory coupling can be enforced by simply ‘rewiring’ the 
extrinsic connection to project to the inhibitory subpopulation (see Figure 6.4). 
 
Figure 6.4 ‘Rewiring’ two-state DCM for fMRI to produce inhibitory coupling. Red and blue 
circles represent excitatory and inhibitory subpopulations respectively. 
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6.6.8 Extensions: Stochastic DCM for fMRI 
In stochastic DCM, we no longer rely on deterministic assumptions and include 
endogenous (stochastic) fluctuations in the evolution of regional activity. These 
fluctuations can be conceptualised as autonomous dynamics that are not caused by 
exogenous inputs, sometimes referred to as state noise (Li et al., 2011). In the case of 
stochastic DCM for fMRI: 
𝑧 = 𝐹 𝑧,𝑢,𝜃 +𝜛 
Here, 𝜛 represents stochastic inputs that drive each node in addition to any other 
exogenous input. Stochastic DCM estimates the hidden states, coupling parameters and 
haemodynamic parameters, as well as the stochastic inputs (sometimes referred to as hidden 
causes in the literature) using a variational Bayesian generalised filtering scheme that is 
discussed in detail in a series of technical papers (Friston et al., 2010; Li et al., 2011). This 
extension has previously been face and construct validated for fMRI data with both high 
and low levels of physiological noise (Li et al., 2011). Recently, stochastic DCM has been 
used to model periods of no experimental stimulation, i.e. subjects in the ‘resting’ state 
(Urner et al. 2013). 
6.6.9 Criticisms of DCM for fMRI 
Since its introduction in 2003, DCM has been used to answer a multitude of 
neurobiological questions, usually comparing competing hypotheses of underlying 
functional architecture using BMS. There have been a number of papers voicing their 
concerns for the method, the most notable being (Lohmann et al., 2012). Lohmann et al., 
highlighted two key issues:  
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1. The combinatorial explosion – The authors point out that models containing a large 
number of nodes contain large numbers of edges, and if the point of your research 
question is to ascertain the presence of edges, or whether inputs act upon them, 
there are very large numbers of potential competing hypotheses. Furthermore, using 
a common DCM dataset, the authors demonstrate that if the reported winning 
model is compared to a series of biologically implausible models, BMS identifies the 
implausible models as more likely generators of the data. 
2. Model fits – The authors then highlight that while BMS reports which of a series of 
models is the best, reporting of absolute model fits are often not included in DCM 
studies. Specifically, they highlight especially poor model fits for subcortical regions 
(e.g. the lateral geniculate nucleus) with R2 values in the range of 0.002 – 0.044, 
which they argue brings the validity of the inferences into doubt. 
In response, Friston et al., suggest that (Friston et al., 2013a): 
1. The combinatorial explosion is primarily a problem of network discovery, not 
necessarily if you are comparing a series of a priori competing hypotheses. 
Furthermore, if one were to use family analysis to compare plausible vs. implausible 
models, one would likely find that the plausible ones are more likely generators of 
the data. 
2. To address the issue of model fit in the lateral geniculate nucleus, the authors 
suggest that different parts of the brain can have different levels of noise – this 
could simply be a greater level of observation noise at the subcortical nodes. 
Furthermore, model selection purely based on model fit would bias selection 
towards complex models that may be over-fitting the data. 
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Daunizeau et al., have similarly critically reviewed DCM (Daunizeau et al., 2011). They 
report that criticisms generally either question the (1) plausibility of the biophysical model, 
(2) robustness of statistical inference, or (3) pragmatics of implementation. With regard to 
plausibility, DCM for fMRI employs a relatively simplistic generative model of neural 
activity that does not rigorously model the complex canonical cortical circuits in the way 
electrophysiological DCMs do. Ultimately, this limitation is common to all inferences 
made from fMRI, that is, the neural signal is observed through the haemodynamic response 
(essentially temporally smoothing the data). This results in a relatively poor temporal data 
structure in comparison to MEG/LFP acquisition. Thus, arguably, the plausibility of the 
observer model is of greater importance. In this regard, while DCM for fMRI estimates 
haemodynamic parameters for each node individually, the model could be better informed 
by including (1) how inhibitory activity impacts on the haemodynamic response, or (2) 
how synaptic activity causes vasodilation, with particular reference to glia (Attwell et al., 
2010b). That being said, validation plays an important role in DCM development, each 
DCM undergoing face and construct validity (Friston et al., 2003; Moran et al., 2009), and 
notably predictive validity in the case of both deterministic and stochastic DCM for fMRI 
(Daunizeau et al., 2012a; David et al., 2008).  
Criticisms of the statistical robustness include (1) the vulnerability of free energy 
optimisation (e.g. models converge at a local minima, rather than the global minimum of 
the free energy landscape), and (2) the potential overconfidence of posterior estimates of 
variational Bayesian schemes. Pragmatic issues raised include optimal experimental design 
and model space definition, however both point are common to any scientific inquiry. 
Detailed discussion of these points can be found in (Daunizeau et al., 2011), who conclude 
that “the DCM approach must strike at a compromise between biophysical realism and model 
 Materials and methods  |  95 
95 
identifiability; both are required to answer difficult questions about brain function”. In sum, 
both informing the models with a greater biophysical plausibility, and advancing the 
statistical inferential machinery will be required to enhance implementations of DCM, but 
currently, the method offers a compromise to deliver a mechanistic insight into brain 
function. That being said, these critiques have highlighted that users should not proceed 
without thorough understanding of the underlying assumptions. 
6.6.10 Alternatives to DCM 
Finally, it is worth briefly discussing other established analyses of effective connectivity, 
namely structural equation modelling - SEM - (Büchel and Friston, 1997; McIntosh and 
Gonzalez-Lima, 1994), or granger causality modelling - GCM - (Roebroeck et al., 2005). 
GCM was first introduced within econometrics (Granger, 1969), and later to 
neurophysiology (Bernasconi and König, 1999). The method emphasises the role of 
temporal precedence in causality. Specifically, A ‘Granger causes’ B if A helps predict the 
future of B, better than information already in the past of B (Friston et al., 2013b). 
Application to fMRI data has only taken off relatively recently (Goebel et al., 2003), and is 
more controversial given the slow dynamics and regional variability of the HRF (dealt with 
in DCM by estimating region-specific haemodynamic parameters). Importantly it is worth 
emphasising that GC models dependency amongst observed data, whilst DCM models 
coupling amongst hidden neural states. One recent study using Human Connectome data 
has found that regions close to large veins and sinuses display the largest Granger causality 
lags (Taylor Webb et al., 2013), i.e. regions effecting other regions tend to map to arteries, 
and receiving regions tend to map to veins and sinuses, suggesting GCM is overly biased by 
non-neural artefact (i.e. blood flow).  
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SEM was also imported from econometrics to determine task dependent changes in path 
coefficients, under the assumption that nodes are driven by stochastic processes (in other 
words, there is no designed perturbation of the dynamics by experimental stimuli like in 
DCM). Parameters are estimated by minimizing the difference between the observed nodal 
covariances, and those implied by a structural model specified a priori (Büchel and Friston, 
1997). Like GCM, SEM is also performed at the level of the observed signal. 
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7 The effect of STN DBS on voluntary 
movement-evoked neural activity 
Parts of the following chapter have been published in Kahan et al., (2012) PLoS ONE. 
7.1 Summary 
In this chapter, I present the results of my first fMRI experiment in 10 PD patients with 
STN DBS whilst they performed voluntary joystick movements, once with DBS ON, and 
once OFF. Data was collected under a previously approved scanning protocol. Despite the 
technical demands associated with the safe acquisition of fMRI data from patients with 
implanted hardware, movement x DBS (ON>OFF) interactions were detected in the insula 
cortex and thalamus using small-volume corrected (SVC) statistics.  
I then asked whether these observed changes were simply caused by modulation of intrinsic 
coupling, or whether STN DBS had modulatory effects on extrinsic coupling between the 
cortex and thalamus. As a proof of concept, competing deterministic DCMs consisting of a 
thalamic and cortical node (insula cortex in this case given the observed interaction) were 
estimated, and BMS was used to identify the most likely generator of the data. Results 
suggest unequivocal evidence for the modulation of reciprocal extrinsic connections. 
My conclusions are twofold: Firstly, fMRI is feasible in a cohort of patients with 
chronically implanted DBS, although technically challenging. Secondly, in a simple model 
of cortico-thalamic coupling, STN DBS has modulatory effects on reciprocal cortico-
thalamic effective connectivity. 
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7.2 Introduction 
As outlined in Chapter 5, STN DBS is now a recognized treatment for patients 
experiencing the motor complications of PD (Fasano et al., 2010; Foltynie and Hariz, 
2010; Krack et al., 2003). However, its mechanisms of action remain unclear. High 
frequency stimulation has been found to both inhibit and excite different neurons within 
the target nucleus, having different effects on different neural elements (Hammond et al., 
2008). Evidence exists for both orthodromic stimulation of STN efferents, as well as for 
antidromic stimulation of STN afferents (Gradinaru et al., 2009; McIntyre et al., 2004b). 
In addition, abnormal patterns of synchronized firing in the STN observed in PD patients 
are suppressed by STN DBS (Hammond et al., 2007; Litvak et al., 2011). 
As reviewed in section 5.4.2, PET and SPECT studies have reported changes in regional 
activity in response to STN DBS, although the results are sometimes conflicting. Regarding 
movement-related activity, studies have reported DBS increasing activity in the 
supplementary motor area (SMA), anterior cingulate cortex (ACC) and dorsolateral 
prefrontal cortex (DLPFC) (Ceballos-Baumann et al., 1999; Limousin et al., 1997; Strafella 
et al., 2003a; Thobois et al., 2002). Additional changes have been noted in the cerebellum 
(Grafton et al., 2006; Payoux et al., 2004), as well as within the subcortical structures 
comprising the BG (Hesselmann et al., 2004; Thobois et al., 2002).  
While altered regional responses have been explored, relatively little is known about the 
effect of DBS on connectivity amongst functional brain networks. Neural processing is 
dependent upon functional integration, that is, finely tuned collaboration between 
functionally specialized regions (Friston, 2009). Increased functional connectivity in 
frontal-temporal-parietal-striatal-thalamic networks has been reported in response to DBS 
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of the fornix in patients with Alzheimer’s disease, and of the external pallidum (GPe) in 
patients with Huntington’s disease (Ligot et al., 2011; Smith et al., 2012). One study has 
reported changes in effective connectivity under STN DBS during a response inhibition 
task; Thobois et al., used a PPI analysis to show altered output from the GPi to the cortex 
under STN DBS (Thobois et al., 2007), however did not explore reciprocal cortico-
subcortical coupling, and the PPI could be ambiguous (see section 6.5 & Figure 6.2). 
As discussed in section 5.4.2.8, fMRI has advantages over tracer-based imaging including a 
superior spatial resolution as well as valuable data modelling methods, but its use in DBS 
patients has been limited by safety concerns. As a result, only a handful of DBS patients 
have been evaluated using fMRI, all during the peri-operative period, without internalized 
neuro-pacemakers (IPGs), that is, before therapeutic stimulation had been established. 
However our own on-site studies have now confirmed that fMRI can be safely performed 
during active DBS with a completely internalized system, provided strict procedures are 
followed (Carmichael et al., 2007).  
7.2.1 Aims 
The aims of this study were threefold: 
1. Confirm the technical feasibility of fMRI during therapeutic STN DBS in patients 
with PD, and identify potential improvements to the protocol. 
2. Identify regions displaying a movement x DBS interaction (either ON>OFF or 
OFF>ON). 
3. Model the cortico-thalamic effective connectivity, and how it is modulated by STN 
DBS; specifically, is there evidence for altered cortico-thalamic coupling. 
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7.3 Materials and methods 
7.3.1 Ethics Statement 
This study was approved by the National Hospital and Institute of Neurology Joint Ethics 
committee (approval number 09/H0716/51). All participants provided written informed 
consent. 
7.3.2 Patients 
Ten PD patients took part in this study Table 7.1. All patients had PD meeting UK brain 
bank criteria, and had received bilateral STN DBS for at least 6 months. Surgery had been 
performed using stereotactic MRI for both preoperative targeting and immediate 
postoperative verification of lead location prior to implantation of the extension cables and 
the IPG (Foltynie and Hariz, 2010; Holl et al., 2010). 
7.3.3 Stimulation Equipment 
All patients had bilateral STN electrodes (model 3389, Medtronic, Minneapolis) and a dual 
channel IPG (Kinetra, Medtronic, Minneapolis) implanted. Stimulation parameters had 
been previously optimised according to clinical response. Inclusion in this study was 
restricted to those patients who: 
1. Could tolerate lying flat while being both off medication and off stimulation  
2. Exhibited minimal head tremor 
3. Demonstrated an immediate >35% improvement in UPDRS part 3 (UPDRS-III) 
off-medication score when stimulation was switched ON compared with OFF. 
Medication was withdrawn for 10-12 hours (overnight) before the scanning session. Before 
scanning, (1) UPDRS-III motor scores were documented both ON and OFF stimulation 
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(OFF was scored approximately 10 minutes after stimulation was stopped), (2) stimulation 
parameters and system impedance were recorded, and (3) IPG counters were reset.  
Participants wore MRI compatible isolating headphones and held an MRI compatible 
joystick in one hand (Cambridge Research Systems, Kent, England: model No: HH-JOY-
4. Angular range: 30 degrees (+/-15 degrees), Grip: 11.5 x 3 cm). The position of the 
joystick in time and space was recorded at a sampling rate of 20Hz. During the task, 
participants were instructed to move the joystick consistently in response to auditory 
stimuli and to avoid excessively fast or large movements12. Their heads were securely 
supported using a vacuum moulded cushion to dampen any head movement. Patients held 
an alarm in their non-moving hand to alert the clinical team if they experienced any 
discomfort during the scan. Patients were asked to keep their eyes closed throughout 
scanning. 
The task was performed both with therapeutic stimulation active (ON), and again when 
their stimulation was inactivated (OFF). During each stimulation condition, the task was 
performed twice, once with each hand. In other words, every patient performed a right and 
left hand movement task while stimulation was ON and OFF. The order of stimulation 
(ON versus OFF) and the movement (right versus left) were randomised over subjects. 
DBS was switched ON or OFF using the patients’ own AccessTM controller, which we 
ensured functioned normally within the MRI environment. 
7.3.4 MRI data acquisition 
All scans were performed with a Siemens Avanto 1.5T MRI scanner (Siemens, Erlangen, 
Germany) using a Siemens-supplied head-transmit/receive coil, similar to the one that 
                                                   
12 In piloting this task, we found that such movements resulted in the joystick handle falling off. 
 The effect of STN DBS on voluntary movement-evoked neural activity  |  102 
102 
detailed tissue-equivalent test-object thermometry experiments had been performed with in 
the on-site safety study (Carmichael et al., 2007). The specific absorption ratio (SAR) in 
the head was limited to under 0.1W/Kg.  
Acquisition parameters were as follows:  
1. T1 weighted magnetization-prepared rapid gradient-echo (MPRAGE) structural 
scan (repetition time TR=1590ms, echo time TE=3.3ms, inversion time 
TI=1100ms, flip angle=15°, field of view FOV=250x250mm2, matrix 
size=192x192, 144 sagittal slices 1.3mm thick, for a spatial resolution of 1.3mm 
isotropic) lasting approximately 10 minutes. This scan, and an additional 8 minute 
resting scan (reported in Chapter 8), allowed a constant period of equilibrium to 
follow each patient’s stimulation adjustment. 
2. GE-EPI Movement session, Hand 1: (TR=3695ms, TE=40ms, flip angle=90°, 
FOV=192x192mm2, matrix size=64x64, 49 axial slices 2.5mm thick, gap between 
slices of 0.5mm, for a spatial resolution of 3x3x3mm3, 96 volumes, acquisition 
time=6 minutes). The fMRI task paradigm consisted of 12 blocks lasting ~30 
seconds each. During each block, a series of 15 audio stimuli (beeps) were sounded 
through the headphones. The time between beeps was randomised to between 1-3 
seconds. The blocks alternated between a “rest” and a “go”. At the beginning of 
each “rest” block the participant heard the word “rest” and was instructed to rest 
their hand on the joystick, ignore the beeps and keep still. At the beginning of each 
“go” block the participant heard the word “go” and was instructed to move the 
joystick in one of four random directions of their choice, and then return the 
manipulandum back to the central resting position. A single movement was defined 
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as moving the joystick from its position of equilibrium and then returning the 
joystick back to this position. The exact timings of the beeps were also recorded.  
3. GE-EPI Movement session, Hand 2: The joystick was then moved to the opposite 
hand, and acquisition 2 was repeated.  
Additionally, field maps were acquired to correct for field inhomogeneity. Patients then had 
their stimulation switched to the opposite condition. The joystick was returned to the hand 
that had first performed the task and the aforementioned acquisitions were repeated. 
At the end of the session, DBS was switched back ON if OFF during the second session, 
and the patient was examined (including a repeat evaluation of UPDRS-III). The DBS 
system was interrogated to check the settings and impedance, and to check for additional 
activations.  The patients were given their regular PD medication and had a final clinical 
assessment after their medication had started to take effect to confirm they had returned to 
their baseline level of Parkinsonian disability before leaving the department.   
Each participant completed the session with four movement task sessions, one for each 
hand during each stimulation condition. This corresponds to a factorial design with three 
factors; task (movement versus no movement); laterality (right versus left) and stimulation 
(ON versus OFF). The whole session took approximately 90 minutes. The connection 
between the electrode lead and the extension cable, commonly sited above the left parietal 
bone caused a loss of signal artefact resulting in data not being acquired in left hemispheric 
sensorimotor areas. Given these regions were a priori regions of interest, particularly when 
examining right hand movements, we elected only to analyse the left hand movement data. 
This resulted in a factorial design with two factors; task and stimulation.  
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Movement durations and reaction times were extracted from the joystick dataset by manual 
examination of the position over time. Paired t tests were used to judge significant changes 
in joystick movements comparing ON and OFF stimulation periods. 
7.3.5 Image processing 
Data were pre-processed and analysed using the SPM12 (Wellcome Trust Centre for 
Neuroimaging, London, UK; http://www.fil.ion.ucl.ac.uk); for effective connectivity 
analyses, DCM12 was used. The SPM Anatomy toolbox (Eickhoff et al., 2005) was used to 
translate peak MNI coordinates into anatomical and functional regions based on 
probabilistic cytoarchitectonic maps.  
Data were spatially pre-processed as outlined in section 6.4.1. In brief, data were first 
corrected using the acquired field maps, then realigned, and normalised to MNI space. 
Data were then visually inspected to confirm they had been correctly normalised given the 
artefact created by the DBS hardware, and were finally smoothed using an 8mm Gaussian 
kernel. Data were high-pass filtered set to the standard threshold (128-s). 
When field maps were examined, the extent and amplitude of the expected distortions 
caused by the DBS hardware on the skull were approximately the same as the extent and 
amplitude of the distortions caused by the presence of the sinuses. This suggests that the 
DBS hardware causes no more distortion than the sinuses do, and the field maps are 
sufficient to correct for them.  
7.3.6 Analysis of regional responses 
Standard SPM (whole brain) statistical analysis then ensued. An epoch-related design, 
where each activation epoch (block) was defined as the time period from the beginning of 
the first movement in a “go” block, to the end of the last movement in that block. Each 
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movement session thus consisted of six motor epochs, corresponding to the six “go” blocks. 
The resulting boxcar stimulus function was then convolved with a canonical 
haemodynamic response function to form expansionary variables or regressors that 
constitute the design matrix. Both (ON and OFF) movement sessions, for each participant, 
were analysed in one design matrix. Six nuisance regressors were included for each session 
modelling the confounding effects of head motion in the design matrix.    
A standard random effects analysis was performed by first computing contrasts of effects at 
the first level, and then analysing these summary statistics at the second level using one 
sample t-tests. Intrinsic masking was used to exclude voxels affected by DBS hardware-
related artefact. 
A T contrast corresponding to the main effect of movement was specified to (1) ensure that 
this could be detected in the DBS setup with a suitable degree of sensitivity and anatomical 
precision, and (2) to define a network of brain regions engaged by the motor task. Further 
T contrasts were specified defining the interaction between task and stimulation. This 
resulted in two contrasts (Main Effect of Movement – Left hand, Movement x DBS 
interaction – Left hand), and ensuing statistical parametric maps (SPMs). 
All 10 subjects’ normalised structural T1 scans (taken during ON) were combined to create 
a group structural T1 normalised to MNI space. One-sample t-tests were performed on 
group data separately for each of the contrasts to produce SPMs that were then 
superimposed on the group structural image. Second level tests on the main effect of 
movement contrast were adjusted for handedness and UPDRS-III ON score by including 
mean-centred confounds in the second level design matrix (multiple linear regression 
model). This accounts for confounding effects due to inter-subject variability in 
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Parkinsonian disability. In the same manner, second level tests on interaction contrasts 
were corrected for handedness and percentage improvement in UPDRS-III score when 
going from OFF to ON.  
The main effect of movement contrast served to define the network of brain regions related 
to voluntary movement. The fifteen peak voxels of clusters larger than 5 voxels with the 
highest z statistics (range: 4.87–3.81) were defined as ‘nodes’ of the motor network. Any 
clusters consisting of purely white matter voxels were omitted.  
A restricted volume analysis was then performed to assess the interaction between 
movement and stimulation within the nodes of the aforementioned network. Restricted 
volumes (8mm radius spheres) were centred on the peak voxel of each node. A statistical 
threshold of p<0.05 (FWE corrected, with a cluster threshold of 5 voxels) was used to assess 
significance. Regions surviving this threshold were considered to show significant 
interactions between movement and stimulation.  
Given that extensive PET imaging studies have previously proposed a network of areas 
involved in the therapeutic response to STN DBS and that this is the first report of fMRI 
activations and their modulation by therapeutic DBS, interaction contrasts were explored at 
lower uncorrected thresholds (p<0.005, cluster size of 5 voxels) in an exploratory fashion. 
The results of this analysis are not formally reported, but regions were considered of interest 
for future study. 
7.3.7 DCM 
Results of the SPM revealed two regions (one cortical, one subcortical) displaying 
significant movement x DBS interactions. The design matrix was rotated for the DCM 
analysis; ON and OFF scans were concatenated into a single session with a single 
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movement stimulus function. Parametric modulators were used to model the movement x 
DBS interaction. The main effect of DBS was modelled as a boxcar, with values of one 
during stimulation ON and zero otherwise.  
Subject-specific peak coordinates of the regional interactions were used to identify nodes or 
regions in the DCM. Data was extracted from spheres (r = 4mm) centred on peak voxels 
(p<0.05 uncorrected threshold) within 16mm of the second level peak in each of the two 
regions. Three subjects failed to show significant peaks in both regions and were excluded 
from DCM analysis. 
The model space compared 16 equally plausible generative models of the two node DCMs. 
The main effect of movement entered the model as a driving input to the cortical node. 
The two nodes were reciprocally connected (A-matrix). DBS entered the model as 
modulatory effect on a subset of connections, including the two intrinsic connections, and 
the reciprocal extrinsic connections, resulting in (24 =) 16 different DCMs per subject, and 
thus (16 DCMs x 7 subjects =) 112 DCMs in total. The model space is presented 
diagrammatically in Figure 7.3. Models were estimated using deterministic DCM. 
BMS (using fixed-effects assumptions) was used to select which of the 16 models had the 
greatest evidence, given the data (Penny et al., 2004; Stephan et al., 2010). Fixed-effects 
model comparison was chosen because subjects were recruited under the assumption they 
have the same functional architecture and that DBS had consistent effects within this 
anatomy. For quantitative interpretation, the coupling parameters of the DCMs were 
averaged using Bayesian Model Averaging (BMA), in which parameter estimates are 
weighted by the model evidence (Stephan et al., 2010).  
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Correlations between the connectivity parameters and the UPDRS-III scores and UPDRS-
III improvements were performed for predictive validity 
7.4 Results 
7.4.1 Clinical response and motor task data 
Clinical responses as measured by the UPDRS-III scores are shown in Table 7.1. The mean 
improvement was 27.5 points (56.7% improvement, p<10-6). Similar improvements were 
also seen when the task data was analysed.  Left hand movement durations and reaction 
times were decreased in the ON condition by an average of 28.87% (p=0.002), and 
20.33% (p=0.025) respectively. The mean movement duration during ON and OFF were 
0.82s and 1.27s respectively. The mean reaction times during ON and OFF were 0.63s and 
0.83s respectively. Post-operative MRI – employing fine cuts through the STN – 
confirmed that each electrode contact lay within or overlapped the anatomical border of the 
STN in both axial and coronal views. 
Scanning proceeded with no adverse events or change in post-scan UPDRS-III scores. Re-
introduction of PD medications led to restoration of baseline motor function. Post-scan 
inspection of the IPG revealed DBS stimulation parameters and circuit impedance were 
unchanged. 
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Sub Age H Post-
op 
UPDRS-III Move duration (s) RT (s) 
OFF ON % OFF ON % OF
F 
ON % 
1 65 L 20 53 21 60.4 1.1 1.3 12.8 0.8 1.0 27.3 
2 72 R 53 47 29 38.3 2.4 0.7 -70.6 1.0 0.6 -44.0 
3 54 R 9 33 10 69.7 0.8 0.6 -26.3 0.6 0.5 -12.5 
4 65 R 67 60 20 66.7 1.0 0.7 -29.6 0.6 0.4 -23.6 
5 50 L 102 51 17 66.7 1.3 0.8 -34.1 0.6 0.5 -21.0 
6 63 R 29 46 19 58.7 0.6 0.5 -19.4 1.1 0.6 -44.6 
7 54 R 19 45 26 42.2 1.0 0.8 -17.0 0.8 0.8 0 
8 56 L 30 52 19 63.5 2.4 1.2 -48.5 1.3 0.6 -52.0 
9 43 L 48 51 23 54.9 0.9 0.6 -31.9 0.7 0.6 -6.1 
10 61 R 8 46 25 45.6 1.1 0.9 -24.1 0.9 0.7 -26.9 
Mean 58.3  38.5 48.4 20.9 56.7 1.3 0.8 -28.9 0.8 0.6 -20.3 
SD 8.51  29.5 7.03 5.32 11.1 0.6 0.3 21.5 0.2 0.2 23.9 
Table 7.1 Summary of patient demographics and response to STN DBS. All assessments took 
place off medication. Age and post-op refer to the age of the patient and months since 
implantation. % refers to the percentage change from OFF to ON, i.e. (OFF-ON)*100/OFF. H 
refers to dominant hand; left (L) or right (R). 
7.4.2 Hardware-related Artefact 
All GE-EPI scans suffered dropout artefact thought to be caused by the subgaleal 
connectors between the leads and extension cables sited over the left parietal bone (see 
Figure 7.1).  
7.4.3 Analysis of regional responses 
The main effect of movement was in accordance with previously published accounts 
(Limousin et al., 1997). The purpose of this contrast was to establish a network of 
functionally specialised nodes associated with task performance in our cohort. A summary 
rendered SPM of the network is displayed in Figure 7.1. 
Adjustment for clinical response to stimulation did not affect the regions that demonstrated 
highest levels of peak level BOLD response. 
Our initial restricted volume analysis of the interaction (movement x stimulation) revealed 
increases in BOLD responses in the right insula cortex, and right thalamus (p<0.05, FWE 
corrected) (i.e. contralateral to left hand movements) when DBS was active Figure 7.1e/f. 
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Subsequent exploratory whole brain analysis of the interaction contrasts at uncorrected 
thresholds (p<0.0005) revealed increases in the left superior frontal gyrus (Premotor area, 
PM, BA 6) and middle frontal gyrus (BA 10/46, DLPFC), right intra-parietal sulcus 
(hIP1), and inferior frontal gyrus pars triangularis (BA 45). See Table 7.2. 
 
Figure 7.1 Imaging results. A typical drop-out artefact in a single subject’s GE-EPI acquisition 
viewed from (a) axial, (b) coronal, and (c) sagittal sections; cross-hair position = -34.8, -21.5, 
53.3mm (MNI coordinates). SPMs in (d) summarize the movement network on a rendered 
MNI brain (p<0.001 uncorrected). Clusters representing BOLD signal increases in the insula 
cortex (e, green arrow), and thalamus (f, green arrow). 
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Size 
(vx) 
T Z P(unc) P(SVC) MNI coordinates Anatomy BA 
    x y z    
20 13.1 4.6 1.8E-6 - -24 -2 62 L SFG 6 
6 10.1 4.3 9.8E-6 - -40 42 20 L MFG 47  
49 9.2 4.1 1.9E-5 0.005 38 -2 0 R Insula   
19 8.9 4.1 2.2E-5 - 38 30 16 R IFG 45 
6 8.9 4.1 2.3E-5 - -24 -14 16 L Putamen   
7 8.6 4.0 2.8E-5 0.017 18 -24 10 R Thalamus   
12 8.4 4.0 3.4E-5 - 20 -36 56 R Postcentral 3 
23 8.3 4.0 3.5E-5 - 38 -40 34 R IPS  
5 8.2 4.0 3.8E-5 - -10 -16 0 L Thalamus   
7 8.0 3.9 4.4E-5 - -30 -22 40 L Postcentral 3 
9 7.6 3.8 6.4E-5 - 32 14 4 R Insula   
20 13.1 4.6 1.8E-6 - -24 -2 62 L SFG 6 
Table 7.2 Results of Movement x DBS (ON>OFF) interaction contrast at second level. 
Thresholded at whole brain peak voxel p<0.0005 (uncorrected), Cluster size>5 voxels (vx). 
Regions in bold were identified in the restricted volume analysis to the motor network described 
in the text (p<0.05, FWE corrected). The remaining regions are reported in view of strong 
support of their involvement from previous publications. BA = Brodmann’s area. 
7.4.4 DCM 
The relative log-evidences across all models for all participants are shown in Figure 7.2. 
Model 15 was found to be the most likely architecture (posterior probability > 95%), 
followed by 3 and 1. The difference in relative log-evidences, ΔF, were 3.77 and 8.25 
respectively, indicating that there is strong evidence in favour of model 15 (Kass and 
Raftery, 1995). Model 15 incorporated modulatory effects on both intrinsic cortical and 
thalamic coupling, as well as reciprocal extrinsic cortico-thalamic coupling. BMA estimates 
of coupling are reported in Figure 7.3. 
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Figure 7.2 BMS results. FFX = Fixed Effects Assumptions. (a) The relative log-evidences across 
all 16 specified models with model 3 showing the highest log-evidence. (b) Given the observed 
data and the models specified, one can be >95% certain that model 15 is the data generator. (c, 
d) This is more clearly illustrated by just including the 4 most likely models. 
7.4.5 Predictive validity 
There was no significant correlation between cortico-thalamic connectivity parameters and 
the clinical scores (P<0.05) to suggest a direct linear relationship between these indices. 
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Figure 7.3 Model space, winning model, and BMA estimates. Model 15 – the winning model – 
is shown enlarged. The blue node represents the right insula cortex, and red node, the right 
thalamus. Green arrows indicate the connection/s that DBS modulates. The ‘movement input’ is 
likely made up of both motor inputs arriving from M1, PM and SMA, as well as sensory inputs 
elicited by on-going movements. Average DCM parameters are included on the enlarged model 
15, units are in Hertz (Hz). Positive A-matrix parameters represent an excitatory effect on the 
target, whereas negative values indicate an inhibition of the target area. Positive B-matrix 
parameters (value in green) represent an increased target response to input (i.e. an increased 
gain), whereas negative values indicate a decreased target response to input (i.e. a reduced gain). 
The coupling during movements with DBS is equal the sum of the A and B value on that 
connection, e.g. during movements with DBS, the cortico-thalamic drive switches from -0.21 Hz 
to (-0.21 + 0.30)= 0.09 Hz, i.e. it switches from an inhibitory to an excitatory drive. 
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7.5 Discussion 
The results of this experiment shed light on both the methodological and neurobiological 
issues set out in its aims: 
7.5.1 Technical significance 
Firstly, this experiment demonstrated that fMRI can be used to study the effects of 
therapeutic STN DBS on brain activity without compromising patient safety or DBS 
function. All sequences used were informed by the existing safety protocol, which was 
established following rigorous on site in vitro experimentation. It is important to stress the 
importance of performing on-site assessments given the variability in scanner configurations 
(Carmichael et al., 2007; Zrinzo et al., 2011).  
Furthermore, the functional data, at least the movement-evoked activity, appeared 
consistent with the published literature. In the analysis of regional responses, the main 
effects of movement contrast was specifically examined for two reasons. Firstly, pertaining to 
the technical feasibility, to assess the reliability of fMRI in these patients, i.e. whether 
regions specialized for task performance that were in accordance with the literature 
(Limousin et al., 1997). Secondly, the contrast helped produce a mask within which to 
search for voxels demonstrating an interaction. 
7.5.1.1 DBS hardware related artefact 
However, by far the biggest challenge faced with these patients was the artefact produced by 
the interface between the extension cable and the electrodes. The issue was exacerbated by 
non-uniformity in the hardware geometry amongst the cohort. In other words, the position 
of the connector between the extension cable and electrodes varied between subjects, largely 
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staying over the left parietal bone laterally, but sometimes placed more anteriorly or 
medially. 
The connector resulted in a drop out susceptibility artefact on GE-EPI acquisitions, 
partially obscuring left sensorimotor regions. While these artefacts were destructive during 
first level analysis, their effects were more marked in the second level analyses due to the 
additive nature of the artefact across the group. The same was true with regards the artefact 
present at the electrode tip. Whilst this artefact was much smaller (in terms of size), the 
additive nature likely made it impossible to detect any BOLD signal in the STN, possibly 
extending into the thalamus.  
That being said, there was no evidence to suggest that BOLD signal from the remaining 
brain was affected. This is in line with previous studies involving implanted electrodes have 
confirmed that similar artefacts do not significantly impair the functional data (Vulliemoz 
et al., 2011). 
As a result of the artefact, data from right hand movements were not formally analysed. We 
included a covariate for hand dominance to minimize variability vis-à-vis laterality of 
function. Other studies investigating motor control generally use right hand movements, 
complicating comparisons with other studies, but this was unavoidable given our standard 
surgical practice of placing the connector to electrode extension cables subcutaneously over 
the left parietal bone. Future fMRI studies in patients implanted at this centre (and thus 
routinely have their artefact over the left hemisphere) should only concentrate on a left 
sided motor task.  
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7.5.1.2 Selection criteria 
Our selection criteria were set such that the cohort studied (1) responded well to STN DBS 
acutely, maximising the difference in clinical phenotype between DBS conditions (the 
minimum UPDRS-III improvement in our sample was 38.5%), and (2) had received DBS 
for at least 6 months, meaning any post-operative oedema had almost certainly subsided. 
While this permitted novel investigation of the modulatory effects of confirmed therapeutic 
stimulation, our conclusions can only be applied to patients who have shown such 
improvements. Similarly, constraining our selection to only patients with good response 
(and a small sample size) implicitly reduced the variance of clinical responses, which may 
explain why none of the correlations between coupling and UPDRS-III scores were 
significant.  
Given the comments made above (section 7.5.1.1) regarding the artefact, in future studies 
it may be worth selecting patients who have more consistent patterns of artefact. This is 
obviously difficult to ensure, but future selection should involve reviewing the patient’s 
surgical report for any mention of the position of the subgaleal wiring. 
7.5.2 Neurobiological significance: Regional responses 
7.5.2.1 Increased motor-evoked responses in the insula 
Increased activity in the insula under DBS is a difficult finding to interpret given the vast 
number of functional properties ascribed to this region. Functional MRI meta analysis has 
revealed the insula cortex is activated by a range of stimuli including emotional 
recall/induction, empathy (as elicited by judging emotional faces), olfaction, gustation, 
interoception (e.g. listening to one’s heartbeat or suppressing the need to void), 
somatosensation, and motor processing (Kurth et al., 2010). This suggests the insula is an 
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extremely non-selectively activated region, thus employing reverse inference to suggest 
possible relevance would be troublesome (Poldrack, 2006). It is tempting to suggest the 
changes under DBS are motor related (especially given the contrast searches for regions 
changed during the movement blocks). However, while reaction times and movement 
durations were recorded and did change, there are a number of other behavioural variables 
that were not recorded that feasibly could have changed under stimulation to satisfy similar 
reverse inferences. 
DBS has previously been found to modulate insula activity, both in patients (Garraux et al., 
2011; Hesselmann et al., 2004), and in animal models of STN DBS (Min et al., 2012). 
Similarly, previous reports demonstrate that PD patients show reduced insula cortex 
activation during self-generated movements (Jahanshahi et al., 1995). Tractography has 
identified pathways connecting the insula cortex to the STN (Lambert et al., 2012), 
consistent with reports of posterior insula lesions resulting in hemiballismus (Etgen et al., 
2003). 
7.5.2.2 Increased motor-evoked responses in the thalamus 
While previous studies have suffered from limited	   spatial resolution making subcortical 
structures difficult to examine, thalamic modulation at rest has been widely reported (Arai 
et al., 2008; Asanuma et al., 2006; Hershey et al., 2003; Hilker et al., 2004; Karimi et al., 
2008; Sestini et al., 2005) – see . Similarly, one study employing a learned joystick task has 
reported movement x DBS interaction (Thobois et al., 2002). Given that the orthodromic 
output of the STN ultimately projects to the thalamus, increased thalamic BOLD response 
is in-keeping with electrophysiologically established orthodromic effects of STN 
stimulation on the thalamus (Benazzouz et al., 2000b; Dorval et al., 2008; Xu et al., 2008). 
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7.5.2.3 Exploratory findings at uncorrected whole-brain thresholds 
Additional interactions were found in the intra-parietal sulcus, IFG, PM and DLFPC 
(p<0.0005, uncorrected). While these changes did not survive FWE correction, their 
detection at stringent uncorrected thresholds, high z-scores, and accordance with previous 
literature (Ceballos-Baumann et al., 1999; Limousin et al., 1997), merit inclusion in this 
report. 
7.5.3 Neurobiological significance: Cortico-thalamic coupling 
As a simple proof of concept, I modelled the potential neuromodulatory effects of STN 
DBS that could have produced the movement x DBS interactions in the cortex and 
thalamus. The model tested is obviously a simplification, specified in order to make first 
inferences on whether DBS alters cortico-subcortical coupling. Importantly, DCM does 
not distinguish between monosynaptic or polysynaptic connections; the BMS was not to 
test nature of direct insula-thalamic connectivity. Rather the insula served as a summary for 
a cortical region modulated by DBS, that sends efferents to the thalamus via BG nuclei, 
and receives thalamic afferents either directly, or more plausibly, via other cortical nodes. 
The winning model included cortico-thalamic, thalamo-cortical, and intrinsic modulation 
of both cortex and thalamus. 
The nature of the coupling and neuromodulation is less significant in this experiment, the 
key finding here is where DBS is acting. Although BMA estimates of the coupling suggest 
that during movements with DBS OFF, the insula has an inhibitory influence on the 
thalamus. DBS was found to reverse this, as well as reduce the intrinsic self-inhibition. 
Precise interpretation of the BMA estimates is complicated by the simplified model 
structure. One can speculate that given the thalamic response to cortical excitation depends 
on the pathway through which the signal is propagated (the hyperdirect and indirect 
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pathways cause an excitation of the GPi/SNr - resulting in thalamic inhibition, whereas 
transmission via the direct pathway disinhibits thalamic neurons), the reported shift from 
predominant inhibition to excitation of the thalamus may suggest that DBS biases the 
thalamus towards the direct pathway afferents. This is somewhat of a leap, and more 
anatomically detailed DCMs are required to test this hypothesis formally (this is 
undertaken in Chapters 8, 10 & 11). 
Modulation at the level of the cortex may be explained by the hyperdirect tract between the 
STN and insula cortex. This supports recent claims from the animal literature that 
antidromic stimulation of axons projecting to the STN produces complex activations of 
cortical circuits (Li et al., 2007), which might also be responsible for the clinical effect of 
DBS (Gradinaru et al., 2009). Further studies employing electrophysiological techniques 
may be required to provide deeper insights into the synaptic mechanisms involved. 
7.5.4 Limitations and reflection 
I believe that while the results of this experiment do contribute to the neurobiological 
understanding of DBS, there are a number of limitations that should be addressed in later 
experiments. 
Firstly, in the analysis of regional responses, our results were only significant using SVC 
statistics. While a lot of the previous neuroimaging work has also reported within these 
constraints, I was disappointed that results were not significant at the whole brain level 
using robust correction for multiple comparisons. On reflection, this could be due to the 
quality of the collected data from both a hardware perspective (e.g. the use of head-
transmit/receive coils), and at the patient level (e.g. patient movement during scanning). 
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That being said, we did our best to minimise head movements (securing the head, realign 
and unwarp, and inclusion of head motion parameters in the first level GLMs). 
Finally, more plausible models of the cortico-thalamic BG loop are required to draw 
informative inferences regarding the modulation of specific pathways. The speculation I 
put forward above requires formal investigation. Furthermore, more plausible models 
might help produce more clinically meaningful estimates of effective connectivity. 
7.5.5 Conclusions 
My conclusions are twofold: Firstly, fMRI is feasible in a cohort of patients with 
chronically implanted DBS, although technically challenging. Secondly, in a simple model 
of cortico-thalamic coupling, STN DBS has modulatory effects on reciprocal cortico-
thalamic effective connectivity. 
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8 The effect of STN DBS on endogenous 
coupling in the basal ganglia motor 
loop 
Parts of the following chapter have been published in Kahan et al., (2014), Brain. 
8.1 Summary 
In this chapter, I present the results of my second fMRI experiment conducted on 12 PD 
patients (10 of which were analysed in Chapter 7) with STN DBS as they lay in the scanner 
at rest with their eyes closed. As discussed, non-invasive characterisations of induced brain 
responses, and the effective connectivity underlying them, generally appeals to DCM. 
When the brain is at rest however, this sort of characterisation has been limited to 
correlations. Using stochastic DCM, I modelled the effective connectivity underlying 
BOLD fluctuations in the resting Parkinsonian BG motor loop, and the modulatory effect 
of DBS. 
Results demonstrate that STN DBS modulates all the major components of the motor 
cortico-striato-thalamo-cortical loop, including the cortico-striatal, thalamo-cortical, direct 
and indirect basal ganglia pathways, and the hyperdirect STN projections. The strength of 
effective STN afferents and efferents were reduced by stimulation, whereas cortico-striatal, 
thalamo-cortical and direct pathways were strengthened. Regression analysis revealed 
predictive validity of coupling parameters on clinical status and response to DBS. 
I conclude that (1) anatomically plausible DCMs of the BG architecture can capture the 
distributed modulatory effects of DBS, (2) STN DBS increases direct, cortico-striatal and 
 The effect of STN DBS on endogenous coupling in the basal ganglia motor loop  |  122 
122 
thalamo-cortical pathways, but reduces coupling of STN afferents and efferents, (3) 
coupling and neuromodulatory effect in the STN afferents and direct pathway predict 
clinical status and therapeutic effect of DBS. 
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8.2 Introduction 
As outlined in section 5.2, progressive asymmetric degeneration of nigrostriatal 
dopaminergic innervation is a primary hallmark of PD. Clinically, this typically produces 
asymmetric motor symptoms that impact on behaviours both ‘during action’ and ‘at rest’. 
Of this latter group, rigidity and resting tremor are most common. STN DBS has become 
an established therapy for managing these symptoms – when dopaminergic medications 
alone are no longer sufficient (Krack et al., 2003; Limousin et al., 1995). While most 
conventional therapeutics aim to restore dopamine concentrations to physiological levels, 
the mechanism of action of STN DBS is less clear. Since the effect of DBS mimics that of 
ablative lesions, it was suggested that DBS ‘inhibits activity’ in the target, which accorded 
with rate-based models of basal ganglia (BG) circuits (Albin et al., 1989; Beurrier et al., 
2001; DeLong, 1990; Meissner et al., 2005). However, the literature – ranging from 
animal to computational models – suggests that stimulation has a myriad of effects on 
various neural elements in and around the STN, culminating in clinical improvement 
(Deniau et al., 2010; McIntyre and Hahn, 2010; Perlmutter and Mink, 2006; Vedam-Mai 
et al., 2012).  
BOLD fMRI signal recorded while the subject lies at rest with eyes closed could represent 
an important tool for clinical diagnosis and understanding brain disorders (Biswal et al., 
1995; Deco et al., 2011; Fox and Greicius, 2010). Brain regions of similar functional 
specialisation have been shown to display functional connectivity during rest (e.g. motor 
and visual networks respectively (Biswal et al., 1995; Lowe et al., 1998)). Parkinsonian 
patients off medication have been shown to display reduced BOLD functional connectivity 
amongst the pre/motor cortex and putamen (Esposito et al., 2013; Wu et al., 2009), 
increased connectivity between M1 and cerebellum (Wu et al., 2009), reduced striato-
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thalamic connectivity (Hacker et al., 2012) as well as increased M1-STN connectivity 
(Baudrexel et al., 2011). Electrophysiological studies report similar changes in coherence 
between the STN and motor cortical areas in resting Parkinsonian patients (Shimamoto et 
al., 2013) that can be restored by dopaminergic medication (Litvak et al., 2011). Thus, 
there is a wealth of evidence implicating dopamine’s neuromodulatory role in resting 
cortico-subcortical circuits. 
As reviewed in detail in section 5.4.2.4, when investigating neuromodulatory effects of 
DBS at rest, previous human imaging studies have largely used either PET or SPECT. 
These studies have demonstrated STN DBS-induced changes in both blood flow and 
glucose metabolism at rest in key constituents of the motor network including M1, 
putamen, and thalamus (Asanuma et al., 2006; Boertien et al., 2011; Ceballos-Baumann et 
al., 1999; Cilia et al., 2009; Geday et al., 2009; Grafton et al., 2006; Haslinger et al., 2005; 
Hershey et al., 2003; Hilker et al., 2008; Jech et al., 2001; Karimi et al., 2008; Limousin et 
al., 1997; Payoux et al., 2004; Stefurak et al., 2003). Imaging in animal models has yielded 
similar results (Lai et al., 2014; Min et al., 2012). One short report described increased 
functional connectivity among premotor regions in response to STN DBS (Mueller et al., 
2013); however, fMRI has been limited in these patients due to safety concerns. This centre 
has conducted on site safety studies, demonstrating that any risk to the patient can be 
minimised under a strict acquisition protocol (Carmichael et al., 2007) – as used in 
Chapter 7.  
Resting state fMRI data does not possess any exogenous (driving) inputs as in task-based 
studies. Thus the evolution of activity in a given region must be driven by endogenous 
fluctuations. Stochastic DCM accounts for this by including stochastic fluctuations in the 
differential state equations and uses Bayesian filtering to estimate the hidden neuronal 
 The effect of STN DBS on endogenous coupling in the basal ganglia motor loop  |  125 
125 
states, coupling parameters and the precision of observation noise (Daunizeau et al., 2012a, 
2012b; Friston et al., 2011; Li et al., 2011) – see section 6.6.8. 
In this experiment, I deconstruct the basal ganglia motor loop using stochastic DCM of 
fMRI data acquired while human patients lay at rest, and examine the effect of therapeutic 
STN DBS on the underlying effective connectivity. Methodological issues pertaining to 
region selection in resting state studies is finessed, permitting analysis of data that is both 
functionally verified and anatomically localised.  
8.2.1 Aims 
Having demonstrated STN DBS has modulatory effects on extrinsic reciprocal cortico-
thalamic coupling (see Chapter 7), and given the clear clinical response of these patients to 
DBS at rest, I hypothesised that clinical improvement could be explained by changes in the 
way neural populations within the motor loop impact upon one another; in other words, 
DBS has modulatory effects on extrinsic effective connectivity.  
Building on results from Chapter 7, this experiment specifically sought to answer whether 
the effect was precisely related to particular pathways of the cortico-basal ganglia-cortical 
loop, or whether there was a diffuse effect on all connections. Furthermore, I explored 
whether clinical measures of PD impairment could be explained by differences in extrinsic 
effective connectivity, within the BG motor loop. 
The aims were thus threefold: 
1. Build anatomically informed models of BG motor loop that allow effects on 
specific pathways to be tested. 
2. Characterise how STN DBS modulates these pathways. 
3. Test whether coupling predicts clinical phenotype or improvement. 
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8.3 Materials and methods 
8.3.1 Ethics 
This study was approved by the National Hospital and Institute of Neurology Joint Ethics 
committee (09/H0716/51). All participants provided written informed consent.  
8.3.2 Patients 
Twelve patients who met UK brain bank criteria for idiopathic Parkinson’s disease – were 
studied (Table 8.1). Selection criteria were as stated in 7.3.2, except there was no minimum 
improvement criteria as in Chapter 7. Medication was withdrawn for 10-12 hours 
(overnight) before scanning. 
UPDRS-III scores were recorded both ON and OFF stimulation before scanning. 
Additionally, stimulation parameters and system impedance were noted, and IPG counters 
were reset13.  
Sub Age Hand Post-
op 
UPDRS-III Right electrode Left electrode 
   OFF ON V P (µs) F (Hz) V P (µs) F (Hz) 
1 65 R 20 53 21 0.5 60 180 3.3 90 180 
2 72 R 53 47 29 3.3 60 130 2.3 60 130 
3 54 R 9 33 10 2.4 60 130 2.4 60 130 
4 65 R 67 60 20 3.7 60 130 3.45 90 130 
5 50 L 102 51 17 3.8 60 185 3.6 60 185 
6 63 R 29 46 19 2.5 60 130 2.5 60 130 
7 54 R 19 45 26 2.4 60 130 2.3 60 130 
8 56 L 30 52 19 3.6 90 145 3.3 90 145 
9 43 L 48 51 23 5.4 60 80 4.1 60 80 
10 61 R 8 46 25 3.2 60 130 2.9 60 130 
11 56 R 28 44 42 3.7 60 130 4.1 60 130 
12 45 R 48 53 44 2.45 60 130 3.15 60 130 
Mean 57.0  38.4 48.4 24.6 3.1 62.5 135.8 3.1 67.5 135.8 
SD 8.6  27.0 6.6 9.9 1.2 8.7 26.7 0.6 13.6 26.7 
Table 8.1 Patient information. Hand = dominant hand, P = pulse width, Freq = frequency. 
Post-op = months since electrode implantation. All UPDRS-III scores were conducted off 
medication. Subjects 11 and 12 were the additional subjects not included in Chapter 7. 
                                                   
13 The pacemaker monitors how many times it has been switched ON/OFF. The counters were 
reset before scanning, and checked the counter after scanning to ensure the pacemaker had not 
turned ON/OFF during scanning. 
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8.3.3 MRI data acquisition 
Scanning was performed in a Siemens Avanto 1.5T MRI scanner (Siemens, Erlangen, 
Germany) using a transmit-receive (Tx/Rx) head coil. The specific absorption ratio (SAR) 
in the head was limited to <0.1W/Kg, as in Chapter 7.  
Subjects received three fMRI scans during each stimulation condition: 
1. Resting state with eyes closed (TR=2420ms; TE=40ms; Flip angle=90°; 
FOV=192x192mm2; Matrix size=64x64; 32 axial slices 3.5mm thick, gap between 
slices of 0.7mm; Spatial resolution= 3x3x4.2mm3; Duration=8 minutes; 200 scans),  
2. Motor task (right hand).  
3. Motor task (left hand).  
A vacuum moulded cushion was used to securely support the head, and limit head 
movement. Patients had an alarm if they experienced discomfort. Details of the motor task 
have been presented in Chapter 7. In brief, subjects lay in the scanner with a joystick in one 
hand and were instructed to move the joystick in a random direction in response to 
auditory tones during ‘go’ blocks, and to ignore the tones and rest their hand on the 
joystick during ‘rest’ blocks. The task was repeated for both hands, serving as functional 
localisers (one for each hemisphere) for subsequent resting state analysis.  
Patients were scanned both ON and OFF. The scanning order was counterbalanced across 
subjects. Thus, two resting state sessions were collected per patient, one for each 
stimulation condition, in addition to two field map scans, an anatomical T1-weighted 
magnetization-prepared rapid gradient-echo structural scan, and the aforementioned 
functional (motor) localisers.  
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Following scanning, active stimulation was restored, normal medication was administered, 
and a UPDRS-III examination was repeated to confirm patients had returned to their 
clinical baseline. The settings, counters and impedance of the DBS system were recorded to 
confirm there were no additional activations induced by the scanner.  
8.3.4 Dynamic causal modelling of resting state fMRI data 
In this experiment, a series of models were specified of the BG motor loop consisting of 
M1, putamen, motor thalamus, and STN in a single hemisphere. The model space (for 
each hemisphere of each subject) consisted of models differing in terms of which 
connections were modulated by DBS.  
The artefact caused by the electrode precluded the acquisition of precise BOLD data from 
the STN region – and this loss of precision was included in our model. This means the 
STN node can be regarded as ‘hidden’ from measurement and is referred to as a ‘hidden 
node’ (David et al., 2011).  
The processing stream is summarised in Figure 8.1. Processing and analysis was performed 
using SPM12 and DCM12. Anatomical masks of the precentral gyrus from each 
hemisphere were created using the Harvard-Oxford cortical structural atlas, as available in 
the FSL suite (http://fsl.fmrib.ox.ac.uk/). Masks from each hemisphere of the motor 
putamen and motor thalamus were created using probabilistic white matter connectivity 
atlases thresholded at 50% probability (Behrens et al., 2003; Tziortzi et al., 2014), 
constraining our analysis to regions that exhibit strong structural connectivity at a 
population level. For the purpose of this experiment, both hemispheres were considered 
independently, given (i) Parkinson’s disease causes asymmetric degeneration of the 
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substantia nigra pars compacta, (ii) severity of motor symptoms are usually asymmetric, (iii) 
DBS settings are often asymmetric. 
 
Figure 8.1 Processing and analysis stream used to define resting BOLD time series for each VOI. 
Processing can be split into five key steps. The GLM-DCT contained a series of cosine functions 
with frequencies (f) characteristic of resting state dynamics. Columns in the GLM-PPI were as 
follows. (A) Main effect of DBS, a boxcar stimulus function with a single epoch lasting the entire 
on session. (B) M1xDBS PPI. (C) M1 BOLD signal (main effect of M1). (D and E) Head 
movement nuisance regressors. (F) Nuisance regressors from extra-cerebral compartments. 
*Functionally defined M1 coordinate was defined using an independent functional localizing 
motor task.  
8.3.4.1 Functional localisation of subject-specific M1 
Using the task data, a contrast defining the main effect of movement for each hand was 
specified, and the peak voxel of this contrast (constrained by an anatomical mask of the 
precentral gyrus contralateral to hand movement) was selected as the hemisphere’s M1 
coordinate. Analysis of the task data is discussed in Chapter 7. Given DCM is ultimately a 
single subject analysis repeated on many subjects, problems of overlapping loss-of-signal 
artefact produced by the DBS hardware were avoided (see section 7.5.1.1). 
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8.3.4.2 Pre-processing 
The first 5 scans of each resting state session were removed and data were corrected for field 
inhomogeneity using the field maps. Data were then realigned, coregistered, anatomical 
images were normalised to MNI space, the resultant normalisation matrix was then used to 
normalise the functional data. Finally, the data were visually inspected and spatially 
smoothed using an 8mm Gaussian kernel. This specific pre-processing routine was 
employed to ensure that any artefacts produced by the DBS hardware did not impact 
normalisation to MNI space. The ON and OFF sessions were concatenated to produce a 
single 390 scan time series. Ultra-low frequency fluctuations were removed in the usual way 
using a high-pass filter (1/128s ≈ 0.0078Hz). Confound time series were extracted from 
predefined coordinates of extra-cerebral compartments (the lateral ventricle and eye globe). 
8.3.4.3 General linear model of resting state dynamics 
Data exhibiting physiologically-relevant resting state (i.e. low frequency) dynamics were 
modelled using a GLM with a discrete cosine basis set (GLM-DCT) consisting of 189 
functions with frequencies characteristic of resting state dynamics (0.0078-0.1Hz) (Biswal 
et al., 1995; Deco et al., 2011; Fox and Raichle, 2007; Fransson, 2005), a regressor 
encoding the effect of DBS, six nuisance regressors from each session capturing head 
motion, and the confound time series from the extra-cerebral compartments. The regional 
BOLD signal was summarised with the principal eigenvariate (adjusted for confounds - 
head movements and extra-cerebral compartments14) of voxels within 4 mm of the subject’s 
M1 coordinate – as identified using an SPM of motor sessions.  
                                                   
14 This was achieved by using an F-contrast including the effect of DBS regressor, as well as the 
discrete cosine set modelling the resting state. 
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A PPI analysis was used to identify voxels within the subcortical nuclei that were sensitive 
to DBS. The corresponding GLM-PPI included the main effects of DBS regressor, the 
BOLD activity from M1 and the PPI. An SPM of a T contrast testing for the PPI was 
masked first with the putamen mask, and then the thalamus mask (of the same 
hemisphere). The BOLD signal (corrected for the same confounds as above) was extracted 
from a sphere (radius 4mm) centred on the peak T-value within each mask, producing 
three VOIs per hemisphere and subject (M1, putamen, thalamus). Here, the putamen and 
thalamus VOIs exhibit a PPI with M1 and DBS. BOLD data from the STN could not be 
considered due to its small size and loss-of-signal artefact caused by the DBS electrode.  
8.3.4.4 Model space and comparison 
VOIs from each hemisphere were used to construct a series of 32 DCMs representing 
different hypothetical architectures. Two-state stochastic DCM for fMRI was used, 
endowing each node with excitatory and inhibitory subpopulations in receipt of noisy 
fluctuating inputs or endogenous activity. The STN was included as a hidden node, whose 
noise precision (given the electrode artefact) was effectively zero, permitting estimation of 
its hidden states and coupling parameters in the normal way. This reflects a strength of 
DCM; the Bayesian inversion of these models solves the complex problem of estimating 
hidden or latent variables. In DCM all parameters of interest are hidden and their 
expression in data serves to estimate these latent variables, regardless of whether their effects 
on the data are local or distributed. This has been capitalised on in electrophysiological 
DCMs (David et al., 2011; Marreiros et al., 2012; Moran et al., 2011a) and is exploited 
here in DCM for fMRI.   
The GPi and GPe were not included in our models; rather it was assumed that thalamic 
afferents arrived via GABAergic projections from the GPi. In other words, striatal 
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GABAergic medium spiny neurons projecting directly to the GPi (constituting the direct 
pathway) were modelled with a net excitatory effect on the thalamus, whereas the 
glutamatergic STN-thalamic inputs had a net inhibitory effect (Figure 8.2). Striatal 
afferents to the STN summarise the polysynaptic putamen-GPe-STN connection that 
produces a net excitatory effect on the STN in accordance with electrophysiological 
findings (Albin et al., 1989; DeLong, 1990; Gradinaru et al., 2009; Kitai and Deniau, 
1981; Kravitz et al., 2010; Nambu et al., 1996, 2000; Rouzaire-Dubois and Scarnati, 
1985). The direct pathway was thus defined as the striato-thalamic excitatory connection, 
and the indirect pathway thus consisted of both the striato-STN and STN-thalamic 
connections. Finally, the hyperdirect pathway was defined as the M1-STN connection. The 
effect of DBS entered the models by modulating a subset of connections.  
 
Figure 8.2 The literature-based anatomical model of the motor cortico-striato-thalamic loop was 
further simplified by removing the pallidal nodes and summarizing polysynaptic connections 
(thick arrows joining the putamen, STN and thalamus). Red arrows constitute excitatory 
coupling, blue arrows inhibitory coupling. Placing priors on the direction of coupling was 
achieved using two-state DCM as displayed in the left-hand panel. *The indirect pathway 
comprised of two connections; the striato-STN and STN-thalamus connections (pointed to with 
the dashed grey arrows). 
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The model space compared DCMs that included modulatory effects on the direct, indirect, 
hyperdirect, cortico-striatal, or thalamo-cortical pathways, or combinations of those five 
pathways (comprising six connections), resulting in (25) 32 models per hemisphere (Figure 
8.3).  
Models were inverted using generalised filtering15 (Friston et al., 2010; Li et al., 2011), 
providing an estimate of the coupling parameters and model evidence. The 32 models from 
each of the 24 hemispheres entered a BMS procedure (fixed effects assumptions) that 
computed the posterior probabilities over competing models (Penny et al., 2004; Stephan 
et al., 2009a). Models were subsequently grouped into families depending on whether they 
expressed modulatory effects on the five pathways discussed above. A post-hoc BMS family 
analysis was used to evaluate the posterior probabilities of a modulatory effect on each (set) 
of the pathways. 
                                                   
15 Generalised filtering is a Bayesian filtering scheme for nonlinear state-space models in 
continuous time, i.e. dynamic causal models (see Friston et al., 2010). 
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Figure 8.3 Model space. Thirty-two models from each hemisphere were specified with DBS 
modulating a combination of five pathways. Green colouring represents a target connection for 
modulatory DBS effects. Put = putamen; Tha = thalamus. 
8.3.4.5 Relationship between winning DCM and clinical response to DBS 
To quantify and validate the effective connectivity estimates generated, classical regression 
models were then used to test for the effect of DBS at the between subject level and as 
predictors of clinical status and therapeutic response to DBS. The model with the greatest 
log-evidence at a group level (i.e. across hemispheres) was considered the winning model. 
Extrinsic connectivity values (and their DBS dependent modulation) from the six 
connections comprising the five pathways of interest were taken from the winning model of 
each hemisphere. The ON coupling for each parameter was calculated using the OFF 
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coupling (DCM A-matrix values), and the DBS modulatory effects (DCM B-matrix)16. 
Paired t-tests were then used to compare coupling parameters in the ON vs. OFF 
conditions. 
The coupling parameters were subsequently entered into a multiple linear regression model, 
as independent variables, with the contralateral UPDRS-III score (excluding axial score) as 
the dependent variable. This was performed separately for the ON and OFF conditions. 
The direction of the coupling (i.e. excitatory or inhibitory) was not considered in the 
model, simply whether the strength of the coupling predicted impairment. Additionally, 
the DBS-induced modulation was calculated for each connection (i.e. exp(DCM.Ep.B)), 
thus modulations >1 denoted DBS increased the coupling, regardless of whether the 
connection targeted excitatory or inhibitory subpopulations. These DBS effects entered a 
final stepwise regression model (employing backwards elimination) as independent 
variables, predicting the percentage improvement in clinical phenotype (i.e. the larger the 
percentage, the greater the clinical efficacy).  
8.4 Results 
8.4.1 Patients 
Scanning proceeded with no adverse effects or change in post-scan UPDRS-III scores, IPG 
function, unexpected IPG activations or change in circuit impedance. Re-introduction of 
medication led to restoration of baseline motor function. Detailed patient and DBS 
parameter information can be found in Table 8.1. The mean clinical improvement to DBS 
off medication was 23.8 points (95% CI: 16.9-37.8, P < 0.0001). When considered by 
                                                   
16 See section 8.6.2 for details of parameterisation. 
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hemisphere, and ignoring axial sub-scores, DBS improved contralateral signs in the limbs 
by 8.9 points (95% CI: 6.8-11.0, P < 0.000001). 
8.4.2 Model fit 
Models from two hemispheres (from two separate subjects) failed to fully converge during 
DCM’s model inversion procedure. The time series from these problematic analyses were 
scaled down by a factor of 2 to suppress high amplitude ‘spikes’. Following this, all 32 
models across the 24 individual hemispheres were inverted successfully, furnishing 
predicted BOLD time series for each of the VOIs. These were pleasingly similar to the 
observed signal. A representative plot showing the observed and predicted data from one 
model is provided in Figure 8.4. 
 
Figure 8.4 Example of model fit; observed and predicted time series from single hemisphere. 
Stochastic DCM produced predicted BOLD data that closely matched the observed BOLD data. 
8.4.3 Bayesian model selection 
Fixed effects BMS across 24 hemispheres revealed that model 32 was the most likely to 
generate the data (posterior probability > 99%). Model 32 included modulatory effects on 
all five of the pathways explored. Subsequent family analysis – where models were grouped 
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by the presence of modulatory effects on the five pathways – confirmed that all 5 pathways 
were >99% likely to be modulated by DBS Figure 8.5. For details of why fixed effects BMS 
was chosen, see section 8.6.3.  
 
Figure 8.5 BMS results. (A) The relative log-evidence across all models, across all 24 
hemispheres, found Model 32 outperformed all other competing models, with a posterior 
probability of >99%. Model 32 exhibited modulatory effects on all five pathways of interest. (B) 
This was confirmed using post hoc family analysis; posterior probability of modulatory effects on 
each of the five pathways was >99%. 
8.4.4 Direction of neuromodulatory effect 
Estimated coupling parameters from the six extrinsic connections were extracted from 
model 32 of each hemisphere. Paired t-tests were used to compare the means of the 
 The effect of STN DBS on endogenous coupling in the basal ganglia motor loop  |  138 
138 
connection strengths ON and OFF DBS. Stimulation increased the strength of the cortico-
striatal (95% CI: 0.01-0.06Hz, P<0.05), direct (95% CI: 0.03-0.07Hz, P<0.001), and 
thalamo-cortical pathways (95% CI: 0.03-0.07Hz, P<0.001). In contradistinction, STN 
DBS reduced the strength of all STN afferents and efferents; the hyperdirect (95% CI: -
0.0011 - -0.0008Hz, P<0.001), striatal afferents (95% CI: -0.0010 - -0.0006Hz, P<0.001), 
and STN-thalamic (95% CI: -0.0008 - -0.0005, P<0.001) connections. See Figure 8.6. 
 
Figure 8.6 Comparison of coupling strength on and off DBS. Paired t-tests revealed significant 
difference between extrinsic coupling on and off stimulation. *P <0.05, **P <0.001 (both 
corrected for multiple comparisons; Bonferroni procedure). (A) Cortico-striatal, direct pathway, 
and thalamo-cortical connections were potentiated by DBS, whereas (B) STN afferents and 
efferents were reduced. Note the difference in scale between A and B, is because of the fact that 
the STN was modelled as a ‘hidden node’. See Chapter Appendix (section 8.6.2) for details of 
calculating ON and OFF coupling. 
The magnitudes of changes to connections involving the STN (i.e. connections 
constituting the hyperdirect and indirect pathways), although highly significant, were 
markedly smaller than the other modulatory effects discovered. This was due to the fact 
that the STN was estimated as a hidden region (see Materials and methods). All p-values 
are corrected for multiple comparisons using the Bonferroni procedure. See Figure 8.6. 
 The effect of STN DBS on endogenous coupling in the basal ganglia motor loop  |  139 
139 
8.4.5 Connection strengths predict clinical impairment 
Separate ON and OFF multiple linear regression analyses revealed consistent results with 
regards to the direction of the regression coefficient for each connection. Three connections 
showed significant predictive capability in both stimulation conditions; the hyperdirect, 
direct, and striatal-STN connections. As the strength of the direct pathway increased, 
clinical impairment was reduced. Surprisingly, the same was true of the hyperdirect 
pathway, despite STN DBS reducing the strength of this connection. The reverse was true 
of the striato-STN pathway; the stronger this pathway, the more disabled the patient. See 
Figure 8.7a. 
8.4.6 Change in connection strengths predict clinical efficacy 
The three connections described above were the only connections of the original six that 
were included in the most parsimonious (after backwards elimination) regression model 
(Fig. 7). DBS scaling of coupling parameters were coded such that scaling >1 conferred 
increased coupling, whereas <1 conferred reduced coupling; thus as scaling increased 
numerically, the coupling got stronger. Consistent with the previous regression, increased 
scaling of the direct pathway predicted increased efficacy (P<0.05). Increased scaling of the 
hyperdirect pathway also predicted increased efficacy (P<0.05), whereas increased scaling of 
the basal ganglia afferents predicted reduced efficacy (although this was only trend 
significant, P=0.067). See Figure 8.7b 
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Figure 8.7 Predictive validity. (A) Coupling parameters on and off stimulation were entered as 
independent variables to predict contralateral severity. *P <0.05. Direction of regression 
coefficients were consistent across conditions; however, only the connections in bold were 
significant predictors in both conditions. (B) DBS-induced scaling of each parameter was entered 
into a separate multiple linear regression model using stepwise backwards elimination to predict 
percentage clinical improve- ment. *P <0.05, ‡P <0.10 (trend significant). The hyperdirect, 
striato-STN and direct pathways remained in the parsimonious model. 
 
Figure 8.8 Summary of the modulatory effects of STN DBS on the BG motor loop. 
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8.5 Discussion 
The results of this experiment speak to both its neurobiological aims, and the pragmatics of 
modelling resting state fMRI sessions. Building on the weaknesses of Chapter 7, I used a 
well-established (if simplified) model of the functional architecture of the motor cortico-
striato-thalamic loop and estimated which connections, or combinations of connections, 
are modulated by STN DBS to produce the observed BOLD signal recorded at rest. The 
architecture specifically enabled questions to be posed regarding individual pathways, as set 
out in the experiment’s aims. Chapter 7 concluded with speculation regarding the 
sensitivity of the thalamus to either direct or indirect pathway afferents; this experiment 
thus permitted formal investigation of this hypothesis in the “resting state”. 
8.5.1 Widespread neuromodulation 
Results of the BMS demonstrate that a model with DBS-related modulatory effects on the 
extrinsic direct, indirect, hyperdirect, thalamo-cortical, as well as cortico-striatal pathways, 
consistently outperforms other (plausible) models. Analysis of the connection strength 
parameters revealed significant differences between active and inactive STN DBS in the six 
extrinsic connections investigated. The relevance of extrinsic coupling parameters to clinical 
phenotype was subsequently demonstrated using two orthogonal regression models; 
extrinsic coupling predicted clinical phenotype, and changes in extrinsic coupling predicted 
DBS-related clinical improvements (see Figure 8.7).  
8.5.1.1 Cortico-striatal coupling & DBS 
STN DBS was found to increase the sensitivity of the putamen to cortical afferents. This is 
interesting given PD patients show reduced MSN dendritic spine density and impairments 
in cortico-striatal glutamatergic transmission (Garcia et al., 2010). Furthermore, 
computational approaches have suggested DA potentiates cortico-striatal synaptic strength 
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(Leblois et al., 2006), and neuroimaging studies have demonstrated increased metabolism 
in the striatum under STN DBS (Geday et al., 2009; Hilker et al., 2002). Animal models 
of STN DBS have suggested stimulation normalises cortico-striatal glutamatergic synaptic 
densities and distributions in 6OHDA-lesioned rats (Walker et al., 2012), and regularises 
striatal discharge patterns in the resting MPTP-lesioned macaque (Santaniello et al., 2012). 
It remains possible that such enhancements could contribute to clinical improvements; 
however, the modulation of this connection was excluded from our parsimonious model of 
stimulation efficacy. 
8.5.1.2 Thalamo-cortical coupling 
Similarly, cortical sensitivity to thalamic afferents showed even greater, highly significant 
enhancements. PET and SPECT functional imaging in STN DBS patients have previously 
documented reduced perfusion and/or metabolism in the resting motor cortex during 
stimulation, and several authors have suggested this is caused either by restoration of 
pallidal inhibition of thalamic outflow or reduced synchronized oscillatory activity between 
motor cortex and basal ganglia (Ceballos-Baumann et al., 1999; Cilia et al., 2009; Geday et 
al., 2009; Grafton et al., 2006; Haslinger et al., 2005; Hershey et al., 2003; Limousin et al., 
1997; Payoux et al., 2004). Our results are not necessarily in disagreement; increased 
effective connectivity between the thalamus and cortex does not necessarily confer greater 
metabolic activity at the target, rather it suggests that during stimulation, while at rest, the 
cortex may respond more efficiently to afferents from thalamus. Nevertheless, changes in 
this connection similarly failed to predict clinical efficacy, thus this effect may not be key to 
the immediate therapeutic mechanism of STN DBS.  
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8.5.1.3 Sensitizing the thalamus to the direct pathway  
STN DBS increased the effective connectivity of the direct pathway, summarised here as a 
net excitatory connection from the putamen to the thalamus. Additionally, the strength of 
this connection predicted clinical severity in both ON DBS and OFF DBS states, and its 
scaling predicted clinical improvement; stronger direct pathway effective connectivity 
diminished Parkinson’s disease impairments. This finding is highly concordant with early 
rate-based models of BG function that propose dopamine depletion results in an 
underactive direct pathway, and an overactive indirect pathway, culminating in thalamic 
inhibition (Albin et al., 1989; DeLong, 1990). Optogenetic investigation in 6OHDA-
lesioned rats has lent further evidence to the beneficial effects of enhancing the direct 
pathway (Kravitz et al., 2010). The mechanism underlying this proposed gain tuning 
cannot be discerned here; our models do not include the GPi, thus I am unable to confirm 
whether modulation takes place further upstream of the thalamus. However, MPTP-
lesioned monkeys receiving STN DBS display a more regular pattern of neuronal firing in 
the pallidal-receiving thalamic nuclei (Xu et al., 2008), and reduced neuronal entropy 
(Dorval et al., 2008), suggesting that STN DBS has downstream effects as far as the 
thalamus.  
8.5.1.4 Desensitising the STN to hyperdirect drive 
Coupling of both STN afferents (from the indirect pathway and hyperdirect pathway) was 
reduced by DBS. The hyperdirect pathway has been previously implicated in the 
generation of beta oscillations:  
Firstly, simultaneous STN LFP and M1 electrocorticography suggest an exaggerated phase-
amplitude coupling between cortical beta-phase and broadband gamma-amplitudes in PD. 
Importantly, cortical gamma was shown to precede STN beta, potentially suggesting 
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hyperdirect drive maintains STN beta. This altered coupling was reduced by STN DBS (de 
Hemptinne et al., 2013). Furthermore, single-unit recordings in 6OHDA-lesioned rats 
receiving STN DBS have shown antidromic hyperdirect activation of M1 layer V neurons, 
modifying their firing probability, and suppressing beta-synchrony at a population level (Li 
et al., 2012). STN LFP and cortical MEG have similarly shown that cortico-STN 
coherence is predominantly cortex leading (Litvak et al., 2011), and optogenetic 
stimulation of the hyperdirect pathway in 6OHDA-lesioned rats has been shown to 
ameliorate Parkinsonian symptoms, supporting the idea that interrupting hyperdirect 
cortico-STN transmission is therapeutic (Gradinaru et al., 2009). 
Secondly, DCMs of LFP data in 6OHDA-lesioned rats (Moran et al., 2011a) and human 
patients (Marreiros et al., 2012) suggest that Parkinsonian spectral patterns at beta 
frequencies can be explained by increased effective connectivity of the hyperdirect pathway. 
Both these results support the hypothesis that STN beta oscillations are caused (in part) by 
increased effective drive from the cortex – something that I found DBS to decrease. 
Notably, in these studies, DCM was employed to explain observed increased β-band power 
at the nodes interrogated, whereas BOLD data (such as in this experiment) are not known 
to possess a reliable correlate of this electrophysiological biomarker.  
From a technical DCM perspective, concurrent results from stochastic DCM for fMRI 
data are encouraging (and rather remarkable), and suggest DCM is able to furnish similar 
underlying functional architectures from datasets with markedly different temporal 
structures. This is potentially valuable, especially when considering the non-invasive nature 
of fMRI. 
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The relationship between hyperdirect coupling strength and clinical severity is particularly 
interesting. Comparing coupling ON and OFF stimulation reveal results that are in line 
with previous studies of effective connectivity, i.e., stronger coupling is associated with 
Parkinsonian phenotypes (Marreiros et al., 2012; Moran et al., 2011a). However, when all 
six connections are considered in a regression model predicting impairment including 
tremor, rigidity and bradykinesia, as rated by the UPDRS-III in humans, stronger effective 
hyperdirect coupling is beneficial to patient symptoms. This finding should be replicated in 
an independent dataset; however, considering hemibody scores may provide a more 
comprehensive evaluation of clinical effects that have not previously been captured by 
animal models or simple ON vs. OFF comparisons. 
Taken together, the results of this experiment suggest that most of the beneficial effects of 
stimulation on the resting motor system appear to be explained by strengthening the 
effective coupling along the direct pathway, and not reducing coupling along the 
hyperdirect pathway.  
Of course, this study cannot address whether the amelioration of the hyperdirect pathway is 
predictive of unwanted effects (or improvements) that are not indexed by the UPDRS-III 
score, and this issue could be the subject of further investigation. Disruption of the 
hyperdirect pathway has previously been used to explain increased impulsivity observed in 
STN DBS patients during high-conflict decision making tasks (Frank et al., 2007); 
however, this has been studied with medial prefrontal projections as opposed to M1 
efferents (Cavanagh et al., 2011). This work suggests that disruption to hyperdirect 
effective connectivity may not be limited to prefrontal projections, at least during the 
resting state. Further work would be required to establish whether disruption to the 
hyperdirect pathway depends on the cortical source, or behavioural context. 
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8.5.1.5 Desensitising the STN and thalamus to indirect pathway afferents 
DBS reduced the effective connectivity of STN afferents arising from the striatum, and 
efferents to the thalamus. These connections summarise the known polysynaptic 
connections between these structures (via the GPe for STN afferents, and GPi for STN 
efferents respectively), although they do not preclude a direct influence. It is difficult to 
compare this finding to the existing literature on the STN afferents from the GPe, 
especially as these two nuclei possess dense reciprocal connections (Marreiros et al., 2012; 
Moran et al., 2011a), although it does suggest that indirect pathway afferents are an 
important determinant of clinical severity. Unlike the hyperdirect pathway though, this 
scaling was in agreement with the direction of neuromodulation induced by stimulation. 
Given the wealth of evidence for more global changes in brain activity under STN DBS 
(e.g. dorsolateral prefrontal cortex - Cilia et al., 2009; supplementary motor area and 
parietal cortex - Hershey et al., 2003; anterior cingulate cortex - Limousin et al., 1997), it is 
possible that our findings may generalise to other loops of the basal ganglia (interestingly, 
mostly reducing their cortical metabolic signatures at rest in PET/SPECT studies). 
Additionally, higher order afferents to the motor cortex (e.g. premotor and prefrontal 
input) could also be subject to modulation, as well as other subcortical nuclei (Asanuma et 
al., 2006). However, finding any behavioural correlates of changes within these circuits at 
rest may be more difficult. 
8.5.2 Limitations and model assumptions 
The model makes a number of simplifying assumptions, most notably the independence of 
the right and left hemisphere BG motor loops. As discussed above, this was motivated by 
the inherent clinical asymmetry observed in patients. However, there is evidence to suggest 
that components of the loops are functionally connected across hemispheres (de Solages et 
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al., 2010). Furthermore, this analysis assumes that DBS of one hemisphere is no more 
effective than DBS of another (i.e. there is no STN-dominant hemisphere).  
Another simplifying assumption is the lack of pallidal nodes in our network. As discussed, 
DCM does not necessarily quantify monosynaptic coupling, thus not all nodes are required 
to estimate effective connectivity. Exclusion of GP dynamics is discussed in section 12.5.3, 
as this is common to the remainder of my experiments.  
Similarly, the inclusion of the STN as a hidden node is also discussed there. The construct 
validity of this extension is presented briefly in the Appendix to this chapter – see section 
8.6.1. 
The range of clinical severity was also fairly small. This was due to the inherent limitation 
of using DBS patients and placing them in MRI scanners; mildly affected Parkinson’s 
disease patients do not receive DBS, and those who have severe symptoms during OFF 
(both medication and stimulation) periods are less likely to engage in MRI research. 
Furthermore, I did not consider axial symptoms in our regression models as they are 
intrinsically difficult to lateralise. 
8.5.3 Conclusions 
These findings highlight the distributed effects of DBS on the Parkinsonian resting motor 
network in human patients in a non-invasive manner, and are largely in agreement with 
invasive animal experiments. The integration of clinical data, (in contrast to the animal 
literature,) suggests that the hyperdirect, direct, and STN afferents arising from the 
striatum are the most important predictors of clinical improvement. Sensitising the 
thalamus to direct pathway afferents, while simultaneously desensitising the STN to its 
afferents appear to increase stimulation efficacy. Intriguingly, STN DBS appears to achieve 
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these effects on the direct and striato-STN pathways, but actually has the reverse effect on 
the hyperdirect pathway, potentially subverting its therapeutic potential. It is tempting to 
hypothesise that sparing this pathway of modulatory effects would improve the efficacy of 
STN DBS; potentially ameliorating unwanted effects of stimulation. 
While previous work has focused on statistical dependencies (functional connectivity) 
between regions of the brain, and how these change with onset of disease/therapy (Deco et 
al., 2011), this study uses validated modelling to derive effective connectivity between 
regions; that is, how neural populations impact on one another (Daunizeau et al., 2012a; 
David et al., 2008). From a methodological standpoint, this work is an example of how 
researchers can use DCM to provide mechanistic insights into neurological/psychiatric 
diseases and their therapies – in a non-invasive manner using fMRI data acquired in the 
resting state. 
8.6 Appendices  
8.6.1 Modelling a hidden node in DCM for fMRI 
In this Chapter, I used stochastic DCM for fMRI to estimate the effect of DBS on extrinsic 
effective connectivity within the BG motor network. As discussed, classic implementations 
of DCM for fMRI require the user to extract summaries of the BOLD signal from a series 
of regions of interest, and an accompanying model structure, so that the hidden parameters 
governing the underlying dynamics can be estimated. Implanted hardware in our patients 
rendered it impossible to collect BOLD data from the vicinity of the STN, an important 
node in our network of interest. To solve this problem, a simple method that has previously 
been used in electrophysiological DCMs (David et al., 2011; Marreiros et al., 2012; Moran 
et al., 2011a) was translated to DCM for fMRI allowing inclusion of the STN as a ‘hidden’ 
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node in the graph, and only used the observed data collected from the remaining nodes to 
fit the models. In this appendix, I demonstrate that the resulting estimates provide 
qualitatively identical results, but quantitatively under-estimate the raw effect size. In other 
words, conclusions about the direction, standardised effect size, and cross-subject stability 
remain consistent, but these DCMs furnish lower raw values for the coupling. 
To test the construct, I inverted two two-state, stochastic DCMs for fMRI per hemisphere 
per subject comprising three nodes; M1, the putamen and the thalamus. VOIs were 
defined as detailed in 8.3.4.3. The two DCMs possessed identical endogenous connections 
(M1àPutamen, PutamenàThalamus, ThalamusàM1, see Figure 8.9a) and DBS entered 
the model as modulatory inputs on all three extrinsic connections. The models differed 
with regard to how the putamen was modelled; one used the observed putamen data, and 
one treated it as a hidden node with noise precision effectively zero. The DCMs were 
inverted and the posterior estimates for the extrinsic connections of the A- and B-matrices 
were extracted, and two multivariate one-sample Hotelling’s T-square tests were used to 
test that these parameters were different from 0. Post-hoc one-sample two-sided t-tests were 
then conducted on individual extrinsic coupling estimates. The posterior estimates were 
plotted to demonstrate qualitative and quantitative difference in the estimates (Figure 
8.9b,c). It is important to note that all values estimated in two-state DCM are log-
transformed, this is not the case in deterministic DCM for fMRI. 
8.6.1.1 Estimates of endogenous coupling (A-matrix) 
Across 24 hemispheres, regardless of the model used, all estimates of extrinsic endogenous 
coupling were significantly different from 0 (P<0.05). Post-hoc one-sample t-tests 
confirmed this was true across all estimates (P<0.05). The estimates were numerically larger 
when the real data was used to fit the model, as opposed to the hidden model. The greatest 
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underestimation occurred at the afferent to the hidden node. That being said, the 
generalised effect sizes as measured with the T-statistic were just as large, indicative that 
although the mean was smaller, the cross-subject variability was also smaller. Furthermore, 
all values were larger than 0, conferring a coupling of >1Hz.  
8.6.1.2 Estimates of DBS-induced scaling (B-matrix) 
Once more, across 24 hemispheres, all estimates were significantly different from 0 
(P<0.05), and post-hoc one-sample t-tests confirmed this was true across all estimates 
(P<0.05). Importantly, because the direction of modulatory effect is of particular interest 
(i.e. does DBS make the connection stronger or weaker, regardless of whether it is 
excitatory or inhibitory), it is noteworthy that the direction of modulatory effect is entirely 
consistent when using the hidden model. In other words, regardless of model used, I 
conclude that DBS strengthens the extrinsic connections of this network. 
8.6.1.3 Conclusions 
DCMs including hidden nodes produce qualitatively similar posterior estimates to DCMs 
fitted with real data from that region; both the direction and cross-subject consistency are 
unchanged. The magnitudes of the estimates are affected, believed to be due to the loss of 
region-specific parameters that would have normally been estimated (e.g. haemodynamic 
parameters). 
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Figure 8.9 Comparison of DCM posterior estimates; ‘hidden’ putamen vs. real putamen data. 
(A) Posterior expectations of the log-transformed extrinsic coupling parameters (i.e. DCM.Ep.A 
matrix) across 24 hemispheres. Blue = hidden DCM, Red = real data DCM. Error bars 
represent standard error of the mean. All values were significantly different from 0, but the 
hidden DCM underestimates the parameters, particularly the afferent to the putamen. Although 
the magnitude of estimate was smaller, the narrower error bars suggest a similarly large 
standardised effect size. (B) Posterior expectations of the log-transformed scaling (i.e. DCM.Ep.B 
matrix) across 24 hemispheres. 
8.6.2 Calculating ON and OFF coupling 
The values of the DCM A-matrix typically reflect the endogenous coupling (in the absence 
of DBS in our case), whereas the B-matrix values estimate the effect of the modulatory 
input (DBS in our case) on the endogenous coupling (Friston et al., 2003). In two-state 
DCM for fMRI, the posterior estimates of these matrices are log-transformed, thus the A-
matrix (DCM.Ep.A) reports log(coupling) values. Furthermore, the B-matrix reports 
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log(scaling) values, such that the coupling under the effect of DBS could be calculated by 
multiplying values of the A- and B-matrices. Thus, to transform to values in Hertz 
commonly reported in DCM studies, OFF = exp(Ep.A), and ON = exp(Ep.A)*exp(Ep.B) = 
exp(Ep.A+Ep.B). This reconfiguration was chosen to simplify things for people not familiar 
with the particular parameterisation of this DCM. 
With regard the regression exploring the predictive capacity DBS-induced modulation, the 
value of the ratio ON / OFF = exp(Ep.A+Ep.B) / exp(Ep.A) = exp(Ep.B). In other words, 
the DBS-induced modulation is formally identical to the values of the B matrix in Hertz. 
8.6.3 Bayesian model selection with fixed effect assumptions 
When using fixed effects model assumptions, one assumes the model structure or 
connectivity is the same for each subject, but the strength of the coupling (or its 
modulation) can show random inter-subject variations. In other words, I implicitly assume 
that DBS modulated the same connections in each subject, but to varying degrees. In line 
with this, I used paired t-tests to explore the effect of DBS in relation to random effects on 
the parameters over subjects. For completeness, I also performed a random effects BMS, 
which produced consistent results; model 32 clearly outperformed the competing 
hypotheses (model exceedance probability > 99%). 
8.6.4 Extracting M1 VOIs given the artefact 
Figure 8.10 details the spatial location of the centre of the M1 VOI, relative to the artefact 
patterns on the functional (GE-EPI) images. A mask of the precentral gyrus taken from the 
Harvard-Oxford Cortical Atlas (in the FSL software suite) is overlaid (in transparent green) 
on the 50th acquisition from each subject. The cross-hairs demarcate the centre of the M1 
VOI extracted. The z represents the level of the axial slice in millimetres (MNI space). 
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Figure 8.10 Spatial location of the centre of the M1 VOI, relative to the artefact patterns on the 
functional (GE-EPI) images. A mask of the precentral gyrus taken from the Harvard-Oxford 
Cortical Atlas is overlaid (in transparent green) on the 50th acquisition from each subject. The 
cross-hairs demarcate the centre of the M1 VOI extracted. The z represents the level of the axial 
slice in millimetres (MNI space). 
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9 The safety of using body-transmit 
MRI in patients with implanted STN 
DBS  
Parts of the following chapter have been submitted for publication. 
9.1 Summary 
In this chapter, I present a series of in vitro experiments aimed at (1) improving the quality 
of collected fMRI data, and (2) widening the potential pool of subjects to recruit from. As 
discussed, the main safety concern with MRI in DBS patients is heating at the electrode 
tips (see section 5.5.1). Previous onsite investigation has shown that heating can be 
minimised with strict adherence to a supervised acquisition protocol using a head-
transmit/receive coil at 1.5T (Carmichael et al., 2007). 
MRI using the body-transmit coil with a multi-channel receive head coil has a number of 
potential advantages including an improved SNR. Furthermore, previous safety studies 
have used old DBS systems that are being used less, thus it was important to confirm the 
MRI safety of newer systems. Therefore, I compared the safety of MRI in an in vitro model 
of bilateral DBS using head-transmit and body-transmit coils respectively, at both 1.5T and 
3T. Additionally, I investigated the effect of transmit coil choice on DBS stimulus delivery 
during MRI.  
Changing from head- to body-transmit coil increased the electrode tip temperature at both 
field strengths, and the position of the phantom relative to the body coil significantly was 
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an important determinant of heating at 1.5T. However, the worst-case at 1.5T remained 
<1°C. 
I conclude that (1) body-transmit cranial MRI at 1.5T, with our specific hardware and 
protocol (head SAR ≤0.2W/Kg), does not produce heating exceeding international 
guidelines, even in cases of exaggerated patient misplacement (2) cranial MRI at 3T 
produces unacceptable heating, (3) patients with ActivaPCTM Medtronic systems are safe to 
be recruited to further fMRI experiments, and (4) ON vs. OFF DBS fMRI studies are not 
confounded by inappropriate stimulus delivery or discrepant heating. 
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9.2 Introduction 
As discussed (see sections 5.4.2.8 & 5.5), the paucity of fMRI studies in DBS patients has 
been largely due to safety concerns with regards to scanning patients with implanted 
systems (Rezai et al., 2005). Two notable and unfortunate case studies have highlighted the 
potential dangers of DBS interacting with MRI scanning when safe operating conditions 
are not observed (Henderson et al., 2005; Spiegel et al., 2003). Thus it is important to 
establish MRI protocols that both minimise risk to the patient, while maximising the 
quality of the resulting clinical or research data. To date, safety considerations have led to 
some compromise in the quality of fMRI data attainable with DBS apparatus in situ, 
particularly the specification of a head-only RF transmit coil effectively precluding the 
image-quality advantages of multi-channel receive coil technology. Furthermore, the 
contemporary gold standard for fMRI in the cognitive neuroscience literature is to use 
body-transmit MR with multi-array receive coils (usually 16 or 32 channels), thus we 
aimed to bring DBS fMRI in line with best practice. 
In addition it was also important to test the safety of scanning patients with the latest 
systems. Only older generation DBS systems have been rigorously safety tested, thus 
recruitment has been limited to the few patients who still have Medtronic Kinetra 
systems17. 
To address these limitations, I investigated the safety of MRI in an in vitro model of a DBS 
patient using a body RF transmit coil. I compared the results with those obtained using a 
head-transmit coil in accordance with our established clinical and research practice, with 
                                                   
17 Patients routinely have their IPGs replaced every 5 years or so. The KinetraTM has not been 
implanted since approximately 2011, so even if some patients at this centre originally received a 
KinetraTM, only a few of them still have one implanted. 
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the purpose of improving the quality and versatility of research and clinical MRI in patients 
with DBS.  
Finally, it was important to establish whether the MR environment confounded fMRI data 
collection with the new devices/coil combinations. Specifically, I compared whether there 
were any differences in induced heating under different stimulation conditions, and 
whether scanning impacted on IPG output. 
9.2.1 Aims 
Through in vitro testing, the aims of these experiments were to:  
1. Confirm head-transmit/receive coil MRI is safe using the currently implanted DBS 
hardware. 
2. Compare the MRI-induced heating obtained using the body-transmit coil to that 
with the head-transmit coil under both 1.5T and 3T field strengths. 
3. Compare the MRI-induced heating between DBS ‘ON’ and ‘OFF’ stimulation 
conditions. 
4. Confirm that fMRI sequences using the body-transmit coil do not impair IPG 
function. 
9.3 Materials and methods 
Standard radiological orientation is used throughout this report. A poly-methyl-
methacrylate phantom with dimensions resembling a human torso was filled to a depth of 
10cm with a gel of poly-acrylic acid partial sodium salt (8 g/L), sodium chloride (0.70 g/L), 
and distilled water (Carmichael et al., 2007; Rezai et al., 2002). At room temperature, this 
gel has been demonstrated to possess electrical and thermal characteristics similar to those 
of human tissue (Carmichael et al., 2007; Park et al., 2003). See Figure 9.1. 
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A Medtronic ActivaPCTM DBS system (Medtronic Inc, Minneapolis, MN, USA) was 
positioned within the phantom in a configuration resembling that in a patient with fully 
implanted hardware. The IPG (Model 37601) was partially submerged in the left ‘pectoral’ 
region of the phantom such that the outer casing was in contact with the gel. Two 18mm 
diameter burrholes were drilled into the superior edge of the phantom, representing the 
superior cranium, and burr-hole caps were fixed into position.  
 
Figure 9.1 In vitro model of DBS patient implanted at this centre. (A) Phantom dimensions. * 
= thermometer recording site, IPG = Implantable pulse generator. (B) Recording the voltage 
output of the IPG. EL = left electrode, ER = right electrode. 
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The simulated target nuclei positions were established at fixed locations analogous to the 
positions of the subthalamic nuclei (STN) relative to the burr-holes in a human (based on 
measurements from STN-DBS implantation surgeries). Two electrodes (model 3389, 
Medtronic Inc, Minneapolis, MN, USA), one on each side, were fixed to the burrhole caps, 
and their ends were positioned in the target ‘nuclei’ regions. Suture silk and a plastic frame 
were used to maintain the path of the electrode leads through the gel. Excess lead was 
coiled around the burrhole 2-3 times on the external surface of the phantom, in an 
arrangement similar to our clinical practice. The leads were connected to the IPG using two 
DBS extension cables (Model 37085) routed along the external surface of the phantom. 
9.3.1 MRI scanning 
Measurements were performed in Siemens MAGNETOM Avanto (1.5T) and TIM Trio (3T) 
MRI systems, both operating at Siemens software level VB17. The phantom was placed 
head first, supine within the bore of the scanner, with the tips of the electrodes at the 
magnet isocentre (i.e. using the tips of the electrodes as a central landmark for image-
volume prescription). The scanner calculated predicted SAR values assuming the phantom 
was a 75 kg, 44 year old male. Imaging was performed with either the respective 
manufacturer-supplied head transmit-receive coil, or using the system body-transmit coil 
with a 12-channel head receive coil. To provide temperature changes of sufficient 
magnitude to assess reliably while minimizing the risk of damaging the DBS equipment, 
turbo-spin echo (TSE) sequences (repetition time (TR) 4000ms; echo time (TE) 111ms; 
bandwidth (BW) 100Hz/pixel; field of view (FOV) 22x25cm; matrix 320x320; echo-train 
length 12, 4 slices; slice thickness (ST) 2mm; 4 averages; scan time 6 minutes 14 seconds) 
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with scanner-reported head SAR 0.2W/kg were used as a ‘worst-case’ test18. Measurements 
were performed twice for each coil combination used, and twice for each DBS stimulation 
condition. The head SAR calculated by the scanner was recorded for each scan.  
Additionally, at 1.5T it was important to examine the effect of changing the phantom 
position relative to the body-transmit coil on electrode heating, in this case with the IPG 
set to ‘OFF’ for all measurements. This was explored to ensure that cranial MRI with the 
body-transmit coil was safe even when patients were misplaced in the scanner. The tips of 
the electrodes were initially positioned at a reference site at the magnet isocentre. The 
phantom was then displaced 150mm into (negative displacement) the scanner and scanned 
using the TSE sequence. This was subsequently replicated at six further successive 
displacements relative to the magnet isocentre (-100mm, -50mm, 0mm, +50mm, 
+100mm, and +150mm).  
To confirm the safety of a typical research fMRI acquisition compared to our worst-case 
test TSE protocols, I performed 1.5T thermometry, with the electrode tips at the magnet 
isocentre, during a gradient-echo echo-planar (GE-EPI) acquisition (TR 3700ms; TE 
40ms; BW 2298Hz/pixel; FOV 19.2cm; matrix 64x64; 49 slices; ST 2.5mm; 96 
measurements 1 average; scan time 6 minutes). The effect of phantom position within the 
scanner was not explored with this sequence. 
9.3.2 IPG settings 
Scanning was performed with the IPG active (‘ON’) and inactive (‘OFF’). During ON 
scans, the IPG was programmed to deliver stimulation typical of that employed in STN 
DBS for PD (Frequency: 130Hz; Amplitude: 3.5V; Pulse width: 60µs). Unipolar 
                                                   
18 At isocentre, scanner reported body SAR = 0.064 W/Kg. 
 The safety of using body-transmit MRI in patients with implanted STN DBS  |  161 
161 
stimulation settings were used so that current flowed from the case to the distal (the 
deepest) contacts of each electrode (RHS = contact 0, LHS = contact 4). 
9.3.3 Fibre-optic thermometry  
The temperature was recorded simultaneously from four loci in the phantom using a 4 
channel fibre-optic temperature thermometer (Neoptix ReFlex – Neoptix, Québec, 
Canada) based on gallium arsenide (GaAs) semiconductor crystal technology (sampling rate 
= 1Hz). Temperature probes were located at the distal electrode contacts (one for each 
electrode lead – see Figure 9.2), the IPG case, and the centre of the phantom ‘head’ region, 
remote from the electrode contacts, providing a control recording of background 
temperature changes (Figure 9.1a). 
 
Figure 9.2 Positioning the fibre-optic probes at the distal electrode contact. The fine golden 
probes are the temperature probes, whereas the grey probes with 4 metal contacts on the end are 
the DBS electrodes. Suture silk was used to ensure that the thermometer probes were opposed to 
the distal electrode contacts, believed to be the site of the greatest MRI induced heating. This was 
fiddly. 
9.3.4 Pacemaker voltage output in during typical fMRI sequences 
To confirm that the fMRI sequences did not disturb IPG function, the voltage between 
contact 0 (i.e., the most distal contact on the quadripolar lead) and the IPG case was 
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measured whilst the phantom was exposed to the typical fMRI sequence. Fine enamelled 
copper wire (Diameter: 0.15mm; Gauge: 40swg) was threaded into the extension cable 
socket in the IPG, such that the end of the wire was in electrical contact with the distal 
electrode contact. A separate wire was in electrical contact with the IPG case. The wires 
were attached to an oscilloscope probe made of gold-plated and nickel-plated brass that was 
firmly secured to the external wall of the phantom. This was in turn connected via a coaxial 
extension cable (Impedance: 50Ω), which passed through a shielded wall into the MRI 
control room, to a digitizing oscilloscope (WaveJet 354A, Teledyne LeCroy - Bandwidth = 
500 MHz) (Figure 9.1b). The voltage was recorded both with and without an active IPG 
output before scanning sessions to confirm the captured signals were in accordance with the 
voltage and frequency that the IPG had been programmed to deliver. Temperature data 
were not collected during these scans as the additional wiring involved may have 
confounded heating estimates. 
9.3.5 Data Analysis 
9.3.5.1 Maximum heating estimates 
Data were analysed using MATLAB (The MathWorks, Inc., Natick, MA, USA). Fifteen pre-
scan temperature measurements from each probe were averaged to provide a probe-specific 
baseline temperature. Temperature change (∆T) was calculated by subtraction of this 
baseline value for each time-point during the scan and for up to 1 minute post-scan to 
allow time for the temperature to stabilise. To remove occasional instrumentally generated 
temperature recording point instabilities a threshold was applied to remove any implausibly 
extreme values (mode +/- 80°C), before a second threshold was applied to prevent 
implausibly large changes in temperature between data points (i.e. the first differential w.r.t 
time was calculated and data points that increased/decreased > 1.9°C/sec were removed). 
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These thresholds were optimised on pilot data collected in the 3T scanner with the body-
transmit coil displaying the greatest and fastest increases in temperatures, and were then 
applied to all data sets.  
Pilot thermometry measurements demonstrated a characteristic exponential increase in 
temperature at the electrode tips, asymptotically approaching a plateau phase towards the 
scan end, with the most extreme heating occurring at the left electrode tip, consistent with 
previous findings (Carmichael et al., 2007). In light of this time-course, a 20 second epoch 
was extracted at the end of each scan (i.e. during the plateau phase, whilst the electrode was 
at its highest temperature) to represent the maximum temperature in each case. Thus there 
were 20 data points for each MRI scan; each scan sequence was tested twice, thus there 
were 40 data points per coil combination per stimulation condition. Using the left 
electrode data as the worst-case temperature rise estimate, paired T tests were used to 
compare MRI-induced ΔT produced by the head-transmit and the body-transmit coils 
respectively (collapsing across stimulation conditions). Additionally, ΔT was similarly 
compared across stimulation conditions (collapsing across coil conditions). 
9.3.5.2 The effect of position relative to the body-transmit coil 
Linear regression analysis was used to analyse the effect of phantom position within the 
body transmit coil. The electrode tip position at the isocentre was defined as 0cm; 
displacement into the scanner (i.e., equivalent to pushing a subject’s feet further into the 
scanner) was coded as a negative displacement, whereas displacement out of the scanner 
(i.e., equivalent to pulling a subject’s feet out of the scanner) was coded as positive 
displacement. Mean ΔT at the left electrode tip during the final 20 second epoch at each 
position was considered the dependent variable, with position the independent variable.  
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9.3.5.3 IPG output during MRI scanning 
Voltage waveforms before and during a GE-EPI fMRI sequence were captured with the 
digital storage oscilloscope and transferred electronically into MATLAB for plotting and 
analysis. The DBS pulse period was calculated by averaging the time between voltage 
excursions greater than 2.5V. The DBS frequency was calculated as the inverse of the 
period, i.e. f = 1 / T. 
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9.4 Results 
Baseline temperatures before the measurements commenced were between 18-20°C. At the 
electrode tips, the TSE sequences produced a ΔT of <1oC and <2oC at 1.5T and 3T 
respectively, regardless of coil used. Any temperature increases at the IPG body were 
<0.2°C in all cases. The reference probe confirmed that gel temperature changes distant 
from any DBS hardware remained within the range of the thermometer sensitivity 
(±0.1oC). In accordance with previous work (Carmichael et al., 2007), the left electrode 
consistently displayed greater heating than the right. Regardless of coil or stimulation 
setting, ΔT plots followed a similar pattern (Figure 9.3); an initial rapid increase in 
temperature resembling a logarithmic plot lasting approximately 50 seconds, followed by a 
curve resembling an exponential recovery eventually tending towards a plateau at a 
maximum temperature at the end of the MRI pulse sequence. When the scan ended, 
temperatures rapidly returned to baseline. 
 
Figure 9.3 Typical temperature trend observed during a TSE sequence at the 4 thermometer sites 
using the body-transmit coil. Green line is the safety limit (1°C). Pink line indicates the end of 
the scan. 
Exposure to MRI at both 1.5T and 3T had no effect on the IPG’s ability to turn on/off 
and communicate with the DBS patient controller. With the phantom positioned at the 
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magnet isocentre, the scanner-reported head SAR remained at 0.2 W/Kg for the prescribed 
TSE sequence, and was 0.1 W/Kg for the GE-EPI sequence, regardless of coil used. 
9.4.1 Pre-scan induced heating 
It is important to note that prior to commencement of the imaging acquisitions, following 
changes in phantom position the scanners automatically perform a ‘pre-scan’ calibration 
procedure lasting approximately 30 seconds. Scanner-induced ΔT were also observed 
during this pre-scan period, specifically during the 3D shim-field estimation. At 1.5T, pre-
scan ΔT were similar to the maximum values observed during the TSE image-data 
acquisitions, regardless of coil used. At 3T, pre-scan ΔT using the head-transmit coil were 
similar to the TSE scan heating. However using the body-transmit coil at 3T, heating at the 
left electrode approached 10°C during the pre-scan procedure, far above the maximum 
temperatures observed during the scans themselves (see Figure 9.4). 
 
Figure 9.4 Heating at the 4 thermometer sites during the ‘pre-scan’ period, potentially coinciding 
with the shimfield estimation produced. Note the change in scale for the 3T plots. 
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9.4.2 Effect of body-transmit coil on electrode heating 
Changing from head- to body-transmit coil produced small but significant increases in the 
observed electrode tip maximum ΔT during TSE scans from a mean of 0.45°C to 0.79°C 
(p < 0.001, 95% CI: 0.29-0.39°C) at 1.5T, and from 1.25°C to 1.44°C (p < 0.001, 95% 
CI: 0.13-0.25°C) at 3T (see Figure 9.5). When this comparison was repeated with the GE-
EPI sequences at 1.5T, this effect was not observed (p = 0.652).  
 
Figure 9.5 Maximum temperature change induced by the TSE sequence. 
9.4.3 Effect of stimulation setting on electrode heating 
I did not observe an effect of IPG stimulation setting (p = 0.42) upon ΔT at 1.5T during 
TSE sequences. However at 3T, ΔT was greater when the stimulator was switched off, 
increasing from a mean of 1.24°C to 1.44°C (p <0.001, 95% CI: 0.14-0.26°C) (see Figure 
9.5).  
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When this was repeated with GE-EPI sequences at 1.5T, active stimulation increased 
electrode ΔT from a mean of 0.43 to 0.51°C (p <0.0072, 95% CI: 0.02-0.14°C), roughly 
an increase of 0.08°C, which falls within the measurement accuracy of our thermometer 
(±0.1oC). 
9.4.4 Effect of position within the body-coil on electrode heating 
Position within the body coil impacted significantly on electrode heating for the same MRI 
acquisition sequence and parameters. Linear regression revealed a significant effect of 
position (beta = -0.02, T = -6.87, p <0.001), indicating that the further the phantom was 
into the scanner, the greater the observed heating at the electrode tips. Worst-case ΔT 
(0.9°C) occurred when the phantom was displaced 15cm into the scanner (Figure 9.6). 
Scanner-reported SAR values varied with phantom position and are presented for 
completeness (Figure 9.6). Head SAR was a maximum (0.2 W/Kg) at 0 displacement, but 
reduced to 0.16 W/Kg at larger displacements in either direction. Both scanner-reported 
body SAR (max = 0.16 W/Kg, min = 0.03 W/Kg) and scanner-reported exposed SAR (max = 
0.10 W/Kg, min = 0.06 W/Kg) reduced as the displacement out of the bore (i.e. +ve 
displacement) increased. 
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Figure 9.6 The effect of position of the phantom within the body-transmit coil on the resultant 
temperature increase. 
9.4.5 Effect of fMRI sequences on IPG output at 1.5T 
The voltage output of the IPG recorded outside of the scanner revealed regular discharges 
with frequency and amplitudes matching the programmed settings (estimated to be 
130.9Hz), confirming our recording circuit functioned as expected. Example plots of the 
voltage between one active electrode contact and the IPG body captured during scanning 
using the body-transmit coil are displayed in Figure 9.7. As previously observed with the 
head transmission (Carmichael et al., 2007), GE-EPI sequences produced high frequency 
(i.e. exceeding the oscilloscope Nyquist sampling frequency) signals due to the sequence RF 
pulses, and lower frequency signals (~1000 Hz) arising from the switching magnetic field 
gradients. The RF excitation pulse induced a large amplitude component (peak amplitude 
<2V), whereas the fat saturation pulse produced a lower amplitude (<0.5V) component. 
The IPG pulse amplitude and frequency appeared superimposed upon and independent of 
the MRI-induced signals components. Similar results (data not presented) were obtained 
using the head-transmit coil. 
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Figure 9.7 The voltage output during a typical GE-EPI fMRI sequence. 
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9.5 Discussion 
This series of experiments provide evidence that cranial MRI at 1.5T using the body-
transmit coil in patients with new DBS systems can be collected without harm to the 
patient, provided a restricted SAR threshold is adopted. Herein, I discuss how this relates to 
current safety data on implanted DBS devices. I additionally discuss how these results do 
not suggest that scanning under this protocol confound fMRI data. 
9.5.1 The safety of active DBS during fMRI using the body-transmit coil 
9.5.1.1 Guidelines 
The current UK and international guidelines impose that MRI-induced heating should not 
cause the temperature within the brain to exceed 38°C, requiring any intra-cerebral heating 
at the electrodes to be ≤1°C (HPA, 2008). Results of this experiment propose that this can 
be safely achieved during 1.5T cranial MRI with a Medtronic ActivaPCTM system, 
regardless of transmit coil used, providing the head SAR is limited to ≤0.2 W/Kg. This 
SAR limit exceeds that currently recommended by the device manufacturer (Medtronic, 
2010) and it is important to state that MRI of patients with implanted hardware outside of 
the manufacturer’s instructions should only be performed following a comprehensive local 
risk assessment specific to the MRI system and particular DBS hardware under supervision 
from MRI experts (in our case, the MRI physics team at the National Hospital). 
9.5.1.2 Experimental design 
MRI-induced heating was measured in the vicinity of the electrode tips, as these regions are 
in direct contact with neural tissue in vivo, and have previously been identified as regions 
that show the greatest MRI-induced ΔT (Baker et al., 2006; Bhidayasiri et al., 2005; 
Carmichael et al., 2007; Georgi et al., 2004; Kainz et al., 2002; Rezai et al., 2002; Sharan 
et al., 2003; Tronnier et al., 1999). Heat dissipation in these regions occurs primarily via 
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thermal conduction and convection within the gel; it should be noted that, despite similar 
thermal properties, the in vitro gel measurements conservatively over-estimate MRI-
induced heating obtained in vivo. In the latter case, heating would be reduced by cerebral 
blood flow (Collins et al., 2004; Salcman et al., 1989).  
TSE sequences with a relatively high SAR were deliberately chosen so as to generate ΔT 
sufficient for accurate measurement given the sensitivity of the thermometry. Heating was 
consistently largest at the electrode tips, with the left electrode displaying the greatest ΔT. 
Such asymmetry has been reported elsewhere and is believed to be due to asymmetry in the 
DBS circuit with respect to scanner field orientation (Baker et al., 2004; Bhidayasiri et al., 
2005; Carmichael et al., 2007), combined with asymmetries in the scanner B1 transmit 
field at 3T due to similar permittivity boundary conditions as seen in human scanning. It 
was unlikely that local conditions in the gel caused this asymmetry as this was observed 
consistently throughout all measurements, including separate temperature recordings and 
multiple gel preparations. 
9.5.1.3 Effect of coil at 1.5T 
Using the head-transmit coil at 1.5T, average maximum ΔT was 0.45°C, compared to 
0.79°C using the body-transmit coil. With the electrode tips positioned at the scanner 
isocentre, scanner-calculated head SAR remained constant (0.2 W/Kg) for both coil 
arrangements, suggesting ΔT differences were not due to varying RF pulse power 
calibration. The different ΔT are most likely explicable by differences in the area of the 
DBS circuit exposed to the RF B1-field in each case, changing the conditions for electrical 
coupling according to Maxwell’s equations (Georgi et al., 2004). A similar mechanism 
presumably underlies our subsequent finding that ΔT is also dependent upon position of 
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the phantom within the body-transmit coil. Furthermore, differences in the design of the 
RF coils (and hence the associated electric fields) may also play a role. 
9.5.1.4 Position in the scanner during body-transmit MRI at 1.5T 
It was important to ensure that cranial MRI was safe, even when patients were accidentally 
misplaced in the scanner19. Heating produced by body-transmit MRI at 1.5T was 
significantly predicted by the position of the phantom in the scanner. ΔT increased the 
further into the scanner the phantom was moved, consistent with more of the DBS circuit 
being exposed to the RF field, increasing the magnitude of the induced currents. The pulse 
sequence parameters were held constant between positions; interestingly, the scanner-
reported head SAR did not directly explain the temperature change. Rather, in a separate 
regression, the whole body SAR significantly predicted the observed ΔT (P <0.05). This 
suggests that the whole body SAR is a better means of confirming safety when using the 
body-transmit coil, and may provide a more meaningful metric for defining maximum safe 
RF exposure. Analogous experiments using the head-transmit coil did not need to be 
undertaken given the position of the patient (and hence DBS circuit) remains fixed relative 
to the transmit coil. 
9.5.1.5 Regardless of coil, 3T confers too great a risk 
Scanning at 3T produced ΔT >1°C suggesting an increased thermal risk compared with 
similar acquisitions at 1.5T. Although relatively modest when using the head-
transmit/receive coil (<2°C), heating exceeded the HPA 2008 recommendations. Since 
there is limited published evidence on what temperature changes are safe in this context, I 
                                                   
19 Scanning with the patient displaced +150mm from isocentre would be equivalent to their 
heads being almost outside the scanner. This would be a rather extreme case of patient 
misplacement, however was collected for completeness. 
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(under the supervision of the MRI physics team at the hospital) have chosen to adhere to 
these recommendations in our current practice.  
9.5.1.6 Pre-scan heating 
The instance of 10°C heating observed during the pre-scan procedure at 3T with the body-
transmit coil is a cause for concern and further investigations are required to determine the 
precise origins of this unexpected ΔT. In any case this observation highlights the 
importance of considering the effects of RF deposition during the pre-scan phase of MRI 
acquisitions as well as during play-out of the main imaging sequence. Throughout the data 
collection process, magnitudes of pre-scan heating at 1.5T remained in keeping with that 
associated with the TSE sequence. 
9.5.1.7 The safety of induced electrical components in the DBS circuit 
Voltage recordings faithfully captured the expected qualitative characteristics of voltage 
signals produced by the DBS equipment, and those induced by the MRI scanner operation. 
Sequences produced intermittent (1) RF and (2) low-frequency gradient-switching signals 
in the DBS circuit, consistent with previous reports (Carmichael et al., 2007; Georgi et al., 
2004). The safety of induced voltages is dependent on both the: 
1. Frequency, which determines the risk of depolarisation and direct neural 
stimulation. The frequency of the RF pulse-induced signals at 1.5T exceed 60MHz, 
and are thus too high to cause neuronal stimulation. The observed induced signals 
related to gradient-switching were significantly lower in frequency (≈1kHz), 
however still exceed any stimulation frequencies known to have therapeutic 
potential. In any case, scanner internal safety checks limit gradient switching rates 
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such that induced tissue currents are outside the range causing direct peripheral 
nerve, and presumably also cerebral neuronal stimulation. 
2. Amplitude, which in combination with the frequency determines the electrode 
temperature increase. The induced voltage peak-to-peak amplitudes remained less 
than 1.5V, i.e. approximately half of the therapeutic DBS pulse amplitude, and 
therefore presumed to be safe. 
9.5.2 Potential confounds of fMRI in DBS patients 
9.5.2.1 IPG delivers programmed DBS during fMRI 
Typical fMRI sequences did not produce any changes to DBS frequency, pulse width or 
amplitude, or general function. Previous studies with older DBS systems have reported 
spontaneous switching on/off of the IPG (Rezai et al., 1999). Carmichael et al. reported 
that, for a different DBS device, approximately 10% of DBS pulses following a 90° RF 
pulse had extended inter-pulse intervals. This was not detected using the ActivaPCTM 
system, which may reflect advances in IPG design. As discussed above, the MRI-induced 
low frequency signals observed are outside the frequency range of therapeutic DBS. 
Furthermore, they appeared during both ‘ON’ and ‘OFF’ stimulation conditions 
suggesting they do not confound any comparisons of the BOLD response between 
conditions.  
9.5.2.2 Temperature should not confound ON vs. OFF comparisons 
As mentioned above, local brain temperature differences due to ON and OFF stimulation 
states could complicate any fMRI study comparing the two conditions. During the TSE 
sequences, DBS was not found to alter heating, however a significant effect of active DBS 
was detected during GE-EPI, increasing the temperature by an average of 0.08°C. 
However, this small difference is comparable with the sensitivity of our thermometry 
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system and I conclude that any effect is of negligible practical importance. This is discussed 
further in section 12.2.2. 
9.5.3 Limitations 
There are a number of important caveats to the presented findings, centred on the 
generalizability of these results to other settings. 
Firstly, electrode heating appears to be dependent on the specific geometry of the exposed 
circuit. This study report results from an arrangement simulating a (single) IPG situated in 
the pectoral region, receiving cranial MRI. Further research is required to confirm the 
safety of scanning patients with abdominal and or multiple IPGs, or scanning other parts of 
the body (e.g. spine, abdomen). 
Furthermore, the phantom was intended to model a typical DBS arrangement for patients 
that have been operated at our centre. Different lead coiling configurations or geometric 
orientations of the DBS components may impact on electrode heating. 
Importantly, these results are based upon scans limited to a scanner-reported head SAR in 
all scans to ≤0.2W/Kg, as obtained on our specific MRI systems. The effect of head SAR 
magnitude on induced heating has been previously explored (Finelli et al., 2002), however 
it is important to note that the modelling used to calculate scanner-reported SARs depend 
upon the scanner and software level, and thus may vary between centres.  
Therefore, whilst this experiment was fundamental to improving the fMRI data in DBS 
patients, it is difficult to generalise these results to other centres. It remains important to 
perform local risk assessments and in vitro measurements to confirm safety before 
proceeding with examinations that do not conform with device manufacturer’s 
instructions-for-use.  
 The safety of using body-transmit MRI in patients with implanted STN DBS  |  177 
177 
9.5.4 Conclusions 
I conclude that (1) body-transmit cranial MRI at 1.5T, with our specific hardware and 
protocol (head SAR ≤0.2W/Kg), does not produce heating exceeding international 
guidelines, (2) cranial MRI at 3T produces unacceptable heating, (3) patients with 
ActivaPCTM Medtronic systems are safe to be recruited to further fMRI experiments, and 
(4) ON vs. OFF DBS fMRI studies are not confounded by inappropriate stimulus delivery 
or discrepant heating. 
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10 The effect of STN DBS on motor-
evoked neural activity & coupling  
10.1 Summary 
In this chapter, I present the results of a third fMRI experiment, conducted in an 
independent cohort of eleven PD patients with implanted STN DBS. This experiment is 
almost identical to my first experiment in Chapter 7, the key difference being an improved 
acquisition protocol and recruitment procedure, as well as extending the time spent 
performing the movement task.  
To summarise, BOLD data was collected whilst patients performed blocks of cued 
voluntary joystick movements, in a direction of their choice. Patients performed this task 
off medication, once with their DBS OFF, and once with it set to deliver therapeutic 
stimulation. SPM was used to determine regions showing a movement x DBS interaction at a 
whole brain level. 
Results demonstrate two clusters surviving whole brain correction for multiple 
comparisons, indicating that both M1 and a midline cerebellar region show increased 
activity during voluntary movements under therapeutic stimulation. No decreases were 
detected. Increases in the insula cortex and thalamus were only detected at uncorrected 
thresholds.  
A model space of 256 DCMs per subject was then constructed, including the BG motor 
loop (exactly as specified in Chapter 8), as well as the cerebellum. The model space asked 
which combination of pathways was modulated by DBS, as well as whether integration of 
the cortico-BG and cortico-cerebellar loops occurred at the cortex or thalamus.  
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Results propose models with integration at the cortex were more likely to generate the data, 
with DBS modulating all the BG connections, as well as the cortico-cerebellar pathway. 
Estimates of effective connection strength from the winning model across the group were 
significantly changed by DBS, however did not predict motor performance or clinical 
impairment. 
I conclude that: (1) under an improved data collection protocol fMRI reveals robust 
increases in M1 and cerebellar activity during voluntary movement, (2) changes in M1 are 
caused by increased thalamo-cortical coupling, (3) similar effects on BG pathways to those 
reported during rest are present during movement, (4) changes in cerebellar activity are 
caused by increased cortico-cerebellar effective connectivity. 
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10.2 Introduction 
In Chapter 7, data from 10 patients with advanced PD treated with STN DBS is presented. 
Patients underwent BOLD fMRI whilst they performed voluntary movements, once with 
their stimulation ON, and again OFF. Analysis of regional responses at the group level 
identified two clusters that were significant at SVC statistical thresholds; one in the cortex 
(insula), and one in the thalamus. A number of other regions previously reported in the 
literature were detected at uncorrected thresholds. 
Given the extensive PET literature demonstrating marked cortical changes following 
therapeutic stimulation (although many do only report at SVC or uncorrected thresholds), 
we replicated the data collection, this time under an improved protocol, in an attempt to 
detect unequivocal changes in regional BOLD signal. The following improvements were 
thus implemented: 
10.2.1 Reducing the variability of hardware artefact patterns 
Firstly, my Chapter 7 highlighted the impact of hardware-related artefact on GE EPI data. 
This was typically manifest as loss of signal artefact primarily surrounding the connection 
between the extension cable and the DBS lead, as well as at the tips of each electrode. For 
the purposes of subject-level SPM analyses, and data extraction for DCM VOIs, these 
artefacts were destructive, but were restricted to only that subject’s individual artefact 
pattern. For example, despite spatially varying artefacts, it was possible to extract data from 
each node from each subject used for the DCM analyses in the experiments presented in 
Chapters 7 & 8. However, group-level SPM analyses were more severely affected due to the 
additive nature of the artefact across the group. In other words, SPM can only compute 
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statistics on voxels from which data was collected in all subjects20. This effectively masked 
out large portions of cortex and subthalamic area bilaterally. In order to combat this, only 
patients with IPGs implanted in their left pectoral region were recruited, as these subjects 
all have their extension cable connector over the left hemisphere.  
10.2.2 Optimising data collection 
Secondly, in Chapter 9, I presented in vitro data confirming that (1) MR-induced heating 
at the electrode tips using the body-transmit MRI at 1.5T does not exceed 1°C, bringing it 
in line with current safety guidelines, and (2) the MR environment does not impair or 
confound IPG output. Given the improved SNR yielded by the multi-array head-receive 
coil used in this protocol, I elected to use this new coil arrangement to optimise data 
collection. As a result, only patients with Medtronic ActivaPCTM systems could be recruited 
to this study. This implicitly meant all subjects had been operated on in the last 3 years, 
which incidentally coincided with greater standardisation in the surgical positioning of the 
extension cable connector to just superior and posterior to the left ear. This serendipitously 
aided point 10.2.1. 
Additionally, given the data from the left hemisphere was so severely affected by the 
artefact, subjects no longer performed the task with their right hands. Instead, subjects only 
performed the task once using their left hand, during each stimulation condition. Due to 
the time saved in removing the right hand task, we increased the task length from 6 to 8.5 
minutes. Finally, patients practiced the task before scanning, and were instructed more 
clearly to plan their next movement in between beeps. 
                                                   
20 This could be done using toolboxes such as GLM Flex 
(http://mrtools.mgh.harvard.edu/index.php/GLM_Flex#What_is_GLM_Flex.3F).  
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10.2.3 Aims 
The aim of this study was thus to: 
1. Re-examine the effect of STN DBS on movement-induced BOLD responses under 
this new protocol. 
2. Build plausible models of underlying dynamics causing any observed movement x 
DBS interactions as realised in Chapter 8. 
10.3 Materials and methods 
10.3.1 Ethics statement 
This study was approved by the National Hospital and Institute of Neurology Joint Ethics 
committee (09/H0716/51). All participants provided written informed consent. 
10.3.2 Patients 
Eleven patients who met UK brain bank criteria for idiopathic PD were studied (Table 
10.1). Patients had received chronic bilateral STN DBS for >3 months. Electrode 
implantation was performed using stereotactic MRI – for both preoperative targeting and 
immediate postoperative verification (Foltynie et al., 2011), ensuring electrode contacts 
were well-sited within the STN. All patients received bilateral electrodes (Model 3389, 
Medtronic, Minneapolis) and a dual channel pacemaker IPG (ActivaPCTM, Medtronic, 
Minneapolis) implanted. Only patients with IPGs implanted in their left subclavicular area 
were recruited, so as to minimise the dropout artefact from impacting on functional data 
from the right hemisphere. Stimulation parameters were set to produce optimal clinical 
responses. Medication was withdrawn for 10-12 hours (overnight) before scanning. 
Inclusion was limited to those patients who could tolerate lying flat with minimal head 
tremor, while being both off medication and off stimulation.  
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As previously, UPDRS-III scores were recorded both ON and OFF stimulation before 
scanning. Additionally, stimulation parameters and system impedance were noted. 
UPDRS-III scores were broken down into; (1) hemi-body scores, which was the sum of all 
lateralised items in the scale, including rigidity, bradykinesia and tremor, (2) rigidity, (3) 
bradykinesia and (4) tremor scores. 
Sub Age Hand Post-
op 
LED L hemibody R hemibody Total 
    OFF ON OFF ON OFF ON 
1 60 R 24 598.75 11 5 12 10 38 21 
2 64 R 22 632.00 22 7 18 10 61 29 
3 34 R 24 1190.00 29 12 24 11 69 30 
4 43 R 5 825.00 11 7 5 1 26 12 
5 50 R 28 72.00 21 11 18 8 55 28 
6 43 R 7 600.00 21 13 16 11 52 31 
7 49 R 37 882.00 26 14 24 15 75 45 
8 52 L 25 460.00 17 2 17 7 45 12 
9 58 R 12 370.00 23 8 19 7 54 22 
10 61 R 9 1731.75 17 12 14 7 43 25 
11 65 R 3 948.00 10 3 10 2 32 8 
Mean 53  18 755.41 19 9 16 8 50 24 
SD 9.7  11.2 443.50 6.3 4.1 5.7 4.0 15.1 10.6 
Table 10.1 Patient information. LED = daily levodopa equivalent dose, L = left, R = right. All 
UPDRS-III scores were conducted off medication. SD = standard deviation. Post-op = months 
since DBS implantation. R + L hemibody scores do not equal total score because there are 
additional points for axial signs that are not detailed in this table. 
10.3.3 MRI data acquisition 
Following onsite tissue-equivalent test-object thermometry experiments confirming that 
(under strict protocol) sequences used in fMRI studies posed no risk to the patient (see 
Chapter 9), scanning was performed in a Siemens Avanto 1.5T MRI scanner (Siemens, 
Erlangen, Germany) using the body-transmit coil and a 12-channel receive-only head coil. 
This differs from previous studies using a head-transmit/receive coil (i.e. experiments in 
Chapters 7 & 8). The decision to modify our protocol was motivated by results in previous 
studies that failed to reach statistical significance at a whole-brain level. The new protocol 
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has subsequently been shown to keep any electrode heating to <1°C (see section 9.5.1.3). 
The SAR in the head was limited to <0.4W/Kg. 
Patients were scanned with their stimulation ON and OFF, the order of which was 
randomised. Patients received three scans in each stimulation condition in addition to 
standard localiser and field map scans: 
1. Anatomical T1 MPRAGE (TR=1900ms; TE=3.14ms; TI=900ms; Flip angle=9°; 
FOV=256x256mm2; 176 sagittal slices 1mm thick; Spatial resolution= 1x1x1mm3; 
Duration=7min 24sec). 
2. Resting state fMRI with eyes closed (TR=2420ms; TE=40ms; Flip angle=90°; 
FOV=192x192mm2; 32 axial slices 3.7mm thick, gap between slices of 0.52mm; 
Spatial resolution= 3x3x3.7mm3; Duration=6min 21sec; 155 scans) – reported in 
Chapter 11. 
3. Movement task fMRI (TR=3650ms; TE=40ms; Flip angle=90°; 
FOV=192x192mm2; 49 axial slices 2.5mm thick, gap between slices of 0.5mm; 
Spatial resolution= 3x3x3mm3; Duration=8min 53sec; 145 scans). 
Patients entered the scanner with their DBS ON, and were either switched OFF or left ON 
before the scans started, resulting in a ~15 minute latency between DBS manipulation and 
starting the task fMRI. The task was based on one used previously, and is discussed in 
detail elsewhere (see section 7.3.4). In brief, patients heard an audio stimulus (beep) every 
1-3 seconds throughout the session, in addition to audio commands alternating between 
“rest” and “go” every 30 seconds. During “go” blocks, patients were instructed to perform a 
joystick movement as fast as possible, each time they heard a beep. A movement consisted 
of displacing the handle from the centre in a direction of their choice, and then returning it 
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back again. Additionally, patients were instructed to plan their next movement between 
each beep. During “rest” blocks, patients were instructed to rest their hand on the joystick 
and ignore the beeps. Patients were given a practice run before entering the scanner, and 
were monitored throughout to ensure they were performing the task correctly. There were 
9 rest and 8 movement blocks in each session. The couch was then withdrawn from the 
magnet, keeping the patient’s head in the head coil, and their DBS was switched to the 
opposite condition. 
10.3.4 Analysis of task performance 
Joystick position (two dimensions, x and y) was recorded at a rate of 20 Hz throughout the 
scanning sessions. Only data during “go” blocks were analysed. Analysis of task 
performance was automated, providing unbiased estimates of velocity and RT. Data were 
first squared and summed over dimensions to ensure movements away from the centre in 
all directions produced a positive displacement. A window of 3 seconds after each beep was 
extracted, and the first derivative was calculated, yielding velocity plots for each voluntary 
movement. The peak velocity (Vmax) of the movement away from the centre was used as a 
summary for movement speed, and the latency from stimulus onset to reaching half their 
Vmax defined the RT. Vmax and RT were averaged across trials in each DBS condition in 
each subject. These summaries were then taken to the group level, where two-tailed paired 
T tests were used to compare the mean Vmax and RT in the different stimulation conditions. 
Significance was set at p<0.05. 
10.3.5 Analysis of regional responses 
Analyses were performed using SPM12 & DCM12 executed in MATLAB R2011b (The 
MathWorks, Inc., Natick, MA, USA). The first 5 scans of each session were removed and 
data were corrected for field inhomogeneity using the field maps. Data were then realigned 
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and unwarped, then coregistered with matching anatomical scans, segmented, normalised 
to MNI space, spatially smoothed using a Gaussian kernel (8mm full-width half maximum) 
and visually inspected. Data were subsequently analysed using the GLM framework; each 
subject’s two task sessions (one for each stimulation condition) were entered into a single 
GLM. Blocked stimulus functions (boxcars) were specified in each session coding the 
effects of voluntary movement. Due to collinearity between the stimulus functions and 
head movements, I explicitly did not include head motion regressors in the first level 
GLMs. While this is not best practice, I did ensure to realign & unwarp the data to try and 
help minimise any head movement induced artefact. Furthermore, subsequent DCM is 
immune to the instantaneous signal fluctuations related to motion, and instead models the 
delayed nature of the haemodynamic response. Stimulus functions were convolved with a 
canonical HRF in the normal way, and the GLMs were then fitted to the data. Three 
contrasts were specified; (1) the main effect of movement, (2) movement x DBS interaction 
ON>OFF, (3) movement x DBS interaction OFF>ON. The resulting T maps from each 
subject were used for second-level random effects analysis. Clusters surviving a cluster-wide 
threshold of p<0.05 (family wise error corrected for multiple comparisons) at a whole-brain 
level were considered significant, and peak voxels within those clusters are reported. 
Contrasts were subsequently examined at lower uncorrected significance thresholds, 
however, the results of which are not formally reported. 
10.3.6 Dynamic causal modelling 
Results from second-level analysis of regional responses identified two clusters displaying 
robust movement x DBS interactions, namely M1 and the cerebellum. Given these findings, 
and the results of Chapter 8, I embellished our BG DCM (which already included M1 as 
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its only cortical node), including a cerebellar node ipsilateral to movements, and modelled 
the effect of STN DBS on movement-related coupling in this patient cohort.  
The GLM was rotated to allow the effect of STN DBS to enter the model as a modulatory 
input. VOIs were extracted using the movement x DBS (ON>OFF) T contrast and 
corrected for the effects of interest (i.e. the main effects of movement and DBS, and the 
movement x DBS interaction regressor) in each subject. The basal ganglia motor loop was 
modelled using observed data in M1, the putamen and thalamus (all contralateral to the 
limb moved). In addition, we included the STN as a hidden node (see section 8.6.1). This 
was achieved by setting the noise precision at that node to effectively zero, permitting 
estimation of its hidden states and coupling parameters in the normal way (see Chapter 8). 
Two-state, stochastic DCM was used in this analysis. As previously, pallidal nodes were not 
included; rather, their connections were collapsed to simplify the circuit. In other words, 
the direct pathway was summarised as an excitatory connection from the putamen to the 
thalamus, and indirect pathway as an excitatory putamen-STN connection, and an 
inhibitory STN-thalamus connection. The cerebellar node received an excitatory M1 
afferent (assumedly via the pontine nuclei).  
The first question addressed by the model space addressed the architecture of the coupling 
between cortico-basal ganglia and cortico-cerebellar loops during voluntary movement. 
Specifically, we examined whether convergence of the two circuits occurs at the thalamus, 
or at the cortex. Therefore, half of the models specified had cerebellar efferents projecting 
to the thalamic node (architecture A), and half simply had a reciprocal connection to M1, 
presumed to be a polysynaptic connection via cerebellar receiving nuclei of the thalamus 
(architecture B).  
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This yielded two sets of models, each with 8 extrinsic (between-region) connections. The 
main effect of movement entered both models as a driving input to M1, and the effect of 
DBS entered as a modulatory effect on extrinsic connections. The model space compared 
DCMs that included modulatory effects on the direct, indirect, hyperdirect, cortico-striatal, 
thalamo-cortical pathways, as well as cortico-cerebellar and cerebellar efferent connections, 
or combinations of those 7 pathways (comprising eight connections), resulting in (27) 128 
models per architecture, thus 256 models per subject (see Figure 10.1). 
 
Figure 10.1 Cortico-BG and cortico-cerebellar integration. Architectures (A) and (B). 128 
variants of each of the two architectures were compared in the BMS. Models differed by which 
combination of extrinsic connections were modulated by DBS. Yellow nodes highlights the 
different sites of integration of the two circuits. 
Models were subsequently compared across all subjects using BMS (fixed effects 
assumptions). Models were subsequently grouped into families depending on whether they 
expressed modulatory effects on the 7 pathways above. Post-hoc BMS family analyses were 
used to evaluate the posterior probabilities of (1) models with architecture A compared to 
architecture B, and (2) models with modulatory effects on each of the 7 pathways. The 
single model with the greatest log-evidence at the group level was considered the winning 
model. 
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Posterior expectations of the extrinsic coupling parameters (from the DCM.Ep.A matrix) 
and modulatory effects (DCM.Ep.B matrix) from each subject’s winning model were 
extracted and transformed to yield coupling OFF DBS (=exp(DCM.Ep.A)), and ON DBS 
coupling (=exp(DCM.Ep.A+DCM.Ep.B)), measured in Hertz. Paired T tests were used to 
compare coupling ON and OFF DBS across the group (Bonferroni corrected for multiple 
comparisons). 
The coupling parameters were subsequently entered into multiple linear regression models, 
as independent variables, with the dependent variable either the (1) contralateral UPDRS-
III score (excluding axial score), (2) percentage improvement in clinical UPDRS-III score. 
Similar models were specified predicting the ON and OFF behavioural measures (Vmax or 
RT), as well as their improvements with DBS. 
10.4 Results 
10.4.1 Clinical effect of STN DBS 
All patients showed significant improvement in clinical PD impairment. UPDRS-III scores 
reduced from an average (± standard deviation) of 50 (±15.1) OFF DBS, to 23.9 (±10.6) 
ON DBS, equivalent to a mean improvement of 52.2% (±12.2%) (p<0.05). Improvements 
were observed across all sub-domains, and across both hemi-bodies (Figure 10.2). 
 The effect of STN DBS on motor-evoked neural activity & coupling  |  190 
190 
 
Figure 10.2 Clinical improvements following STN DBS. All scoring was performed off 
medication. Higher scores confers greater impairment. Blue dashed line indicates the maximum 
number of points in the respective sub-scale. * p<0.01 **p<0.001. 
10.4.2 The effect of STN DBS on peak velocity and reaction time 
STN DBS significantly increased Vmax (p = 0.0062), but improvements in RT were only 
trend significant (p = 0.06). To confirm the validity of the analyses, strong negative 
correlations were identified between Vmax and total UPDRS-III (r = -0.56, p = 0.0066), and 
the bradykinesia subscores (r = -0.64, p = 0.0012). 
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Figure 10.3 The effect of DBS on Vmax and RT. (A) The mean velocity plot for a single 
movement trial – ON and OFF compared. Cue sounds at time = 0 with joystick in central 
position. Positive velocity occurs when subject moves joystick away from central position in their 
chosen direction, slows to 0 at maximal displacement, then velocity is negative as the handle is 
returned to the centre position. (B) Mean RT and Vmax ON and OFF stimulation; RT only 
trend significant. (C & D) Scatter plots of total UPDRS score, and bradykinesia subscore against 
Vmax (both ON and OFF values for each subject included). 
10.4.3 The effect of STN DBS on regional BOLD responses 
Scanning proceeded with no adverse effects; DBS system impedances were unaffected by 
scanning, and following administration of medication, patients returned to their pre-scan 
clinical baseline. The main effects of movement contrast at the group level revealed a map of 
motor cortical regions that are characteristically engaged during voluntary movements, 
consistent with the PET and fMRI literature that have employed similar tasks. There were 
not any obvious stigmata of motion artefact (e.g. cortical ‘rims’ or spurious ventricular 
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activations), which, in combination with the classical motor regions activated, suggested 
that the data were not significantly corrupted by motion artefact. Inclusion of covariates for 
hand dominance and clinical improvement at the second level did not significantly change 
the results. 
The group-level movement x DBS ON>OFF contrast revealed two large clusters that 
survived cluster-wise whole brain correction, located in the precentral gyrus hand area, and 
cerebellum (see Figure 10.4 & Table 10.2). A cerebellar atlas normalised to MNI space 
using FLIRT (Diedrichsen et al., 2009) revealed that the cluster encompassed the left crus 
V, as well as the vermis and right-sided crus V and VI. There were no significant DBS-
related reductions in movement-induced regional response using the OFF>ON interaction 
contrast. 
 
Figure 10.4 Movement x DBS (ON>OFF) interactions. Two clusters were identified as 
significant in (A) M1 hand area contralateral to movements, and (B) midline cerebellum 
encompassing left crus V, vermis and right crus V & VI. Second level SPMs overlaid on the MNI 
brain. SPMs are thresholded at p<0.001 (uncorrected). Additional activations at this threshold 
can be seen in the SMA and midbrain (A). 
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Cluster-wise Peak-wise MNI coordinates (mm) 
PFWE Voxels Punc T Z Punc x y z 
0.00180 245  9.4E-05 8.27 4.44 4.4E-06 6 -60 -18 
Cluster B in Figure 10.4 6.46 3.97 3.6E-05 4 -70 -30 
   6.36 3.94 4.1E-05 -2 -60 -22 
0.00010 369 5.1E-06 7.79 4.33 7.4E-06 34 -22 60 
Cluster A in Figure 10.4 6.06 3.84 6.1E-05 42 -14 52 
   5.73 3.73 9.5E-05 30 -22 70 
Table 10.2 Results of second level whole brain search for movement x DBS interaction. Clusters 
surviving cluster wise significance (corrected using the family wise error correction for multiple 
comparisons = PFWE) of p<0.05 were considered significant. Peak voxels of clusters are reported. 
Punc = uncorrected P values. 
10.4.4 Bayesian model selection 
All 256 models successfully converged. BMS revealed that model 192 was the most likely 
generator of the data across the group (posterior probability > 99%) - Figure 10.5. This 
model had parallel basal ganglia and cerebellar loops, converging at the level of the cortex 
(architecture B). The model encompassed DBS-induced modulatory effects on all the 
connections within the BG loop, as well as the projection from M1 to the cerebellum. 
Subsequent family analyses confirmed that (1) models with architecture B were more likely 
to generate the data than architecture A, and (2) models incorporating modulatory effects 
on cortico-striatal, direct, indirect, hyperdirect, thalamo-cortical, and cortico-cerebellar 
connections respectively outperformed sparser models (posterior probabilities > 99%). 
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Figure 10.5 Results of (A) BMS and (B) post-hoc family BMS analysis. Looking at (A), it is 
clear that models with architecture B outperform equivalent models with architecture A. Model 
192 has the highest model evidence with posterior probability = P(m|Y) > 99%. Dashed grey 
line at highest competitor (model 190). 
10.4.5 The effect of STN DBS on extrinsic coupling 
Posterior coupling estimates extracted from model 192 from each subject revealed 
significant changes in cortico-striatal, direct, indirect, hyperdirect, thalamo-cortical, and 
cortico-cerebellar coupling. Cortico-striatal (p<0.05, corrected), direct (p<0.05, corrected), 
thalamo-cortical (p<0.05, corrected) and cortical-cerebellar (p<0.05, uncorrected) coupling 
increased under therapeutic STN DBS, whereas hyperdirect, striato-STN and STN-
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thalamic coupling was reduced during DBS (p<0.05, corrected). The magnitudes of change 
of coupling involving the STN were smaller than other changes observed (although still 
highly significant), in line with previous experiments utilising hidden nodes. Multiple 
linear regression analyses predicting clinical impairment or improvement using the 
coupling parameters failed to reach statistical significance. 
 
Figure 10.6 The effect of DBS on posterior estimates of extrinsic coupling. *P<0.05 
(uncorrected), **P<0.05 (Bonferroni corrected), ***P<0.001 (Bonferroni corrected). Note the 
different scale used for M1-cerebellum, and coupling with the STN. STN-thalamus coupling 
was set to be inhibitory a priori. 
10.5 Discussion 
The first part of this experiment was, in essence, a replication of my first experiment under 
a superior acquisition protocol. Following detection at the second level of robust 
interactions in M1 and the cerebellum, DCM was used to explore how these results were 
generated, specifically by developing the BG DCMs conceived in Chapter 8. The results of 
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this experiment reveal that (1) therapeutic STN DBS significantly increases motor-evoked 
BOLD responses in M1 and cerebellum, and (2) that the changes observed during 
movement are most likely caused by modulation of both BG pathways, as well as cortico-
cerebellar dynamics. 
10.5.1 STN DBS increases motor-evoked responses in M1 & midline cerebellum 
Results demonstrate robust interactions (ON>OFF) in both M1 and the cerebellum, both 
regions richly involved in control of voluntary movement. This is in line with results from a 
similar H215O PET study using an almost identical joystick task in unilateral DBS patients 
(Payoux et al., 2004). In that paper, the interaction was explained by reductions in activity 
at rest, resulting larger apparent motor-evoked activity (Figure 10.7). 
 
Figure 10.7 Previously reported movement x DBS interaction in M1 thought to be caused by 
reductions in baseline activity. Taken from Payoux et al., 2004 (Figure 3B in that publication). 
Coordinates reported in Talairach space. 
However, modulation in both M1 and cerebellar cortex have shown mixed results in 
previous DBS neuroimaging studies (discussed in 5.4.2.6). One early study using unilateral 
STN DBS patients reported reduced motor-evoked activity in M1, although the cluster 
(−42, −12, 26 in Talairach space) appears quite low and lateral for it to be the equivalent 
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hand region reported here (Ceballos-Baumann et al., 1999). Similarly, reductions claimed 
in (Thobois et al., 2002) appear quite medial, and intriguingly posterior to the central 
sulcus.  
Only one previous paper has reported movement x DBS interactions in the cerebellum. 
Grafton et al., collected rCBF PET whilst six unilateral DBS patients performed a visuo-
motor feedback task, reporting both increased and decreased evoked responses in different 
parts of the lateral cerebellar cortex (Grafton et al., 2006). In contrast, DBS induced 
changes in resting cerebellar metabolism have been widely reported, in both the vermis 
(Asanuma et al., 2006; Bradberry et al., 2012; Cilia et al., 2009; Sestini et al., 2002), and 
lateral cerebellar cortex (papers demonstrating vermis changes, and Garraux et al., 2011; 
Hershey et al., 2003; Nagaoka et al., 2007; Tanei et al., 2009; Vafaee et al., 2004; Volonté 
et al., 2012; Wang et al., 2010). 
10.5.2 The integration of cortico-basal ganglia and cortico-cerebellar loops 
The first result of the BMS analysis solved what was in fact a question that presented itself 
during model specification. Given the significant interaction observed in the cerebellum, it 
was important to integrate cortico-cerebellar dynamics into my model of the BG, thus the 
question of how these loops were organised required either an a priori constraint of some 
form (i.e. that one architecture is more plausible), or was a simple model selection question. 
Anatomical studies suggest that the thalamus can be parcellated into discrete pallidal 
receiving nuclei (VLa, VApc, and VM) and nuclei such as the VLp – equivalent to Vim 
thalamus in Hassler’s nomenclature (Gallay et al., 2008) – that receive afferents from the 
deep cerebellar nuclei. Thus the anatomical literature would probably support that 
architecture B is the more plausible generative architecture (Wu and Hallett, 2013). In the 
end, the decision was made to ask the question empirically, and the BMS results in fact 
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evidenced anatomical hypotheses, i.e. parallel cortico-BG and cortico-cerebellar loops are 
integrated at the level of the motor cortex. While not specifically a question set out a priori, 
this finding has not previously been reported in the human neuroimaging literature, thus is 
of interest to those studying both PD and motor control (under the assumption that the 
PD architecture is consistent with healthy controls). 
10.5.3 Cortical changes are best explained by an increased sensitivity to basal 
ganglia afferents 
Interestingly, model selection suggests that increases in motor-evoked BOLD signal in M1 
are better explained by a selective increase in sensitivity to its BG afferents, as opposed to 
cerebellar afferents. This is in agreement with classic rate-based models of the BG and PD 
(Albin et al., 1989; DeLong, 1990), and has been much speculated as a possible mechanism 
for previously observed cortical changes in the PET/SPECT literature (early examples 
include Ceballos-Baumann et al., 1999; Limousin et al., 1997; etc.), but until now has not 
been formally tested. Under therapeutic DBS, my results show that M1 shows an afferent 
specific gain modulation. Put simply, M1 becomes selectively more sensitive to BG 
afferents, whereas its sensitivity to incoming cerebellar signals remains unchanged.  
10.5.4 Therapeutic STN DBS increases thalamic sensitivity to direct pathway 
afferents during movement 
This is in line with the results outlined in my previous fMRI experiment (section 8.5.1.3), 
which, as discussed there, is in line with a growing wealth of physiological data, as well as 
early models of BG function and PD (Albin et al., 1989; DeLong, 1990). Similarly, DBS 
again was shown to reduce the STN and thalamic sensitivity to hyperdirect and indirect 
afferents, this time during voluntary movement. This combination of findings evidences 
speculations voiced in the discussion of Chapter 7, i.e. DBS appears to bias the sensitivity 
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of the thalamus towards its direct pathway afferents, resulting in a greater net excitatory 
drive during voluntary movements (section 7.5.3). 
However, in contrast to findings at rest (Chapter 8), regression models of coupling 
predicting either clinical status, clinical improvement, or behavioural measures (Vmax or 
RT), failed to reach statistical significance. This could be due to a lack of sufficient 
statistical power; this study only considered 11 hemispheres, Chapter 8 included 24. 
Furthermore, this study necessarily included seven independent variables in the design 
matrix, whereas Chapter 8 only included 6 (due to the lack of cerebellar connections). 
Finally, the models and thus parameters are fundamentally different given the models 
discussed here include an explanation of cortico-cerebellar dynamics, not previously 
explored in Chapter 8. Experiments in Chapter 11 explore this in more detail. 
10.5.5 The effect of STN DBS on cortico-cerebellar dynamics during movement 
BMS and post-hoc comparisons of coupling estimates propose that during voluntary 
movements, STN DBS increases the effective connectivity from M1 to the cerebellum. In 
other words, DBS appears to be altering the cerbellum’s sensitivity to cortical afferents. As 
in previous experiments, DBS was modelled as a modulator of effective connectivity, thus 
these results do not explain how DBS spreads to modulated regions, rather that the result of 
DBS is that they are modulated. In terms of explaining its biological plausibility, 
anatomical and histological investigation have demonstrated structural connectivity 
between the BG (specifically striatum and STN) with the cerebellum and deep cerebellar 
nuclei (Bostan et al., 2010; Hoshi et al., 2005; Wu and Hallett, 2013). Without a control 
population, it is difficult to determine whether this increase is some form of normalisation 
of the dynamics of the motor network. It is tempting to interpret these results as an 
improvement of distant functional integration in the context of STN DBS; distant here 
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meaning a similarly specialised node that is independent of the BG circuit. This is discussed 
further in Chapter 11. 
Previous studies comparing PD patients to control populations have repeatedly reported 
increased cerebellar activity during both movement (Catalan et al., 1999; Rascol et al., 
1997; Yu et al., 2007), as well as increased resting state functional connectivity amongst 
M1, PM and cerebellar cortex (Wu et al., 2009). One recent study using multiple PPIs to 
characterise effective connectivity between regions of the motor system have similarly 
yielded increased connectivity between these regions in PD cohorts (Wu et al., 2011). 
Those authors have suggested that this could be explained in terms of compensation for 
underactive frontal cortical components of the motor network. While such differences 
between patients and controls have been reported, changes induced by DBS appear to be 
more ambiguous. These results do not support the compensation hypothesis posed by 
previous authors, in fact advocate the opposite, namely that DBS results in increased M1-
cerebellar effective connectivity. 
10.5.6 Limitations 
This experiment suffers the same limitations of my modelling studies so far. A general 
discussion of these limitations is presented in section 12.5. 
10.5.6.1 Regional responses: Head movements and motor task 
Head movements were explicitly excluded from first level GLMs in this experiment, owing 
to an observed collinearity with the main effect of movement condition. While this is not 
best practice, had these not been excluded, the model’s ability to estimate main effects of 
movement and interactions would have been compromised. This specific limitation is 
discussed in the context of findings from Chapter 7 in section 12.2.5.  
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10.5.6.2 Regional responses: What about the thalamus and the insula? 
My first experiment (Chapter 7) identified two movement x DBS interaction clusters that 
were significant at SVC statistical thresholds; one in the insula, and one in the thalamus. 
Exploring the ON>OFF contrast at uncorrected peak thresholds in this cohort did reveal 
clusters in bilateral insula cortex (peak voxel p<0.013) and thalamus (peak voxel p<0.012), 
but were not significant at whole-brain corrected thresholds. By adopting the same SVC 
analysis as performed in Chapter 7, I was similarly unable to replicate this result. This 
failure to replicate findings is discussed in the thesis discussion (section 12.3.2). 
10.5.7 Conclusions 
This experiment presents robust interactions between movement and DBS in both M1 and 
the cerebellum, both displaying increased BOLD signal during voluntary movements with 
active DBS. Results of my DCM and BMS reveal that these interactions are most likely 
explained by modulatory effects in both the basal ganglia motor loop and cortico-cerebellar 
dynamics. Interestingly, BOLD increases at M1 are more likely caused by an increased 
sensitivity to its basal ganglia afferents, as opposed to afferents from cerebellar loops. 
I conclude that: (1) under an improved data collection protocol fMRI reveals robust 
increases in M1 and cerebellar activity during voluntary movement, (2) changes in M1 are 
caused by increased thalamo-cortical coupling, (3) similar effects on BG pathways to those 
reported during rest are present during movement, (4) changes in cerebellar activity are 
caused by increased cortico-cerebellar effective connectivity. 
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11 The effect of STN DBS on endogenous 
coupling in BG & cortico-cerebellar 
loops 
11.1 Summary 
In this chapter, I present the results of a fifth fMRI experiment, conducted in the same 
cohort of PD patients as studied in Chapter 10. As in Chapter 8, BOLD data was collected 
whilst patients lay in the scanner at rest with eyes closed. Patients were scanned off 
medication, once with their DBS OFF, and once with DBS ON. 
Building on results of Chapters 8 & 10, I re-examine the effects of STN DBS on 
endogenous coupling, this time including cortico-cerebellar dynamics. This experiment 
aimed to characterise the effects on both cortico-BG and cortico-cerebellar circuits at rest. 
A model space of 256 DCMs per subject was constructed, identical to that tested in 
Chapter 10. The model space asked which combination of pathways was modulated by 
DBS, as well as whether integration of the cortico-BG and cortico-cerebellar loops occurred 
at the cortex or thalamus. As in Chapter 10, results propose that models with integration at 
the cortex were more likely to generate the data. Winning models included DBS 
modulating all the BG connections, as well as the cerebellar-cortical connection. Estimates 
of effective connection strengths amongst the BG motor loop across the group were 
significantly changed by DBS, however, cerebellar-cortical effective connectivity was not 
found to significantly changed by the intervention. Regressions of coupling estimates and 
clinical status/improvement did not identify significant predictive relationships. 
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I conclude that (1) previous findings of modulatory effects on BG effective connectivity 
under STN DBS whilst patients lay at rest have been partially replicated in an independent 
patient cohort, and (2) whilst models incorporating modulatory effects on cerebellar-
cortical coupling prevail, random effects analysis at the group level does not identify 
significant differences in cerebellar-cortical coupling under DBS. 
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11.2 Introduction 
Data presented in Chapter 10 demonstrate that STN DBS produces robust increases in M1 
and cerebellar activity during voluntary movement. Modelling of how these interactions 
were generated revealed that STN DBS produced modulatory effects on both BG 
dynamics, as well as cortico-cerebellar dynamics. Results in the BG were in agreement with 
the modelling presented in Chapter 8, despite the fact that the patients were performing 
voluntary movements, and the additional modelling of cortico-cerebellar dynamics. 
Given the demonstrated importance of the cortico-cerebellar loops in the generation of 
voluntary movements, and the modulatory effects DBS has on these dynamics during 
movement, this experiment asks if similar modulatory effects take place in the resting state 
as well. In other words, does STN DBS produce identical effects during movement and rest 
at all parts of the motor circuit, or are there context-dependent effects. 
In addition, there is a consensus in the literature that tremors (either resting or postural) in 
PD are in someway attributable to dysfunction of cortico-thalamo-cerebellar dynamics 
(Helmich et al., 2011; Mure et al., 2011; Ni et al., 2010). Thus, it was of interest to 
include cortico-cerebellar dynamics in models of data acquired in the resting state. 
Previous neuroimaging studies in the resting state have reported mixed results in the 
cerebellum. Some report increased activity under DBS (Cilia et al., 2009; Garraux et al., 
2011; Nagaoka et al., 2007; Sestini et al., 2005; Tanei et al., 2009; Vafaee et al., 2004) in 
both lateral cortex and midline vermis, whereas others report decreased activity (Bradberry 
et al., 2012; Hershey et al., 2003; Volonté et al., 2012; Wang et al., 2010). Thus while the 
direction of modulation may seem somewhat inconclusive, stimulation-induced changes in 
the cerebellum’s endogenous activity has been widely reported. 
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The aims of this experiment were to: 
1. Determine whether STN DBS produces modulatory effects on cortico-cerebellar 
dynamics during the resting state. 
2. Replicate findings from Chapter 8 in an independent patient cohort, taking into 
account cerebellar dynamics. 
11.3 Materials and methods 
11.3.1 Ethics statement 
This study was approved by the National Hospital and Institute of Neurology Joint Ethics 
committee (09/H0716/51). All participants provided written informed consent. 
11.3.2 Patients & MRI data acquisition information 
The patient cohort used in this study were identical to the cohort used in the previous 
chapter (see section 10.3.2). Details of the MRI data acquisition protocol are detailed in 
section 10.3.3. Resting state scanning took place before completion of the motor task in 
each DBS condition. As a result, the time between switching stimulation setting and 
scanning was approximately 10-15 minutes, depending on the patient. 
11.3.3 Dynamic causal modelling 
Given the findings of the movement task data in this cohort (see Chapter 10), namely, that 
STN DBS increased motor related activity in M1 and the cerebellum, and that DBS had 
modulatory effects on coupling within both the cortico-basal ganglia, and cortico-cerebellar 
loops, the cerebellum was included in the DCMs. This permitted specification of an 
identical model space to that used in Chapter 10. In other words, this experiment mirrors 
previous analysis of data collected during voluntary movement, however substitutes task 
fMRI data for resting state data. 
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Only data from the right hemisphere were considered in this analysis because subjects only 
performed left hand movement tasks, allowing the right M1 to be functionally defined in 
each patient. Had we wanted to explore both hemispheres, we would have had to use 
different VOI extraction methods for each hemisphere, which was suboptimal (e.g. for the 
left hemisphere we could have extracted from within a sphere centred on the mean of the 
equivalent VOI in Chapter 8). VOI selection proceeded in a similar manner to as described 
in Chapter 8 (section 8.3.4). In brief, the coordinates of the peak voxels of the M1 (MNI 
coordinates: 34, -22, 60mm) and cerebellar (MNI coordinates: 6, -60, -18mm) clusters in 
the task data second level analysis of the movement x DBS interaction contrast (ON>OFF) 
were used to guide data selection. Masks from right motor putamen and right motor 
thalamus were created using probabilistic white matter connectivity atlases thresholded at 
50% probability (Behrens et al., 2003; Tziortzi et al., 2014), constraining our analysis to 
regions that exhibit strong structural connectivity at a population level. The first 5 scans of 
each resting state session were removed and data were corrected for field inhomogeneity 
using the field maps. Data were then realigned, coregistered, anatomical images were 
normalised to MNI space, the resultant normalisation matrix was then used to normalise 
the functional data. Finally, the data were visually inspected and spatially smoothed using 
an 8mm Gaussian kernel. The ON and OFF sessions were concatenated to produce a single 
300 scan time series. Ultra-low frequency fluctuations were removed in the usual way using 
a high-pass filter (1/128s ≈ 0.0078Hz). Confound time series were extracted from 
predefined coordinates of extra-cerebral compartments (the lateral ventricle and eye globe). 
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The resting state was modelled using a GLM-DCT consisting of 145 functions21 with 
frequencies characteristic of resting state dynamics (0.0078-0.1Hz) (Biswal et al., 1995; 
Deco et al., 2011; Fox and Raichle, 2007; Fransson, 2005), a regressor encoding the main 
effect of DBS, six nuisance regressors from each session capturing head motion, and the 
confound time series from the extra-cerebral compartments. The principal eigenvariate was 
extracted (adjusted for confounds - head movements and extra-cerebral compartments) of 
sphere (r = 4 mm) of voxels, centred on the peak voxel of an F contrast spanning the DCT 
components, within 4 mm of the group M1 coordinate. 
A PPI regressor was created using the extracted M1 data and the main effect of DBS 
regressor (Friston et al., 1997). A GLM-PPI was specified including the main effects of DBS, 
the extracted M1 data, and their PPI. A SPM testing for the PPI was masked first with an 
anatomical putamen mask, and then the thalamus mask, and then a sphere (r = 4 mm) 
centred on the cerebellar peak voxel from the second level task analysis. The BOLD signal 
(corrected for the same confounds as above) was extracted from a sphere (radius 4mm) 
centred on the peak T-value within each mask, producing four volumes of interest (VOIs) 
per hemisphere and subject (M1, putamen, thalamus, cerebellum). As previously, data from 
the STN was not extracted, and was instead modelled as a hidden node. 
VOIs were used to construct 256 DCMs per subject, each differing according to which 
connections were modulated by DBS. The model space compared DCMs that included 
modulatory effects on the direct, indirect, hyperdirect, cortico-striatal, thalamo-cortical 
                                                   
21 The number of functions is somewhat arbitrary; the purpose is to include enough components 
to thoroughly span the frequency domain of interest (0.0078-0.1Hz), while maintaining degrees 
of freedom for estimation. The reader might have noticed that in section 8.3.4.3, 189 
components were used. This is simply because in that GLM, there were more scans (390), thus 
we could afford to include more components. In reality both GLMs are likely over-specified. 
However, the purpose of these SPMs is simply to inform the first step of VOI extraction. 
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pathways, as well as cortico-cerebellar and cerebellar efferent connections, or combinations 
of those 7 pathways, as described previously.  
Models were subsequently compared across all subjects using BMS (fixed effects 
assumptions). Models were then grouped into families depending on whether they 
expressed modulatory effects on the 7 pathways above. Post-hoc BMS family analyses were 
used to evaluate the posterior probabilities of (1) models with architecture A compared to 
architecture B, and (2) models with modulatory effects on each of the 7 pathways. The 
single model with the greatest log-evidence at the group level was considered the winning 
model. 
Posterior expectations of the extrinsic coupling parameters (from the DCM.Ep.A matrix) 
and modulatory effects (DCM.Ep.B matrix) from each winning model were extracted and 
transformed to yield coupling OFF DBS (=exp(DCM.Ep.A)), and ON DBS coupling 
(=exp(DCM.Ep.A+DCM.Ep.B)), measured in Hertz. Paired T tests were used to compare 
coupling ON and OFF DBS across the group (Bonferroni corrected for multiple 
comparisons). 
Finally, the coupling parameters were subsequently entered into multiple linear regression 
models, as independent variables, with the dependent variable either the (1) contralateral 
UPDRS-III score (excluding axial score), (2) percentage improvement in clinical UPDRS-
III score. 
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11.4 Results 
11.4.1 Clinical effect of STN DBS 
All patients showed significant improvement in clinical PD impairment. UPDRS-III scores 
reduced from an average (± standard deviation) of 50 (±15.1) OFF DBS, to 23.9 (±10.6) 
ON DBS, equivalent to a mean improvement of 52.2% (±12.2%) (p<0.05). Improvements 
were observed across all sub-domains, and across both hemi-bodies (Figure 11.1). 
 
Figure 11.1 The effect of STN DBS on clinical PD impairment. All clinical scoring took place 
off-medication. This is exactly as in Figure 10.2 for patient demographics, see Table 10.1. 
11.4.2 Bayesian model selection 
All 256 models successfully converged. BMS under fixed effects assumptions revealed that 
model 224 was the most likely generator of the data across the group (posterior probability 
> 99%). In agreement with Chapter 10, this model had architecture B, i.e. parallel BG and 
cerebellar loops, converging at the level of the cortex. The model encompassed DBS-
induced modulatory effects on all the connections within the BG loop, as well as the 
projection from the cerebellum to M1. Subsequent family analyses confirmed that (1) 
models with architecture B were more likely to generate the data than architecture A, and 
(2) models incorporating modulatory inputs on cortico-striatal, direct, indirect, 
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hyperdirect, thalamo-cortical, and cerebellar-cortical connections respectively outperformed 
sparser models (posterior probabilities > 99%). Results are presented in Figure 11.2. 
 
Figure 11.2 Results of BMS (A) across entire model space, (B) post-hoc analyses of model 
families. 
11.4.3 The effect of STN DBS on extrinsic coupling 
Posterior coupling estimates extracted from model 224 from each subject revealed 
significant changes in cortico-striatal, direct, indirect, hyperdirect, thalamo-cortical, and 
cortico-cerebellar coupling. Cortico-striatal (p<0.05, corrected), direct (p<0.05, corrected), 
thalamo-cortical (p<0.05, corrected) coupling increased under therapeutic STN DBS, 
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whereas hyperdirect, striato-STN and STN-thalamic coupling reduced during DBS 
(p<0.05, corrected). As before, the magnitudes of change of coupling involving the STN 
were smaller than other changes observed (although still highly significant). Importantly, 
while model selection favoured models with modulatory effects on cerebellar-cortical 
connections, when examining for changes in the coupling parameters, paired T tests failed 
to find significant differences between the coupling parameters ON and OFF DBS. 
Multiple linear regression analyses predicting clinical impairment or improvement using 
the coupling parameters failed to reach statistical significance (P>0.5). 
 
Figure 11.3 The effect of STN DBS on extrinsic coupling across the group. *P<0.05 (Bonferroni 
corrected), **P<0.001 (Bonferroni corrected). Same axis scaling used in this plot as in Figure 
10.6. There was insufficient evidence to suggest cerebellum-M1 coupling was significantly 
changed by STN DBS; uncorrected P value reported. Note the different scale used for M1-
cerebellum, and coupling with the STN. STN-thalamus coupling was set to be inhibitory a 
priori. 
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11.5 Discussion 
In this experiment, the effects of STN DBS on endogenous dynamics within the cortico-
basal ganglia motor loop were re-examined, this time including cortico-cerebellar dynamics, 
given their relevance to improvements in voluntary movements under DBS (see sections 
10.4.3 & 10.5.5), as well as their hypothesised role in PD tremor (Helmich et al., 2011). 
Results demonstrate qualitatively identical modulatory effects within the basal ganglia to 
those reported in my previous resting state dataset (an independent dataset, collected under 
a different scanning protocol, excluding cortico-cerebellar dynamics; see Chapter 8), that 
are also consistent with modulatory effects in the BG reported during movement. DBS-
induced coupling differences between the cortex and cerebellum did not survive random 
effects analysis across the group in the most likely generative model. 
11.5.1 Consistent modulatory effects on the basal ganglia motor loop 
Results from this experiment suggest that even with the additional modelling of cortico-
cerebellar dynamics, the effects of DBS on the BG motor loop appear consistent with 
sparser models of the resting state (i.e. results from Chapter 8). Once again, results suggest 
that DBS reduces the effective connectivity of the hyperdirect pathway, indirect afferents to 
the STN, and indirect afferents to the thalamus, while simultaneously increasing the 
coupling down the direct pathway, cortico-striatal, and thalamo-cortical projections. 
Perhaps of more interest is the consistency of effects on the BG motor loop regardless of 
behavioural state. In other words, STN DBS appears to be producing qualitatively identical 
effects on the BG, indiscriminate of whether the patient is engaged in voluntary 
movements or simply at rest in the scanner. Given the general state-dependence of neural 
activity and functional integration, the fact that DBS produces certain state independent 
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effects is rather remarkable, and perhaps makes sense given its therapeutic ability across a 
range of behavioural states that patients engage in. 
Furthermore, this may also help explain negative effects of STN DBS. For example, as 
discussed previously, authors have reported increased impulsivity in STN DBS patients 
during high-conflict decision making tasks (Frank et al., 2007). The identical DBS effects 
on BG dynamics during the two different behavioural states explored in this thesis may 
generalise to further behavioural states, such as decision making. In which case, the 
impulsivity deficits reported might result from this common mechanism. With regard 
decision making, it has been proposed that the disruption of the hyperdirect pathway is 
specifically responsible (Cavanagh et al., 2011). 
However, it is also worth considering the nature of resting state fMRI. The previous 
discussion is based on there being an obvious difference between motor-task and resting 
state fMRI. Put simply, just because the patient is not engaged in the motor task, does not 
necessarily mean the patient is not moving at all during the resting state session. To explore 
this question further, it may be worth scanning patients performing a completely 
orthogonal task (e.g. engaging in a cognitive process), and see if there is an effect of state. 
That being said, it is impossible to not move during any MRI session.  
11.5.2 Cortico-cerebellar dynamics during rest 
Contrasting the effects of STN DBS on cortico-cerebellar dynamics at rest and during 
movement is also particularly interesting. Model selection favoured models with 
modulatory effects on cerebellar-cortical afferents (in contrast to my findings during 
movement). However, the posterior estimates across the group of the effective connection 
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strength between cerebellum and cortex were not found to be statistically significantly 
changed by DBS. 
Taken together, results propose that during rest, there does not appear to be significant 
neuromodulation of cortico-cerebellar coupling, in either direction, whereas during 
movement, cortico-cerebellar coupling is increased. Thus, while effects on the BG motor 
loop, the circuit directly targeted by DBS, appear to be context-independent, the 
integrative abilities of the cortical targets of the BG show context-dependent modulatory 
effects.  
11.5.3 Coupling did not predict clinical impairment 
As in Chapter 10, linear regression modelling did not identify coupling in any of the 
pathways to have significant predictive capacity of either clinical status, or clinical efficacy 
of DBS. However, as discussed in section 10.5.4, this may be due to the power of the 
regression analysis to detect effects in such a small cohort with so many explanatory 
variables. Another possibility is that there was a high degree of posterior covariance 
amongst the coupling parameters, making them highly correlated, as has been observed in 
more complex DCMs (Rowe et al., 2010). 
11.5.4 Limitations 
This experiment suffers the same limitations of the presented modelling studies so far. A 
general discussion of these limitations is presented in section 12.5. 
One notable limitation of the comparison between resting and movement experiments 
presented in the previous two chapters pertains to how the data were analysed. This is 
presented in detail in section 12.3.4. 
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11.5.5 Conclusions 
My conclusions are twofold: Firstly, previous findings of modulatory effects on BG 
effective connectivity under STN DBS whilst patients lay at rest have been partially 
replicated in an independent patient cohort. Secondly, whilst models incorporating 
modulatory effects on cerebellar-cortical coupling prevail, random effects analysis at the 
group level does not identify significant differences in cerebellar-cortical coupling under 
DBS. This suggests possible behavioural context-independent effects on the BG motor 
loop. 
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12 Discussion 
12.1 Summary 
In this chapter, I discuss the results of my five experiments and their significance to our 
understanding of how STN DBS produces therapeutic effects in patients with PD. My 
discussion is split into three fundamental questions, followed by a discussion of limitations. 
Specifically, I first reflect on the technical aims of this thesis, the safety and feasibility of 
collecting fMRI in DBS patients. I review what I have achieved and discuss which aspects 
require further research.  
I then discuss the neurobiological significance of my movement fMRI experiments, before 
turning my attention to effects of STN DBS on endogenous coupling. Discrepancies in 
results are considered, and limitations of my experiments are critically examined. 
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12.2 Is DBS fMRI safe & experimentally feasible? 
The first aim of this thesis was to assess the experimental feasibility of conducting fMRI 
research in patients with implanted DBS systems, specifically PD patients with STN DBS. 
I have included safety issues with this discussion point, as the two are very much related, 
and is often the first question asked when presenting this work at conferences or talks. 
12.2.1 The safety of fMRI in DBS patients 
Prior to starting this research, the National Hospital for Neurology and Neurosurgery had 
in place a specific protocol for MRI scanning patients with implanted DBS hardware based 
on on-site in vitro studies (Carmichael et al., 2007). This protocol was (and still is) 
employed on a weekly basis to perform anatomical scans following implantation of DBS 
electrodes to verify targeting precision (that is, before implantation of the IPG). Those 
studies formed the basis of the protocol used to collect data presented in my first two fMRI 
experiments (Chapters 7 & 8). However, following some disappointing results in my first 
experiment, and some concern recruiting patients with newer systems, I felt it was worth 
trying to improve scanning protocol, which would both boost the quality of the collected 
data and maximise potential recruitment. Furthermore, the ability to collect higher quality 
scans has obvious implications on the (admittedly rare22) occasions that DBS patients 
require cranial MRI post-surgery. 
12.2.1.1 Functional MRI in DBS patients at 1.5T 
Functional MRI data presented in this thesis was collected exclusively in 1.5T MRI 
scanners, and is the largest known cohort of DBS patients to receive fMRI. Given this, it is 
important to note that there were no adverse effects of scanning in any of the patients 
taking part in my experiments. All patients returned to their clinical baseline following re-
                                                   
22 If imaging is required, CT is usually adequate – but on occasion MRI needs to be used. 
 Discussion  |  219 
219 
administration of their medication, there were no significant changes to the DBS circuit 
impedances between any contact combinations, and there were no unexpected switching 
on/off of the IPG whilst in or around the MRI scanner. This was true under both safety 
protocols used in this thesis. 
Safety was determined primarily by assessing the heating produced at the electrode tips 
given the general agreement within the literature that this represents the foremost danger of 
scanning (Baker et al., 2006; Georgi et al., 2004; Golombeck et al., 2002; Kainz et al., 
2002; Rezai et al., 1999, 2002; Sharan et al., 2003). In addition, I performed several pilot 
scans with the DBS electrodes taped to my head to confirm to myself that electrode 
‘migration’ really was not a cause for concern23. The safety thresholds used in in vitro results 
in Chapter 9 (<1°C) were based on current international guidelines (HPA, 2008), and 
assume that the heating produced is not dispersed by cerebral blood flow (which it likely is 
– (Collins et al., 2004; Salcman et al., 1989)). As an illustration of the margins of safety 
used, it is worth considering that under these recommendations, high fevers (40°C), which 
are not known to cause neural tissue damage, would be considered too dangerous (Finelli et 
al., 2002). It is also worth noting that other studies employing fMRI in these patients have 
not conformed to as strict guidelines: Phillips et al., report using a GE-EPI sequence that 
produced as much as 1.36°C of heating using a 3T scanner (Phillips et al., 2006), and Jech 
et al., have used T2-weighed sequences with a SAR as high as 0.98 W/Kg, producing 
heating of 1.1°C. 
My results confirm that both head-transmit MRI is safe in patients in ActivaPCTM systems, 
and propose that using body-transmit MRI is sufficiently safe at 1.5T, even in extreme 
                                                   
23 This was largely done to relax my prior beliefs about strong magnets and metal. It was not 
formally measured given previous studies have demonstrated that MRI at 1.5T is not associated 
with electrode movement (Uitti et al., 2002). 
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cases of misplacement of the patient (±15cm from iso-centre). This was confirmed 
following successful safe data collection in Chapters 10 & 11. This technical 
accomplishment is itself a significant advance to the field. However, like all the literature on 
the safety of scanning patients with implanted devices, these findings are not immediately 
generalizable given the inherent between centre differences in scanners, and scanner 
software versions. Centres looking to perform similar studies must make sure to perform 
their own on-site in vitro experimentation before embarking on in vivo investigation. 
12.2.1.2 Scanning at 3T 
One published study has already scanned patients immediately following electrode 
implantation at 3T, reporting no temporary or permanent adverse effects (Phillips et al., 
2006). While this is promising, the conclusions of this work suggest that as things stand at 
our centre, scanning at 3T is too dangerous (see section 9.5.1.5). Of particular concern is 
the heating occurring during the pre-scan process. The MRI physics team at the hospital 
have contacted Siemens to ask them specifically what occurs during this period that could 
produce the large temperature changes reported. However, even if the cause is identified, 
heating during scanning still exceeded acceptable limits, bringing into doubt whether 3T 
MRI in these patients will ever be feasible. 
12.2.2 DBS hardware, fMRI and experimental confounds 
In terms of the potential technical experimental confounds of performing fMRI in DBS 
patients, this thesis specifically addressed two: (1) interruption of programmed stimulation 
by the MR environment, and (2) different heating effects seen during different DBS 
conditions. 
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Results from Chapter 9 show that ActivaPCTM devices appear to deliver programmed 
stimulation during fMRI, regardless of whether head-transmit or body-transmit MRI was 
employed. Furthermore, this new device did not appear to ‘drop’ any pulses or deliver 
additional stimulation, as has been previously reported with older devices (Carmichael et 
al., 2007; Georgi et al., 2004). 
Regarding heating effects across stimulation conditions, my results were somewhat 
confusing and lacked some consistency across field strengths. The results of the effect of 
DBS condition (presented in section 9.4.3) are summarised below in Table 12.1: 
 TSE sequence GE-EPI sequence (fMRI) 
1.5T -0.01°C (p =0.420) +0.08°C (p <0.008) 
3T -0.20°C (p <0.001) - 
Table 12.1 The effect of activating the IPG on maximum heating achieved during different 
sequences at different field strengths. All values are relative the heating achieved during OFF 
stimulation. The measurement sensitivity was ±0.1°C. 
I have not been able to explain the differences in ΔT observed across sequences and field 
strengths; clearly more work is required, especially at 3T. Perhaps working with higher 
energy sequences will enable the effect of stimulation to be better characterised, as heating 
effects may be exaggerated, which will be useful given the limited sensitivity of the 
thermometer. At 3T, Phillips et al., have reported different heating effects under different 
stimulation conditions; in that instance, activating the DBS increased mean heating by 
0.08°C, although the comparison was not statistically analysed (Phillips et al., 2006)24. One 
can speculate that if the effect is indeed true, it is likely due to differences in the circuit 
impedances in the two stimulation conditions. 
                                                   
24 That study also used an external pacemaker with externalized extension cables running from 
the skull to the control room. Thus, there are a number of other factors (geometry of cables) that 
make those results difficult to compare to these. 
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For the purposes of my studies however, these results confirmed that if there is any 
difference in heating effect between ON and OFF conditions during fMRI, it is sufficiently 
small (in a model that implicitly over-estimates heating,) that it is within the range of the 
thermometer sensitivity. Thus, it is assumed that any real heating occurring in vivo is likely 
negligible and does not confound fMRI studies comparing ON and OFF stimulation 
conditions. 
12.2.3 Hardware-related artefact 
On reflection, artefact remains one of the key complicating issues in DBS fMRI, one that 
does question the feasibility of certain experiments, and one that was unfortunately not 
addressed in this thesis. The two major sources of artefact in fully implanted patients are 
the (1) connection between extension cable and electrodes, and (2) electrode tips.  
The first experiment was short-sighted in this regard, although arguably excusable. At the 
time of scanning the only published fMRI studies had focused on patients who had yet to 
receive their IPGs, thus delivered active stimulation using an external stimulator connected 
to the patients’ externalised leads via a long extension cable. The resultant cable geometry 
was obviously very different to that of an implanted patient, thus it was difficult to predict 
what the artefact would look like when the patient had their DBS in situ. In fact, the 
experiment in Chapter 7 is, to my knowledge, the first report of performing fMRI in 
patients with fully implanted systems. 
The metal screws that secure the extension cable to the electrodes likely cause the artefact at 
this junction, and typically produced much larger loss of signal artefacts than the electrodes 
themselves. This was first noted by Arantes et al., in their fMRI study in externalised 
patients (Arantes et al., 2006). Regarding the artefact at the electrode tip, previous in vitro 
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experiments have attempted to characterise and optimise sequences to minimise its effect 
(Pollo et al., 2004). However these experiments have focused on sequences commonly 
employed for anatomical scans, posing questions like which sequence is optimal for post-
implantation electrode verification scanning? Two studies have examined the artefact at the 
lead during GE-EPI sequences, reporting loss of the MR signal in a volume extending as 
much as 1 cm from the electrode (Georgi et al., 2004; Shrivastava et al., 2012).  
These artefacts were especially destructive at second level analysis (again, something that no 
one else had performed in DBS patients). As voiced in section 7.5.1.1, their effects were 
more severe in the group analyses due to the additive nature of the artefact across the 
group. Thus at the second level, even when recruitment was limited to patients known to 
have their connectors at a relatively fixed location (as in the second cohort), the SPM 
“whole brain” volume mask excluded a large portion of the left hemisphere (presented in 
Figure 12.1). 
 
Figure 12.1 The resultant search volume for second level analysis in Chapter 10. The image 
presented is the MNI brain with the mask.nii image (found in the same directory of the 
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estimated SPM.mat) overlaid in transparent pink. The blue-grey brain regions are therefore 
regions not included in the “whole brain” search volume. Yellow arrows highlight regions lost 
due to the DBS artefact including the left hemisphere cortex and bilateral thalamus area. 
So, do these artefacts make fMRI in DBS patients unfeasible? In my opinion, it appears to 
depend entirely on the scientific question pursued25. If the experimenter wants a truly 
unbiased search across all regions of the brain to detect some factor x DBS interaction in 
patients with chronically implanted hardware, then yes, unfortunately that is not going to 
be possible in these patients, in a similar way to how it would not be possible to do an 
unbiased search in GE-EPI data that had not been corrected for susceptibility artefacts 
(Devlin et al., 2000; Hutton et al., 2002). For example, analysis of data in temporal or 
orbitofrontal cortex has long been complicated by identical issues, and can be aided by 
correcting for field inhomogeneity (Hutton et al., 2002) and/or optimising the EPI 
parameters (Weiskopf et al., 2006). Therefore, future work should certainly focus on 
optimising scan parameters to minimise the observed artefact. 
Regardless of progress made on that front however, there will likely always be some artefact, 
and given the small size of the nuclei targeted in DBS operations, it is unlikely that DBS 
fMRI will be able to inform us about neural activity at the target nucleus26. Thus, if the 
experimenter wants to know whether activity at the STN changes under DBS, then an 
fMRI study is not suitable as things stand. Similarly, if the experimenter wants to look for 
task x DBS interactions that they believe are likely to occur in the in the left parietal and 
frontal cortex, the artefact from the connector is likely to render the experiment unfeasible 
                                                   
25 …like almost everything in science. 
26 In fact, given the size of the STN, it is questionable whether current fMRI can ever really 
attribute activity to nuclei of these sizes at all, especially considering most authors employ 3 mm 
isotropic scanning, and then spatially smooth their data. This is forgetting of course that the 
HRF has a spatial dispersion, as well as a temporal one (Penny et al., 2005). For this, lessons 
might have to be learnt from the growing literature on brainstem fMRI (see section 13.2.2).  
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– this may be particularly relevant for those wanting to explore the known adverse effects of 
STN DBS on verbal fluency (Cilia et al., 2007).27 
12.2.4 Recruiting patients with advanced PD, severe motor symptoms & DBS 
The following points are not entirely specific to DBS fMRI studies, however are worth 
briefly mentioning because they were important considerations in these studies. Scanning 
patients presents a number of challenges; both with regard experimental design, and 
pragmatics. 
12.2.4.1 Implications on experimental design 
Experiments in Chapters 7 & 10 sought to identify regions displaying movement x DBS 
interactions and model the underlying functional architecture. Despite one of the key 
advantages of fMRI over PET being the improved temporal resolution and the ability to 
perform event-related designs, epoch designs were chosen for two reasons28: (1) because that 
is what had been done previously in the PET literature, and (2) because they are the most 
efficient at identifying regions engaged in simple tasks such as our own (Henson, 2007). 
Efficiency was key because it was necessary to minimise the time spent in the scanner, given 
the discomfort associated with being off medication, and for half of the session, off 
stimulation too. The discomfort factor is actually an important issue in these types of studies, 
and certainly (but unavoidably) confounds comparisons between the ON and OFF state. 
In retrospect, I should have collected survey data post-scanning, and attempted to correct 
                                                   
27 These studies could be possible if the surgeons and patients agree to have their systems wired 
down their right side. This is equally feasible from a clinical perspective, however the standard 
surgical practice here is to implant the IPG in the left pectoral area.  
28 On this note, it is worth clarifying that while this thesis has used terms like the “main effect of 
voluntary movements” or “movement x DBS interactions”, “movements” are more accurately 
blocks of movements including the gap between actual movements. 
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for levels of discomfort across the group. Furthermore, it implicitly biases recruitment to 
those patients who can tolerate the discomfort. 
12.2.4.2 Washout periods 
Related to this is the latencies adopted between de/activating DBS and scanning, as well as 
the gap between stopping medication and scanning. In an ideal world, both washout 
periods would have been longer such that scanning really captured the true off/OFF state, 
as well as the off/ON state. While the vast majority of its clinical effect is delivered within 
the 10 minute window adopted, the literature reports that delivery (or removal) of full 
efficacy can take hours (80% of efficacy on rigidity and bradykinesia subsides after 30 
minutes of DBS OFF – see Figure 12.2 adapted from (Temperli et al., 2003)). 
Unfortunately, the pragmatics of doing this would be incredibly difficult, and arguably 
questionable from an ethics perspective.  
 
Figure 12.2 The time taken for PD symptoms to return following discontinuation of STN DBS. 
Adapted from (Temperli et al., 2003), Figure E in that paper. Green line estimates the time at 
which fMRI data acquisition began. 
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12.2.4.3 DBS circuit impedance 
On the matter of recruitment, all participants in these experiments had their DBS system 
impedances checked before scanning to ensure there were no potential lead fractures or 
vulnerable circuit components. This was important because our safety data had been 
collected in fully functioning systems, and thus the safety of scanning patients with lead 
fractures was unknown. Theoretically, a loose connection or circuit defect could cause a 
large voltage across the defect, potentially causing excessive heating or a spark (Georgi et al., 
2004). One case report of such an event has been reported with ECG equipment (Kugel et 
al., 2003). 
Additionally, all patients in this study had to tolerate lying flat in the scanner with minimal 
head tremor in both DBS conditions. The reason for this was based on two factors: (1) 
head movements reduce the quality of the data (discussed in the next section), and (2) the 
safety data was collected in a static in vitro model and did not study potential currents that 
could be induced by moving the DBS circuit within the magnetic field. This again biased 
selection away from patients with a more tremulous phenotype. 
All these factors, in addition to only selecting patients with left pectoral IPGs in the latter 
experiments, complicated patient recruitment. Of the patients that we felt could tolerate 
scanning based on their clinical history: 
• 2 patients could not be scanned due to high system impedances (subclinical), 
• 2 patients could not be scanned due to excessive head tremor, 
• 1 patients started scanning but could not tolerate being OFF stimulation, 
• 1 patients started scanning and could not tolerate being enclosed in the scanner, 
• 23 patients successfully completed scanning sessions. 
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12.2.5 Task fMRI & motion artefacts 
To most economists the single equation least squares regression model, like an old 
friend, is tried and true… As with most old friends, however, the longer one 
knows least squares, the more one learns about it. An admiration for its 
robustness under departures from many assumptions is sure to grow. The 
admiration must be tempered, however, by an appreciation of the model's 
sensitivity to certain other conditions. 
D. E. Farrar and R. R. Glauber, 1967 
A prominent source of noise in fMRI is motion of the subject during scanning, producing 
both spin-history and susceptibility-by-movement artefacts (Andersson et al., 2001; Friston 
et al., 1996; Wu et al., 1997). As a means of nullifying this, data in these experiments were 
first realigned and unwarped (see section 6.4.1). Subsequently, data collected in 
experiments in Chapters 7, 8 & 11 were modelled using GLMs including realignment 
parameters (i.e. head motion parameters) as nuisance regressors in an attempt to explain 
away any obvious correlates of head motion. 
In the second task fMRI study in Chapter 10, head movement covariates were specifically 
not included in the first level GLMs, owing to the noted collinearity between stimulus 
function and head movements (reported in section 10.3.5). A representative example from 
that experiment can be seen in Figure 12.3. Simply put, the GLM is not well equipped to 
cope with interdependent (sometimes referred to as correlated, collinear or multicollinear) 
explanatory variables; the columns of the design matrix are assumed to be controlled 
elements of a laboratory experiment, where experimental factors are orthogonal with respect 
one another (Farrar and Glauber, 1967; Friston et al., 1994b) 
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Figure 12.3 Example of non-orthogonality between head motion regressors and the stimulus 
function. Taken from Sub006 from Chapter 10 with their head motion regressors included in 
the design matrix. Green brackets highlight motion regressor collinearity. Pink arrows 
demonstrate shared variance between given head motion regressors and the stimulus function, 
with correlation coefficient. 
As a result, one obvious difference between task experiments in Chapters 7 and 10 is the 
presence of those covariates in the first level analysis. Thus, it could be that the differences 
in results could be due to collinearities in those GLMs that were initially missed. To 
investigate this, the data from Chapter 7 were re-analysed using the same batch pipeline as 
used in Chapter 10. Results at the second level found no evidence for any movement x DBS 
interactions surviving SVC or cluster wise whole brain significance thresholds, suggesting 
that collinearity between hand and head movements was unlikely to be masking true 
experimental effects. 
Addressing a more general issue, head movements are clearly an important source of noise 
in all fMRI studies, especially in PD patient cohorts. In brief, it is assumed that voxel X 
corresponds to brain volume Y throughout scanning, and upon head movement, this 
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assumption is broken. Therefore the variance in the signal from voxel X is going to be a 
function of both the experimental factors, and the head movement. Head movement 
variance tends to be more pronounced than experimental variance, and if the movements 
are collinear with the experimental stimuli (for us, hand movement blocks), identifying 
experimental effects becomes more difficult (Friston et al., 1996; Wylie et al., 2014). 
In studies such as the ones presented herein, when PD patients are scanned in two 
treatment states, one associated with less tremor, differences in BOLD signal could 
therefore result from either a biological difference (i.e. a real difference), or a difference in 
the SNR of the two datasets. To confirm therefore that there was not a significant 
difference between the motion during ON and OFF, the second cohort’s average variance 
of each of the 6 motion parameters from task sessions during both conditions are presented 
below (Figure 12.4). These simple comparisons suggest that the ON vs. OFF comparisons 
presented in Chapter 10 are not significantly confounded by differences in head motion. 
 
Figure 12.4 Comparing the variance of parameters of head motion during task fMRI sessions 
ON and OFF DBS (data from Chapter 10). Variance = standard deviation. The mean 
variances across the group are presented. P values are for the paired T test comparing ON and 
OFF sessions and are uncorrected for multiple comparisons. There is no evidence to suggest there 
is an effect of DBS on variability of head motion during scanning.  
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12.2.6 Conclusions 
So, let us return to the question set out in this sub-section, is DBS fMRI safe & 
experimentally feasible? In my opinion, the answer is yes, but these experiments are 
certainly more restrictive than fMRI in other patient cohorts, and far more restrictive than 
fMRI in control cohorts. Undertaking such studies requires careful consideration of:  
1. Safety and MRI protocol, including on site in vitro testing. 
2. Limitations posed by the hardware-related artefact. 
3. Balancing experimental ideals with pragmatic recruitment and patient comfort. 
4. Motion artefact in patient cohorts (especially with movement disorder cohorts). 
12.3 What does STN DBS do to the PD brain whilst engaged in 
voluntary movements and whilst “at rest”? 
Turning our attention to its neurobiological significance, this thesis presents a series of 
experiments that examine the effect of STN DBS on neural activity both whilst patients 
perform blocks of voluntary movements, as well as whilst patients lay in the scanner at rest. 
To my knowledge, this work is the first fMRI study to examine patients with bilateral STN 
DBS with fully implanted systems. As a result, all had their DBS parameters optimised over 
a period of at least 3 months, and had received chronic stimulation at confirmed 
therapeutic parameters. Any effects of inflammation were likely to have passed by the time 
patients underwent scanning. 
12.3.1 The nature of the voluntary movements studied 
It is worth briefly pausing to clarify exactly what is meant by voluntary movements. The task 
used has been employed in a number of previous PET studies (Ceballos-Baumann et al., 
1999; Limousin et al., 1997). While movements are cued by the auditory stimuli during 
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the “go” blocks, the voluntary component arises from the choice of direction in which the 
handle can be moved with each trial. Furthermore, subjects were instructed to plan their 
next movement between cues. Thus, modelling the movement block additionally includes 
periods of planning and initiation, as well as the movement themselves. 
12.3.2 Where does DBS produce the greatest changes in motor-evoked 
responses? 
Both experiments in Chapters 7 and 10 sought to identify key components of the motor 
system that demonstrated movement x DBS interactions. Results from Chapter 7 detected 
two such clusters that were significant at SVC statistical thresholds; in other words, only 
when the search volume was limited to spheres surrounding key nodes of the motor 
network (identified using the orthogonal contrast – the main effect of movement) were these 
changes statistically significant. The data were fastidiously interrogated to ensure that 
analysis had not been confounded; for example, collinearity of experimental effects with 
head motion (discussed in 12.2.5). At the time of analysis (and subsequent publishing) 
these data were the best achievable, thus provided the best insight at that time, 
acknowledging of course that results failed to reach whole brain significance following 
correction for multiple comparisons. That particular paper concluded with this important 
limitation (Kahan et al., 2012). However, following collection of the second dataset under 
an improved protocol (having learnt from previous studies), the two clusters identified were 
only significant at liberal whole brain uncorrected thresholds, whereas two additional 
clusters, not detected in Chapter 7, were significant at the whole brain corrected level. 
larger effect sizes are more likely to be causal to behavioural changes. 
Another important finding was the lack of detection of any decreased motor-evoked 
responses under DBS in either study (i.e. movement x DBS interactions OFF>ON). As 
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reviewed in 5.4.2.6, studies have previously reported decreases in parts of the precentral 
gyrus (Ceballos-Baumann et al., 1999; Thobois et al., 2002) and cerebellum (Grafton et al., 
2006). 
Based on the results of these experiments, I conclude that, in terms of regional responses to 
blocks of voluntary movements, therapeutic STN DBS produces its most marked effects on 
M1 and the cerebellar cortex, increasing the activity in both of these well established 
component nodes of the motor network. 
12.3.3 Does STN DBS change cortico-subcortical effective connectivity? 
Moving on to address the third aim of this thesis, all four of my fMRI experiments have in 
some way posed this scientific question, in progressively greater detail. In my first 
experiment (Chapter 7), given the lack of interaction clusters that survived corrected whole 
brain statistical thresholds, the insula and thalamus (both clusters that survived SVC) were 
chosen to summarise the respective cortical and subcortical systems. In DCM, interactions 
in a given region are typically explained by some modulatory effect of an experimental 
factor on at least one of the afferents to that region. In the simple reciprocal architecture 
specified (see Figure 7.2), the observed data could well have been explained by modulatory 
effects on each node’s respective intrinsic afferents, suggesting that modulatory effects on 
cortex and thalamus are not dependent on the two interacting. However BMS 
demonstrated that both extrinsic and intrinsic afferents were modulated by STN DBS, 
suggesting that both the cortex and thalamus experience a gain “tuning”, altering their 
sensitivities to incoming signals from each other. Put simply, the answer to the question in 
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this sub-section was most likely29, but the nature of this change, its anatomical detail, and 
significance to clinical efficacy were unclear. 
The question then became more specific. Chapters 8, 10 & 11 each asked which of the 
known pathways coursing through the BG, and subsequently cerebellum, were modulated 
by DBS.  
The BMS results as well as subsequent comparisons of parameter estimates clearly 
demonstrated that regarding the BG, STN DBS had relatively consistent effects. In each of 
the datasets studied in Chapters 8, 10 & 11; STN DBS increased cortico-striatal coupling, 
direct pathway (or more specifically, excitatory striato-thalamic) coupling, and thalamo-
cortical coupling. In contradistinction, DBS reduced hyperdirct cortico-STN coupling, as 
well as STN afferents from the striatum (considered the proximal limb of the indirect 
pathway), and STN-thalamic (distal limb of the indirect pathway) effective connectivity 
(presented graphically in Figure 12.5). In other words, STN DBS:  
• Increases the putamen’s response to cortical afferents; 
• Biases thalamic sensitivity towards the direct pathway afferents; 
• Reduces the sensitivity of the STN to incoming signals;  
• Increases the gain of cortical targets to information arriving from the BG.  
The relevance of these findings to the published literature has already been discussed at 
length in section 8.5.1. 
                                                   
29 Remember, the answer to all model comparison questions (arguably all statistics for that 
matter) that select a winning model end in “most likely”. This probabilistic estimate is 
conditional on both the data and the competing models tested. The job of BMS is to allow the 
experimenter to compare competing plausible hypotheses. The job of the experimenter is to come 
up with interesting and plausible hypotheses. 
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Figure 12.5 Summary of the effects of STN DBS on effective connectivity within the motor 
system. 
12.3.4 Does STN DBS produce state-independent effects on the BG motor loop? 
The follow-up question is of particular interest; are the effects of STN DBS dependent on 
behavioural state? This was briefly addressed in section 11.5.1. To summarise, DCMs of 
the cortico-BG and cortico-cerebellar dynamics were fitted to data collected in two 
different behavioural states (voluntary movements and at rest). BMS was then used to select 
the most likely generative architecture for each state, parameter estimates from the winning 
model were extracted and paired T tests were used to test for a significant effect of DBS on 
each connection at the group level. Through qualitative comparison, it was clear that the 
 Discussion  |  236 
236 
direction of modulatory effects on pathways in the BG were consistent across behavioural 
states. From that, it was inferred that STN DBS produces state-independent 
neuromodulatory effects on the BG.  
This inference however is limited in two keys ways: Firstly, while both experiments model 
the dynamics of the 5 nodes with identical model spaces and endogenous connections, the 
data for each region was not extracted from anatomically identical voxels, despite being 
from the same group of subjects. This is due to discrepant methods used to extract VOIs in 
the two experiments, and ideally would have been identical. 
Secondly, in an ideal analysis, data during movement and rest would have been considered 
in one large first-level GLM, including effects of movement blocks (i.e. the 30-second boxcar 
functions used in the previous experiment), as well as main effects of DBS, and main effects of 
context. That way, all data would have been in one DCM with effects of movement driving 
M1, and effects of DBS and context modulating connections. This framework would have 
(1) solved the problem of discrepant VOI extraction methods mentioned above, and (2) 
allowed quantitative analysis of context x DBS interactions, as opposed to the qualitative 
(and arguably speculative) comparison presented in this discussion. This unfortunately was 
not possible given the difference in the sequence parameters between resting state and task 
fMRI. These differences in sequence parameters (specifically the TR and voxel dimensions) 
were introduced for pragmatic reasons to do with minimising the time in the scanner, 
whilst maximising the amount of data that could be collected.  
In fact, the current findings could be interpreted in a completely different way, speaking to 
a more general methodological neuroimaging question. If one were to assume that the 
effects of intervention are identical in both states (which is what we have found in the BG) 
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such a comparison could equally be asking which type of dataset is DCM more efficient at 
estimating modulatory effects in, task data, or “resting state”? 
Finally, it is also worth highlighting that not all the effects appear to be context-
independent. Our modelling suggests that whilst effects on the BG remain fairly constant 
between movement and rest, some effects of DBS appear to be task dependent. Specifically, 
DBS increases the response of midline cerebellar activity to incoming signals from the 
cortex (see 10.5.5), during movement, but not during rest. It would be interesting to 
determine whether or not this phenomenon generalises to other functionally specialised 
motor cortical regions by including these regions in future DCM experiments. 
12.3.5 Concluding speculation 
If the inference discussed above is valid, this may shed light on the potential generalizability 
of DBS to other neurological or psychiatric conditions. Put simply, DBS appears to be 
producing the same local effects on a circuit irrespective of what the circuit is engaged in 
doing. Specifically DBS is (1) reducing the target’s response to incoming signals, and (2) 
altering the sensitivity of neural populations that are anatomically related to that target to 
their incoming afferents30. Assuming DBS directly produces at least (1), translating its 
therapeutic potential to brain disorder X would require characterisation of the neural 
dynamics in condition X, and identification of nodes in that architecture that show 
increased afferentation in the disease state (as has been shown to occur in PD with the STN 
- (Marreiros et al., 2012; Moran et al., 2011a)). In order to test this hypothesis, future 
                                                   
30 It is also interesting to consider whether or not STN DBS is actively doing both of these things, 
or whether DBS does (1), which then results in (2). This could be investigated by scanning 
subthalamotomy patients before and after surgery; in theory, subthalamotomy would result in a 
reduction of the STN’s response to its afferents, and its output to the thalamus thus I would 
hypothesise that this could produce at least (1), with possible modulatory effects on the STN-
thalamus coupling. If this also produces all the effects on coupling produced by DBS, it is very 
possible that DBS is acting similarly. 
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experiments must both establish that STN DBS is producing consistent effects across 
different disease populations, as well as characterise the modulatory effect of other DBS 
therapies in both PD (e.g. GPi DBS), and other diseases. This is discussed further in 13.5. 
12.4 Does effective connectivity predict clinical parameters? 
Given STN DBS was found to significantly alter extrinsic effective connectivity within the 
BG motor loop, it was interesting to see if the furnished coupling estimates had some 
predictive capacity for clinical status, clinical improvement and behavioural performance. 
This was attempted in all DCM experiments, but unfortunately, only yielded significant 
results in Chapter 8 (performed on our first resting state cohort). In that experiment, 
multiple linear regression analyses were performed (n=24 hemispheres, with 6 explanatory 
variables), finding: 
• Contralateral31 hemibody clinical score OFF DBS was predicted by a linear 
combination of all OFF DBS extrinsic coupling in the BG motor loop, each 
connection providing a statistically significant contribution to the model. 
• Contralateral hemibody clinical score ON DBS was predicted by a linear 
combination of all ON DBS extrinsic coupling in the BG motor loop, but only 
hyperdirect, striato-STN and direct pathway provided statistically significant 
contribution to the model. 
• Finally, using a stepwise elimination regression to yield the most parsimonious 
model, percentage improvement in contralateral hemibody clinical score was 
predicted by a linear combination of the modulatory effect on the hyperdirect, 
                                                   
31 Contralateral to hemisphere modeled.  
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direct pathway and striato-STN coupling, but the latter variable’s contribution was 
only trend significant (p<0.1). 
At the time of analysis and subsequent publishing, this provided (1) predictive validity of 
stochastic DCM parameter estimates, (2) further evidence that coupling was an important 
determinant of clinical phenotype (or behaviour in general), (3) understanding of which 
coupling parameters were the most important determinant of therapeutic efficacy (i.e. 
hyperdirect, direct pathway and striato-STN coupling), and (4) the direction of change 
associated with clinical efficacy. Multiple linear regression analyses were employed 
specifically because of their ability to simultaneously consider multiple dimensions of the 
data; in other words, because all parameters were considered to be potential sources of the 
variance in the clinical response, linear modelling allowed us to consider them all together, 
and not just do multiple individual parameter correlations (which would then result in 
another multiple comparisons problem). 
Unfortunately, these interesting relationships could not be reproduced in subsequent 
experiments. This could be due to one of three reasons, either (1) the detected relationships 
are not true, (2) the analysis was not suitably powerful enough to detect the effect, or (3) 
the analyses were different, and thus are not true replications. Considering the second 
option, subsequent experiments included and an extra explanatory variable (because the 
models included an extra connection, see 12.5.6), and fewer hemispheres (because the task 
fMRI was only performed using the left hand, in Chapter 10). The statistics literature tends 
to recommend sample sizes an order of magnitude larger than was possible in our 
experiments to produce robust estimates in multiple linear regressions; different formulae 
suggest different sizes, for example, Green suggests N > 104 + m (Green, 1991), whereas 
Harris’ formula proposes a minimum of N > 10m (N being the sample size, and m being 
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the number of independent variables in the regression) (Harris, 1985). Considering the 
third option, the parameters included in Chapters 10 & 11 were taken from models that 
included cortico-cerebellar dynamics, thus these results are not a true replication of the 
originals32. 
Unfortunately though, despite their biological plausibility (see 8.5.1), it remains possible 
that there are not strong predictive relationships between coupling and clinical 
status/efficacy. Further studies with much larger cohorts are required to deliver a more 
confident verdict on this question. Furthermore, it would be desirable to collect objective 
measures of clinical features such as rigidity, tremor, and bradykinesia. While the UPDRS-
III is the current gold-standard in clinical neurology, objective measures would enhance 
tracking of disease progression (over years), but could also potentially provide reliable time 
series data that could be integrated into fMRI designs.  
12.5 Limitations 
12.5.1 Resting state fMRI 
One of the advantages of resting state fMRI is its clinical compatibility; in other words, the 
only expectation you have of the participant is that they can lie in the scanner and stay still. 
For obvious reasons, it is also popular amongst the experimenters as well. However, the lack 
of experimental manipulation brings with it a complete lack of experimental control. In our 
case, analyses were restricted to regions believed a priori to be involved in motor processing, 
informed either empirically from these experiments, or from the literature. Furthermore, 
PD patients switching from ON to OFF and vice versa, demonstrate a very obvious change 
                                                   
32 It is also worth noting that the priors used by DCM for fMRI were updated in January 2014 
by the SPM methods team. Given these priors were the most informed at the time of analysis, the 
decision was made to adopt these. I did not replicate the experiments with the old priors. This is 
one of the key strengths and potential weaknesses of working with Bayesian schemes. 
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in motor phenotype, even when they lie in the scanner at rest. Thus in some respects, these 
studies do have an element of experimental control.  
However, as most fMRI participants will confess, it is remarkably easy to fall asleep in the 
scanner, especially over a 5 minute period with eyes closed. Thus, there is a risk that 
patients may have fallen asleep during these scans, despite our encouragement to stay 
awake. The important question that emerges is whether there is a change in motor 
phenotype between sleep and wake in PD patients, the answer to which is yes, although 
difficult to prove without waking the patient. For example, patients typically do no tremor 
in their sleep; however assessing rigidity in sleep is almost impossible. Thus it remains 
plausible that data could have been collected during sleep, in which case, the motor 
phenotype would not have been as measured in the pre-scan clinical assessment. 
Finally, it is also worth noting that it is commonplace in the resting state fMRI literature to 
correct for physiological parameters such as respiratory and cardiac rates collected during 
the resting state session. Physiological parameters have been shown to explain significant 
variance in the spontaneous BOLD signal collected at rest (Birn, 2012; Biswal et al., 1996), 
and thus they are often included in first level GLMs. The reason these parameters were not 
collected and included was purely pragmatic; the equipment was not available in our 
centre, thus did not have the opportunity to explore this in these experiments. That being 
said, respiratory and cardiac noise are generally most prominent in frequencies >0.1Hz; our 
analyses used the DCT to direct VOI extracted towards regions demonstrating 
hypothesised neural fluctuations (0.0078-0.1Hz) (Birn, 2012; Biswal et al., 1996, 1995). 
That being said, respiratory and cardiac noise can alias to lower frequency bands within the 
ranges specified by the DCT (Lund, 2001). 
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12.5.2 Anatomical precision & DCM VOI selection 
The DCM studies presented attempt to model the dynamics of the BG motor loop. The 
components of this circuit are obviously very small relative to cortical regions usually 
examined in the neuroimaging literature. While extraction of the subcortical VOIs was 
anatomically informed using thresholded probabilistic tractography atlases (Behrens et al., 
2003; Tziortzi et al., 2014), the anatomical precision of the VOIs remains imperfect, 
especially with regard the thalamus, which is well known to host a number of smaller sub-
nuclei. The effective spatial resolution of the GE-EPI data collected in these studies were 
approximately 3 mm isotropic, this was before the data was spatially smoothed using a 
Gaussian kernel of 8 mm FWHM. This point, in fact, was what prevented a more detailed 
modelling of the BG motor loop by including the GPi and GPe (see 12.5.3). 
Secondly, Chapter 8 extracted data and modelled the dynamics of both hemispheres, 
despite the artefacts obscuring parts of the precentral gyrus. As a result, as evident in 
Appendix 8.6.4 of that chapter, M1 VOIs tended to be extracted from more slightly more 
medial regions of the precentral gryus than equivalent VOIs from the right hemisphere. 
That being said, DCM results did not significantly differ between the hemispheres. 
Finally, DCMs in Chapters 10 & 11 include a cerebellar node. The peak voxel of the 
cluster found to show a movement x DBS interaction was located in the medial cerebellum, 
and subsequent VOI extraction in both experiments was based on this medial location. 
Interactions were detected in the cerebellum bilaterally, however given the peak occurred 
medially, the decision was taken to use this as the centre-point for searches in first level 
SPMs. Other studies that have examined the cerebellum in PD typically discuss more 
lateralised activity.  
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12.5.3 Pallidal dynamics in PD 
As briefly discussed, the pallidal nodes of the BG motor loop were explicitly excluded from 
our DCMs. Given the effective spatial resolution of the data, the small sizes of the GPe and 
GPi and their anatomical juxtaposition, it was decided that extracting data that could be 
confidently attributed to each nucleus would be questionable. 
As a result, the pallidal components of the BG motor loop were assumed to function as 
simple relays to either the thalamus (GPi), or the STN (GPe). On reflection, this 
assumption is similarly questionable. The reciprocal dynamics of the GPe and STN have 
been implicated in the generation of beta oscillatory activity in the BG (Marreiros et al., 
2012; Moran et al., 2011a). In those DCM papers of LFP data, compared to medicated 
patients and control animals respectively, patients off medication or 6-OHDA lesioned 
rodents had increased input to the STN from both the hyperdirect and GPe afferents, as 
well as stronger coupling from the STN to the GPi33. Furthermore, in post-hoc 
contribution analyses, small changes in the STN-GPe effective connectivity resulted in 
large fluctuations of beta expression. In addition a number of other authors have used 
forward models to investigate these dynamics, many of which highlight the central role of 
the STN–GPe circuit in the elaboration of pathological oscillations (Gillies et al., 2002; 
Holgado et al., 2010; Terman et al., 2002). Including pallidal dynamics in DCMs of fMRI 
data will be an important and interesting development, however will only be achievable if 
the spatial resolution of data improves. 
                                                   
33 Note that these results are largely in agreement with the results presented in this thesis, despite 
the different modality used (allowing for non-invasive characterization), and our sparser model. 
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12.5.4 Artefact, the STN & hidden nodes 
Due to signal drop-out around the electrode, it was not possible to record BOLD data from 
the STN itself. Therefore, the STN was modelled as a hidden node, enabling inference on 
its afferents and efferents based on the influence they exert on nodes from which precise 
recordings were available34. This is standard practice in dynamic causal modelling of EEG 
data, where some sources are hidden or silent because they cannot be ‘seen’ by scalp 
electrodes (David et al., 2011; Marreiros et al., 2012). In principle, the hidden node could 
be any brain region with the connectivity fingerprint specified by the model (i.e. any brain 
region excited by both M1 and the putamen, and that exerts inhibition on the thalamus). 
Given the anatomical and electrophysiological literature on the functional anatomy of the 
BG, our hidden node was attributed to the STN. Including hidden nodes can reduce 
associated effect sizes (because the parameters of hidden nodes are not informed by 
empirical data and shrink to their prior expectations of zero). This has been demonstrated 
empirically in Appendix 8.6.1 of Chapter 8. 
12.5.5 Modelling DBS as a modulatory input, not a driving input 
It is important to note that DBS was modelled as a modulatory effect on extrinsic coupling, 
not as a driving input to individual nodes. Thus, this work specifically addresses the effects 
of DBS on extrinsic coupling; it does not address how these changes are mediated or 
delivered to the therapeutic targets. For example, as discussed, STN DBS has been found to 
induce antidromic effects on the cortex (Li et al., 2012). While this finding may explain 
how DBS reaches its target, it does not mean there is a DBS-dependent effective 
connection from the STN to cortex – the consequences of antidromic stimulation would be 
                                                   
34 The hidden state work-around essentially suggests that recording a series of NaNs is equivalent 
to recording a real time series; the only difference is the precision of the data. In other words, no 
data is the same as some very imprecise data. 
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expressed orthodromically in cortical efferents (and afferents) to/from basal ganglia or other 
regions. 
12.5.6 The number of nodes and edges 
As discussed, DCM does not assume that edges between nodes are monosynaptic. Thus, 
complicated chains of connections could be conveniently summarised. One limitation of 
the modelling experiments presented in this thesis is the exclusion of other cortical motor 
and frontal territories that are commonly studied in PD. For example, DCM and SEM 
have previously been used to model the cortical dynamics between M1, SMA, PM, and 
portions of the PFC, and have been shown to be altered by dopamine in PD patients 
(Rowe et al., 2002, 2010). While in theory, developments in DCM have permitted 
estimation of very large models (Seghier and Friston, 2013), including many nodes has its 
complications. Firstly, especially with stochastic DCM, the time taken for models to 
converge increases significantly with the number of nodes and edges (although this has 
improved in the latest implementations). Secondly, inclusion of more nodes (especially 
cortical) will result in many more edges, given that almost all cortical regions are 
reciprocally coupled in some way (Friston et al., 2014). This implicitly increases the 
potential model space, and the potential for posterior covariances among coupling 
estimates. The added dimensionality of the data would additionally induce a more 
problematic multiple comparisons problem if post-hoc T tests were used, as were here. 
Finally, this would also increase the number of explanatory variables in any potential 
regression analysis, thus requiring a much larger patient cohort if one wanted to predict 
clinical status from the coupling, as was attempted in this work. Given these factors and the 
relatively small sample sizes achievable in this patient cohort, M1 was included as the 
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representative motor cortical node, capturing thalamo-cortical dynamics. Future work 
should attempt to include other important cortical targets of the BG. 
12.5.7 High frequency STN DBS 
Finally, it is worth highlighting that all work presented in this thesis and discussions of the 
mechanism of action of DBS are limited to high frequency DBS (typically 130Hz). While 
these frequencies are commonplace in the treatment of PD and tremor, experience in this 
centre suggests that DBS at lower frequencies (80Hz) is clinically useful in certain STN 
DBS patients, despite not a lot of published evidence supporting this (Sidiropoulos et al., 
2013). Furthermore, other forms of DBS utilise much lower stimulation frequencies, for 
example, clinically effective PPN stimulation is typically programmed to deliver 20-30Hz 
stimulation (Stefani et al., 2007). 
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13 Future research 
Parts of the following chapter have been published in Kahan & Foltynie (2013), Neuroimage. 
13.1 Summary 
In this chapter, I discuss the future of DBS fMRI. I outline five key areas of research that 
would enhance our understanding of both the mechanisms underling DBS, as well PD 
pathogenesis from a systems level perspective. 
Specifically, I discuss (1) optimisation of data collection, (2) integration of fMRI data with 
multimodal approaches including structural connectivity data and current field mapping, 
(3) modelling synaptic repercussions of DBS, and finally (4) extending this research beyond 
STN DBS to address common effects of DBS therapies. 
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13.2 Optimising data collection 
13.2.1 Artefact minimisation 
As discussed in 12.2.3, an important goal of future research should be to characterise and 
minimise the artefact observed at both the electrode tips, and at the junction between the 
electrodes and extension cable. This should be studied systematically in a spherical 
phantom head model, examining individual parts of the circuit, and contributors to the 
signal drop out. In terms of sequence development, it is worth considering the literature on 
GE EPI in the OFC, a region that suffers from similar drop out artefact due to its 
proximity to the air/tissue interface created by the frontal sinuses. Tilting the slice angle has 
produced beneficial results there; Deichmann et al., found that artefact is maximised when 
the slice is parallel to the surface between tissues with different susceptibility (Deichmann et 
al., 2003), thus it is worth experimenting with the slice angle in DBS fMRI. Alternatively 
(and/or additionally,) reducing the slice thickness would also reduce the artefact, however 
would bring with it reductions in SNR, requiring more data to be collected to be collected 
(thus more time in the scanner) in order to produce data of similar quality. Given the 
nature of the cohort, this may be untenable. Finally, it may also be worth considering using 
spin-echo (SE) fMRI (as opposed to gradient-echo used here). SE BOLD would 
theoretically both reduce drop out artefacts, as well as increase the potential spatial 
resolution of the data. However, SE BOLD also has a reduced sensitivity (halving the 
SNR), requiring four times the data to be collected (Norris, 2012).  
Finally, it was inferred that the signal loss near the extension cable was due to the metal 
screws used to connect the cable to the electrodes. If this inference were true, one obvious 
solution would be to encourage the manufacturer to use alternative screws, or otherwise 
consider competitor systems from other manufacturers to see which system delivers the 
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least artefact. Market pressure may be the optimal (if slow) means of driving changes in this 
regard, assuming such changes in the hardware do not impact on the clinical efficacy. 
13.2.2 Improved segmentation and normalisation 
Another important future development that will benefit DBS fMRI will be the finessing of 
subcortical segmentation and normalisation in SPM. Currently, SPM segments the brain 
into three canonical tissue types; grey matter, white matter and cerebrospinal fluid. 
However, it is clear that three tissue types is a significant simplification. Recent work 
studying the brainstem has employed multiparametric mapping (MPM), specifically using 
quantitative magnetisation transfer and proton density maps to create tissue probability 
maps for four tissue types in the brainstem alone. These tissue probability maps correspond 
well with both post-mortem high resolution MT-T2* data, as well as ex-vivo 9.4T MRI 
microscopy data, and permit a highly accurate warping of individual data (Lambert et al., 
2013). Extensions of this work to include the nuclei of BG and thalamus are in 
preparation35, although application to DBS fMRI would have to contend with the artefact 
produced in the GE EPI sequences. To address this, pre-operative MPM scans may prove 
beneficial for subsequent post-operative fMRI. 
13.2.3 Respiratory and cardiac artefacts 
Given the physiological artefacts associated with fMRI, particularly at the level of the 
brainstem (Brooks et al., 2013), where there are likely interesting effects of DBS that we 
have yet to detect, one very simple improvement to the current acquisition protocol is to 
simultaneously collect both heart and respiratory rates using pulse-oximetry and respiratory 
                                                   
35 Personal communication with Lambert et al.; Poster presented at OHBM 2014, “Fine Grain 
Cortical Segmentation using Multiparametric Maps at 3T”. 
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bellows respectively. These physiological parameters could then aid and potentially bolster 
results of GLM analyses using methods such as RETROICOR (Glover et al., 2000). 
13.3 Integration with structural connectivity & anatomy 
The relationship between structural and functional connectivity is an extensive and growing 
discipline (Bullmore and Sporns, 2009; Sporns, 2014). Of particular relevance to DBS is 
the potential to map the structural architecture intersected by the active electrode contact. 
DBS targeting tracts and white matter is gaining increasing interest in the treatment of 
different diseases (Henderson, 2012), given white matter’s greater sensitivity to electrical 
stimulation than grey matter. In the case of Major Depressive Disorder (MDD) trials of 
DBS of the subcallosal cingulate region have produced mixed results. Recent work though 
has suggested that the position of the electrode relative to the subcallosal cingulate white 
matter (specifically forceps minor, uncinate fasciculus and cingulum bundle) is an 
important determinant of clinical efficacy (Riva-Posse et al., 2014). 
In the same vein, it would be of great interest to determine the relationship between 
structural and effective connectivity within the BG motor loop, and clinical response. In 
this centre, patients able to tolerate longer sessions in the scanner are currently receiving 
high-resolution pre-operative DTI and MPM scans at 3T to learn more about the impact 
of structural connectivity on clinical status and efficacy of DBS. Additionally, either using 
indices of structural connectivity to guide VOI extraction on a subject by subject basis, or 
informing DCM’s priors of the network’s structural connectivity matrix (Stephan et al., 
2009b) could enhance the modelling process. A sub-group of the second DBS cohort 
reported in Chapters 10 & 11 received these scans, and we are planning to explore these 
relationships in more detail. 
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Related to this point, it is also worth considering the subject-specific current field produced 
by DBS, as opposed to simply assuming DBS is stimulating the same regions at the same 
intensity regardless of stimulation parameters or the patient’s anatomy. This was largely 
ignored in this thesis, despite growing interest in optimising stimulation settings based on 
current fields (Butson et al., 2007; Mikos et al., 2011). The relationship between 
stimulated volume, stimulation settings and resultant effect on effective connectivity in the 
BG should be explored in future studies. 
13.4 Modelling synaptic mechanisms underlying 
neuromodulation 
This subsection specifically addresses more biologically plausible modelling of the finer 
detail mechanisms underlying the modulatory effects of DBS using electrophysiology, not 
fMRI. 
13.4.1 DCM for EEG/MEG & DBS 
Unlike fMRI data, EEG/MEG and LFP datasets have a rich temporal structure allowing 
much more complicated models of cortical and subcortical function to be employed (David 
et al. 2005). Electrophysiological DCMs use physiologically plausible neural mass and 
neural field models, embedding each region with several neuronal subpopulations 
representing key constituents of grey matter (David et al. 2006; Jansen & Rit 1995). Most 
include excitatory pyramidal output neurons, inhibitory interneurons, and excitatory spiny 
input neurons. Intrinsic connections are estimated for each region (in the case of Figure 
13.1; reciprocal connections between the pyramidal and inhibitory interneurons, reciprocal 
connections between the pyramidal and spiny input neurons, and a self-inhibitory 
connection in the inhibitory population). Extrinsic connections are also subdivided into 
forward, backward or lateral connections, each arriving as afferents to different 
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subpopulations in accordance with primate connectivity patterns (Felleman and Van Essen, 
1991). The firing rate of each subpopulation is treated as a hidden state, dependent on the 
average pre-synaptic inputs, post-synaptic membrane potential, and constants summarising 
the biophysical membrane properties. The forward models used to map the neural activity 
to the observed data are discussed in depth elsewhere (see review - Moran et al. 2013). 
Putting aside the elegant mathematics, these DCMs can be used in exactly the same way as 
we have discussed. Importantly, given the additional complexity of the generative models 
employed, these DCMs can furnish estimates of much more subtle parameters than those 
estimated in DCM for fMRI. For example, these DCMs have been applied as a 
“mathematical microscope” to probe neurotransmitter receptor function (Moran et al. 
2011), but can also be used in a similar way to DCM for fMRI to explore extrinsic 
coupling parameters (Marreiros et al. 2012; Moran et al. 2011). In order to gain insights 
into the synaptic mechanisms underlying DBS, future studies should make use of 
developments in DBS electrophysiology that now permit LFP recording during stimulation 
(Eusebio et al., 2011b; Little et al., 2013), and the more complete modelling offered by 
electrophysiological DCMs.  
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Figure 13.1 The relative complexities of modelling fMRI and EEG/MEG/LFP data. (A) The 
basic fMRI model, with a single intrinsic connection, and non-specific extrinsic afferents and 
efferents. (B) The two-state fMRI model containing four intrinsic connections linking the 
excitatory and inhibitory subpopulation. (C) The convolution based ERP and LFP model – an 
example of a biophysical model employed in EEG/MEG/LFP data (adapted from Moran et al. 
2009) - is relatively more complex. Firstly, three subpopulations are modelled with five intrinsic 
connections. Additionally, extrinsic afferents are categorised as either forward connections 
arriving at the input population, backward connections arriving at both the output and 
interneuron populations, or lateral connections arriving at all three populations. All extrinsic 
efferents project from the output pyramidal population. Red populations signify glutamatergic 
cell types, blue populations signify GABAergic cell types. Dashed lines represent extrinsic 
connections, solid lines represent intrinsic connections. INs = interneurons. 
13.4.2 Combining STN LFP and global BOLD 
Additionally, although this may be a long term idea, there are newer generation devices 
coming to market that have the capability of recording LFP data from the DBS target 
during active stimulation, as well as from additionally implanted cortical sources or even 
ECoG sheets. Supposing those devices were similarly compatible with fMRI, and the 
scanner did not significantly impair the recording LFP data, simultaneous neurophysiology 
and fMRI could enable more detailed modelling of the BG motor loop. 
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13.5 A common effect? 
13.5.1 STN DBS and other BG circuits 
One avenue of research that is in fact possible to explore with the current resting state 
datasets would be the effect of STN DBS on other circuits of the cortico-BG (see section 
5.2.2 for introduction on BG loops). For example, STN DBS has been shown to impact on 
both saccade and smooth pursuit eye movements (Antoniades et al., 2012; Nilsson et al., 
2013; Yugeta et al., 2010). Given these findings, it would be interesting to model the 
dynamics of the BG oculomotor circuit, modulation of which may explain the 
improvements noted. The oculomotor circuit’s cortical target is believed to be the FEF, 
projecting to the body of the caudate nucleus (as opposed to the posterior putamen 
modelled in these studies – see Figure 5.1) (Alexander et al., 1986). It would be interesting 
to see if similar effects are produced by DBS on this circuit, despite specific targeting of the 
supero-postero-lateral STN believed to house sensorimotor function (Yelnik et al., 2007). 
Similarly, this could be reproduced with higher-level circuits (DLPFC, OFC and ACC) to 
see if STN DBS produces generalised effects on these circuits. If this were the case, this 
would provide further evidence for a generic effect of DBS on a given target region. 
13.5.2 STN DBS in other diseases 
As voiced in section 12.3.5, it would be similarly interesting to establish whether or not 
DBS has a common mechanism regardless of which disease is being treated. If the effects 
on the BG motor loop are independent of the behaviour executed, so long as the target 
circuit is implicated in the generation of some other symptoms, perhaps its effects are also 
independent of symptoms exhibited? This hypothesis could be tested by scanning patients 
who have received STN DBS for reasons other than PD. STN DBS has been trialled in a 
other conditions, including obsessive-compulsive disorder (OCD) (Chabardès et al., 2012; 
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L. Mallet et al., 2008), as well as a complicated case study of a patient with PD and 
Tourette’s syndrome (Martinez-Torres et al., 2009). 
13.5.3 Different targets, different diseases 
Finally, this work should be extended to characterise the effect of DBS of other targets in 
both patients with PD, as well as other conditions. One obvious cohort to scan would be 
PD patients with implanted GPi, or even Vim DBS electrodes, and explore the effects on 
the BG motor loop (and cortico-cerebellar dynamics) as performed in this thesis. 
Unfortunately, from a pragmatic perspective, both groups would be difficult to scan given 
GPi DBS is typically reserved for PD patients with dyskinesias, and patients with tremulous 
PD are given Vim DBS; both cohorts are likely to move more in the OFF condition, thus 
attention must be paid to the effects of motion on the datasets.  
Extending this beyond PD would be similarly fascinating. At this centre, data has already 
been collected from patients with dystonias receiving GPi DBS36; such data would appeal 
to modelling of the BG motor loop in the manner described in this thesis, or elaboration of 
the circuit to include the GPi, perhaps as a hidden node. Similarly, this centre is currently 
running trials of low frequency DBS of the nucleus basalis of Meynert as a treatment for 
PD dementia and dementia with Lewy bodies (Gratwicke et al., 2013). As part of these 
clinical trials, patients will be receiving both task37 and resting state fMRI during each of 
the blinded stimulation periods, and the current plan is to model the effect of DBS on the 
cortical visual attention network, as well as the effects on the BG motor loop. In addition, 
scanning patients partaking in trials examining hypothalamic DBS for the treatment of 
cluster headache could yield greater insights into its pathogenesis, and DBS’s clinical 
                                                   
36 Not my data - currently being analysed. 
37 Posner’s task of visual attention will be the task undertaken in these patients.  
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efficacy. A summary of diseases that are currently being treated with DBS, and potential 
studies are presented in Table 13.1.  
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Disease Targets  Circuit dynamics of interest 
PD, 
dystonia & 
essential 
tremor 
(ET) 
STN 
GPi 
Vim 
PPN 
These diseases are all thought to involve pathology of the BG motor 
loop, as well as cortico-cerebellar circuitry. Similar modelling to that 
employed in this study would be of great value in characterising the 
modulatory effects of DBS on this circuit, and identify any common 
features. 
Obsessive-
compulsive 
disorder 
(OCD) 
STN 
NAcc 
IPT 
AIC 
OCD is more complicated than the above, due to the variety of the 
possible targets. If STN, surgeons have previously targeted the antero-
medial STN straddling the limbic and associative portions of the 
nucleus (L. Mallet et al., 2008). Volumetric imaging and fMRI studies 
have implicated the OFC and ACC BG loops with the disease, 
including the ventral striatum/NAcc (Ahmari et al., 2013; Bourne et al., 
2012; Lozano and Lipsman, 2013). All four targets are thought to 
alleviate pathological cortico-striatal coupling. Thus it would be 
interesting to model the effects of DBS of either target on this circuit. 
Tourette’s 
syndrome 
(TS) 
GPi 
CM-Pf 
DBS for TS is another potential avenue of research, similarly thought to 
involve pathology of the BG. In contrast to OCD however, the GPi or 
CM thalamus is targeted in these patients. Results from clinical trials 
suggest some benefit in tic reduction (Ackermans et al., 2011). The 
circuit dynamics of interest include the prefrontal and ACC BG loops, 
as well as the motor loop. 
PD 
dementia 
(PDD) & 
DLB 
NBM Clinical trials in this centre and others are in the midst of exploring the 
effect of NBM DBS in patients with dementias. The patients at this 
centre either have PDD or DLB. Both task and resting fMRI is being 
collected during both stimulation conditions. Dynamics of interest are 
diffuse; the theory is that DBS will increase cortical ACh, which has 
widespread neuromodulatory effects (Gratwicke et al., 2013). Patients 
suffer lapses in visual attention, thus the task fMRI is a simplified 
Posner task. In addition, given the proximity of the NBM to the GPi, it 
will be of interest to model the motor BG loop as well. 
Tables continues on next page 
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Alzheimer’s 
disease 
(AD) 
NBM 
Fornix 
Similar to PDD and DLB, AD patients have also enrolled in trials of 
NBM DBS; early results demonstrating safety, increased cortical 
glucose metabolism, and potentially some disease stabilization after 1 
year follow up (Kuhn et al., 2014). Additionally, trials are exploring the 
efficacy of DBS of the fornix. Open label data at 1 year (n=6) suggest 
“possible improvements and/or slowing in the rate of cognitive 
decline… in some patients” (Laxton et al., 2010), as well as increased 
functional connectivity in “two orthogonal networks” (frontal-
temporal-parietal-striatal-thalamic network and a frontal-temporal-
parietal-occipital- hippocampal network) (Smith et al., 2012). 
Major 
Depressive 
Disorder 
(MDD) 
SCC 
NAcc 
ITP 
MFB 
The SCC has been repeatedly implicated in the pathophysiology of 
depression, and is an area of convergence of white matter tracts 
projecting to the brainstem, hypothalamus, and insula, as well as OFC, 
PFC and ACC. SCC DBS reduced hyperactivity in the target in 
responsive patients (Mayberg et al., 2005), with patients doing better 
when their electrodes intersected forceps minor and uncinate fasciculus, 
as well as the cingulum bundle, and projections to subcortical nuclei 
(Riva-Posse et al., 2014). One hypothesised circuit of interest would 
model the dynamics between the PFC, SCC, ACC and ventral 
striatum, and the effect of SCC DBS. 
Table 13.1 Diseases for which DBS has been used (to varying degrees of success), and the circuit 
dynamics that would be interesting to model ON and OFF stimulation. Abbreviations: STN = 
Subthalamic nucleus, GPi = globus pallidus interna, Vim = thalamic ventralis intermedius, 
PPN = pedunculopontine nucleus, NAcc = nucleus accumbens, ITP = inferior thalamic 
peduncle, AIC = anterior limb of internal capsule, CM-Pf = centromedian-parafascicular 
thalamus, NBM = nucleus basalis of Meynert, SCC = subcallosal cingulate area, MFB = medial 
forebrain bundle. For review of DBS in psychiatry see (Lozano and Lipsman, 2013) 
  
 Conclusions  |  259 
259 
14 Conclusions 
Remember that all models are wrong; the practical question is how wrong do 
they have to be to not be useful 
George Box & Norman Draper, Empirical Model Building and Response 
Surfaces, 1987. 
14.1 Advances in the field 
Experiments presented in this thesis demonstrate: 
1. Functional MRI is both safe and feasible in patients with implanted DBS 
hardware under certain MRI protocols. I demonstrate that so long as the 
sequence energy deposition is kept low (<0.4 W/Kg), scanning at 1.5T using either 
the head-transmit/receive coil, or the body-transmit coil with a multi-channel head 
receive coil produces <1°C heating in the DBS system, complying with 
international safety recommendations for intra-cranial heating. Furthermore, we 
did not observe significant differences in heating under different DBS conditions 
during routine fMRI sequences, suggesting that studies contrasting DBS conditions 
should not be confounded by electrode temperature. Additionally, measurements of 
DBS IPG output did not suggest that scanning produced any disruption to the 
programmed stimulation settings, or induced additional components that posed 
any danger to the patient, or significant confounds in fMRI studies. Importantly 
however, while these results enabled the safe collection of data in subsequent 
experiments, the generalizability to other centres of these in vitro experiments 
remains limited, and I stress again that centres seeking to collect fMRI data in 
implanted patients must ensure to collect onsite in vitro data with their scanning 
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protocol. Finally, DBS fMRI presents a number of technical limitations that must 
be considered in the experimental design; not all regions of the brain can be 
recorded from, and future experiments should be tailored to this important 
limitation. This material is presented in Chapter 9. 
2. During voluntary movements, STN DBS increases regional BOLD response 
most potently in M1 and the cerebellum. Increased responses in the insula cortex 
and thalamus were additionally reported, however later experiments using an 
optimised protocol suggest that interactions are most marked in the aforementioned 
regions. These findings are supported by results previously reported in the PET 
literature, and highlight that modulation of BG produce changes in both cortical 
and cerebellar motor processing. We did not observe any statistically significant 
decreases in regional responses under therapeutic STN DBS. This material is 
presented in Chapters 7 & 10. 
3. Modelling STN DBS as a modulator of extrinsic effective connectivity suggests 
that DBS has consistent effects on the BG during both movement and resting 
sessions. These effects include increasing the effective connection strength of the 
(1) direct pathway, supporting rate-based models of BG pathway function and PD, 
(2) cortico-striatal pathway, specifically the M1-putamen connection in these 
studies, (3) thalamic output to the cortex (M1 in these experiments). In contrast, 
DBS decreases the response of the STN to afferent signals from the hyperdirect 
pathway, and the indirect pathway (acknowledging that this latter pathway was 
considerably simplified in this work). In addition, the thalamic response to STN 
activity was similarly reduced by therapeutic stimulation. In relating these changes 
to observed changes in motor symptoms, when considering models only including 
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the BG motor loop at rest, I demonstrate that the strength of the direct and 
hyperdirect pathways, as well as the indirect pathway afferents to the STN have 
significant predictive capacity on contralateral motor impairment. Unfortunately, 
subsequent modelling including cerebellar dynamics (and fewer observations) failed 
to reproduce these predictive relationships; larger studies are required to confirm 
my initial observations. This material is presented in Chapters 8, 10 & 11. 
4. During movement, STN DBS additionally modulates cortico-cerebellar 
dynamics. Finally, during performance of voluntary movements, I demonstrate 
that STN DBS additionally modulates integration within the cortico-cerebellar 
loop; specifically in this case, increasing the cerebellar response to afferents from 
M1. This highlights the role of cerebellum in the production of voluntary 
movements in PD, and potentially reflects a normalisation of task-dependent 
functional integration, although further studies with control cohorts would be 
required to test this hypothesis. During resting sessions, we did not observe 
significant modulatory effects on cortical-cerebellar dynamics, suggesting that these 
modulatory effects are state-dependent, whereas modulatory effects on the BG are 
independent of task or cognitive state. This material is presented in Chapters 10 & 
11. 
14.2 Concluding remarks 
This thesis poses questions of functional integration; in other words, does connectivity 
change under STN DBS, can it be characterised in a group of patients, and is it related to 
the clinical improvements observed? The scientific rationale for the study of connectivity in 
clinical cohorts has recently been reviewed by (Rowe, 2010). To summarise, phenotypes 
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observed in neurological diseases are not solely caused by focal lesions to a specific node. 
Function is dependent on the integration of specialised nodes, thus neurology (and 
psychiatry) is the result of both nodal lesions and what we will term lesions of coupling. 
Biologically, lesions of coupling might result from impaired neurotransmitter function (or 
receptor function), or subtle structural changes in cortical architecture that alters the 
function of the canonical microcircuit. Interestingly, neurodegenerative conditions and 
dementias often involve loss of neuromodulatory neurotransmitters such as DA, 
acetylcholine and noradrenaline, all of which have been hypothesised to alter neural gain in 
some form, i.e. responsiveness to afferent drive (Chance et al., 2002; Eldar et al., 2013; 
Friston et al., 2012; Servan-Schreiber et al., 1990). Studying connectivity (both functional 
and effective) may even be more sensitive to pathology than regional activity alone (Rowe, 
2010; Rowe et al., 2007). The advantage of the effective connectivity methods employed 
herein, as opposed to examining correlations in functional data is that the direction of 
influence can be characterised, and the superadded effect of DBS on this influence can be 
estimated. Furthermore, working within this framework tends to remove speculation often 
voiced in the conclusions of neuroimaging studies. For example, a number of studies have 
documented changes in cortical response following either STN DBS or dopaminergic 
medications (Grafton et al., 2006; Hughes et al., 2010), and subsequently infer that these 
changes are likely caused by downstream changes in BG output, given the anatomy. Under 
the DCM framework, prior beliefs such as the well-characterised structural and functional 
anatomy are embedded in the scientific question, allowing the experimenter to specifically 
pose simple model selection questions such as is the thalamo-cortical output modulated by the 
intervention? These methodological concepts are not new; in fact, some of the earliest 
applications of similar modelling techniques were in PD patients receiving pallidotomies. 
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In that case, surgery was shown to attenuate pallido-thalamic and thalamo-cortical 
connectivity (specifically to the mesial frontal motor areas), as well as changes upstream 
from the lesion (Grafton et al., 1994). 
In this thesis, I present an additional perspective on the mechanism of action of STN DBS 
in PD at the systems level, casting DBS as a modulator of extrinsic effective connectivity. I 
believe further study into the effects of DBS on functional integration in both PD patients, 
and those with other neurological or psychiatric conditions, will enable characterisation of 
its distributed effects, and perhaps one day, rational development of this therapy, based on 
the dynamics of a diseased brain network, and the effects DBS has on said dynamics. 
However, it is always worth remembering that all models are wrong. What I have presented 
in this thesis is an attempt to distil an extremely complex system that produces complicated 
behaviours into a graph of a handful of nodes and edges that the literature has shown to be 
important in PD pathogenesis and DBS efficacy. Obviously, these experiments make a 
number of simplifying assumptions, however, returning to the quote I placed at the 
beginning of this Chapter, is the presented modelling wrong enough to not be considered useful? 
My opinion, unsurprisingly, is no. However, I look forward to further work, from both 
myself, and from others, which challenges and refines the ideas presented herein. 
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